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Abstract 
 Functional dyspepsia is characterized by postprandial fullness, early satiation, epigastric 
pain, bloating, and nausea symptoms in the absence of structural changes in the gastrointestinal 
tract. Numerous works have been performed to identify the peripheral characteristics of functional 
dyspepsia and its association with dyspeptic symptoms, including changes of gastric motility, 
visceral sensitivity, secretion of hormones, functions of immune system. However, the 
pathophysiological mechanisms involved and standard treatment strategies are still lacking. The 
role of the dysfunction of the brain-gut axis and the effect of the food ingestion in the 
gastrointestinal symptoms of functional dyspepsia patients have therefore been attracting more 
interest in recent years. How the food is processed differently in the peripheral and in the central 
nervous system in functional dyspepsia has, however, received little attention in comparison to 
other functional gastrointestinal disorders.  
In this thesis, we used various approaches to examine the physiological and neuronal 
mechanisms in functional dyspepsia patients. We commenced by summarizing previous functional 
neuroimaging studies to establish their limitations. To bridge the resulting research gap, we 
investigated physiological and attentional responses to visual food cues, and measured the altered 
brain activity before and after the food ingestion in functional dyspepsia patients.  
 In the paper I, we reviewed the current status of brain research related to functional 
dyspepsia and were able to clearly show a knowledge gap regarding neural mechanisms of food-
related factors in functional dyspepsia patients. In paper II, we introduced how to design the 
neuroimaging study and interpret the results of it to clinicians. In paper III, we report findings of 
an eyetracking and behavioral study on functional dyspepsia patients. The patients showed 1) 
greater dyspeptic symptoms even after ingestion of a lower calorie and food intake from standard 
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breakfast; 2) decreased pleasantness ratings to food images; and 3) reduced visual attention to food 
images in comparison to healthy controls. In paper IV, we report findings of a functional magnetic 
resonance imaging study during meal ingestion (yoghurt with different fat content and label info) 
in functional dyspepsia patients. The patients showed 1) greater abdominal pain, burning, and 
discomfort after high fat labeled yogurt ingestion than after low fat labeled yogurt ingestion 
irrespective of fat content, 2) increased activity in occipital areas before and after ingestion 
irrespective of fat content and label and increased activity in the middle frontal gyrus before 
ingestion, 3) increased functional connectivity between the insula and the precuneus after ingestion 
of yogurt with low fat label, and 4) greater nausea-related increased functional connectivity 
between the insula and the occipital gyrus after ingestion of high fat yogurt than of low fat yogurt. 
Furthermore, bidirectional influences between quality of life and depression, as mediated by 
dyspeptic symptoms and the impact of food craving on the amplitude of brain activity in the middle 
frontal gyrus, as mediated by depression in functional dyspepsia patients were recorded. In 
conclusion, the abnormal dietary behavior, reduced positive emotional response and visual 
attention to food images, and the role of cognitive perception of fat on the aggravation of dyspeptic 
symptoms should be considered in clinics and in research for functional dyspepsia.  
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1. Introduction  
1.1. Definition of functional dyspepsia 
Functional dyspepsia, the second most common functional gastrointestinal disorder after 
irritable bowel syndrome, is defined as the presence of symptoms localized in the gastrointestinal 
tracts without any structural or systemic diseases that might explain the symptoms [1]. Functional 
dyspepsia patients have a relapsing-remitting course of postprandial fullness, early satiation, 
epigastric pain, burning, nausea, and vomiting symptoms [2]. A large scale epidemiology study 
showed that the prevalence of functional dyspepsia ranges between 11 and 29.2% in general 
population [3] and a systematic review suggested that 20-70% of patients remain symptomatic by 
the end of the follow-up period of 1.5-27 years [4]. Although functional dyspepsia does not increase 
mortality, it should not be underestimated; its high prevalence and chronic nature cause a 
considerable social and economic burden and reduce work productivity in patients [5]. An outsized 
survey estimated that dyspepsia costs 0.5-1 billion pounds each year in the UK [6]. Furthermore, 
functional dyspepsia reduces disease-related quality of life of patients, and somatization, abuse 
history, and depression have been identified as the important risk factors for decreased quality of 
life in patients [7].  
According to the ROME IV criteria [8], the most recent diagnostic criteria for functional 
gastrointestinal disorders, functional dyspepsia comprises postprandial distress syndrome and 
epigastric pain syndrome patients. Postprandial distress syndrome is characterized by meal-related 
dyspeptic complaints, and epigastric pain syndrome refers to epigastric pain and burning symptoms 
which do not exclusively occur after meal ingestion. There is also a considerable overlap between 
postprandial distress syndrome and epigastric pain syndrome patients in clinical practice. The 
definition of postprandial distress syndrome was therefore adapted from the ROME III to the 
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ROME IV criteria to include epigastric pain or burning, belching, and nausea as supportive remarks 
[8, 9]. Furthermore, a large overlap between gastroesophageal reflux disease [10-12], irritable 
bowel syndrome [13, 14], and functional dyspepsia causes challenges in research and in practice.  
 
1.2. Diagnosis  
Diagnosis of functional dyspepsia is challenging since it depends predominantly on 
subjective symptom reports by patients. Following a proposal for a classification for functional 
gastrointestinal disorders in 1990 [15], the first ROME criteria (the ROME I) was developed for 
irritable bowel syndrome in 1992 and for functional gastrointestinal disorders in 1994 [16]. Over 
the past decades, the definition of functional dyspepsia has evolved (the ROME II in 1999 [17]; 
the ROME III in 2006 [9]; the ROME IV in 2016 [8]), and the current standard diagnosis of 
functional dyspepsia is the ROME IV criteria. It comprises of a checklist of subjective symptoms 
with onset, duration, and frequency of symptoms (criteria fulfilled for the last 3 months with 
symptom onset at least 6 months before diagnosis, at least 1 or 3 days per week), and upper 
gastrointestinal endoscopy is also required to locate any structural abnormalities [8]. Subgroups of 
functional dyspepsia were defined as ulcer-like dyspepsia, dysmotility-like dyspepsia, and 
unspecific (non-specific) dyspepsia in the ROME II criteria, and have been divided into 
postprandial distress syndrome and epigastric pain syndrome from the ROME III criteria to this 
day. Furthermore, since a relationship between meal and dyspeptic symptoms has been revealed 
[18], it was described in the ROME III and IV criteria.  
Although the standard criteria already existed, various issues also became the object of 
controversy. First of all, the term functional dyspepsia is not easily understood by patients, and 
clinicians also interpret it in different ways [1]. This may result in misdiagnosis of functional 
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dyspepsia patients as well as of other functional gastrointestinal disorders such as gastroesophageal 
reflux disease or gastroparesis. Furthermore, the definition of dyspeptic symptoms varies in most 
cultures and is also ambiguous. For instance, the term “discomfort” may or may necessarily be 
pain-related [19].  
 
Tests and questionnaires 
Standard diagnosis is based on subjective reports and upper gastrointestinal tract endoscopy. 
Nevertheless, clinicians and researchers have examined Helicobacter pylori infection, gastric 
emptying time with scintigraphy or magnetic resonance imaging, gastric accommodation using 
imaging techniques or drinking/nutrient challenge test, gastric sensitivity using barostat 
(mechanical stimulation) or nutrient infusion (chemical stimulation), and gastric motility using 
manometry or electrogastrography [20].  
In addition to the ROME diagnostic questionnaire, several other questionnaires have been 
developed and validated for functional dyspepsia. The Nepean dyspepsia index questionnaire is a 
validated questionnaire for both functional dyspepsia symptoms and functional dyspepsia-specific 
quality of life [21, 22]. The original version of Nepean dyspepsia index consists of 15 items of a 
symptom checklist that measures the frequency, intensity and level of upper gastrointestinal 
symptoms, 25 items measuring quality of life during the prior 2 weeks, and a further 11 items 
measuring the importance of the above items using a 5-point Likert scale. Another two short forms 
of Nepean dyspepsia index were developed and contain 25 [21] and 10 items [23], respectively. 
Leeds Dyspepsia Questionnaire [24], Hong Kong index of dyspepsia [25], Functional dyspepsia-
Related Quality of Life Questionnaire [26], Leuven Postprandial Distress Scale for patients with 
postprandial distress syndrome [27], Glasgow Dyspepsia Severity Score [28] have been developed 
and validated to measure dyspeptic symptoms and disease-related quality of life. In addition, 
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questionnaires on anxiety, depression, somatization, stress, sleep behavior, eating behavior, and 
other possible comorbidities have also been used depending on the research interests. Recently, 
Fujikawa et al. proposed a new questionnaire – the Naniwa scale – which has not yet been validated. 
It measures pain, burning, gastric acid reflux, fullness and bothersome nausea, belching, heaviness 
(food remains in the stomach for several hours after meals), and bloating symptoms using a 7-point 
Likert scale with an illustration of the eight upper abdominal regions and detailed descriptions of 
each symptom [29]. Since patients might not be familiar with the upper gastrointestinal tract 
anatomy and medical terms of symptoms, this approach would be an excellent opportunity to gather 
more reliable data from patients.  
 
1.3. Pathogenic factors  
Some of the pathophysiological mechanisms involved in functional dyspepsia remain 
unknown, suggesting that various physiological functions, pathogenic factors, and heterogeneous 
symptoms are at work. Symptoms of functional dyspepsia do not affirmatively indicate inherent 
pathophysiology, symptoms and gastric functions are even poorly correlated, and no physiological 
measurements or psychological tests have been validated for functional dyspepsia. So far, our 
knowledge of pathophysiological abnormalities in functional dyspepsia is practically limited to the 
functional abnormalities in the gastrointestinal tract, such as delayed gastric emptying, impaired 
gastric motility and intra-gastric meal distribution, visceral hypersensitivity to mechanical or 
chemical stimuli, changed hormone secretions, and immune cell functions. However, the 
prevalence of impaired gastric functions (particularly gastric accommodation and the gastric 
emptying) did not differ between postprandial distress syndrome and epigastric pain syndrome 
patient groups, nor did it explain symptom severity in patients with functional dyspepsia [30].  
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Since meal-related complaints, dietary behavior, and nutrition intake have become 
interesting topics in functional dyspepsia, more recent studies investigated the role of dietary habits 
in functional dyspepsia. Fat ingestion in particular is a potential factor in dyspeptic symptom 
triggering [31-33]. For instance, in a recent study, the most symptom-related food was fatty food 
(27.1%) followed by hot spices (26.4%) and carbonated drinks (21.8%) in patients with functional 
dyspepsia [32]. However, evidence on the amount, frequency, and composition of nutrients, meals, 
or snacks remains inconclusive.  
Critics recently raised the issue that the stomach and the gastrointestinal system may not be 
responsible for dyspeptic symptoms. Only a small number of studies have investigated the 
psychological characteristics of functional dyspepsia patients and revealed the crucial role of 
anxiety, depression, and somatization [34]. Furthermore, the abnormality of the brain-gut axis (the 
mutual communication between the enteric nervous system and the central nervous system of 
neuronal and hormonal signaling) may be one of the key mechanisms behind functional dyspepsia 
[35]. Indeed, neuroimaging provided new findings on altered functional and anatomical changes in 
the brain of patients. One recent systematic review [36] showed that abnormal brain activity was 
frequently reported in somatosensory cortex, insula, thalamus, prefrontal cortex (sensory 
processing regions), hippocampus, and amygdala (limbic regions) in functional dyspepsia patients 
compared to healthy controls. Functional neuroimaging techniques now enable us to comprehend 
brain activity generated by signals from the gastrointestinal tracts as well as the effect of emotion 
and psychological factors in functional dyspepsia.  
Furthermore, an earlier survey showed a significant effect of a family history in dyspepsia 
patients [37]. The role of genetic factor (G-protein β3 genotypes) in upper gastric symptoms [38] 
and in the impairment of the gastric emptying [39] in functional dyspepsia patients has also been 
demonstrated. It was also proposed that the g-protein β3 and cholecystokinin-A receptor genotypes 
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were involved in the pathogenesis of functional dyspepsia [40]. These findings suggested that 
genetic factors, dietary habits, and eating behavior of family contribute to the pathogenesis of 
functional dyspepsia.  
Gastrointestinal motility, secretions, perception, and immune responses are regulated by 
the enteric nervous system. The latter receives considerable innervation from the autonomic 
nervous system, which is one of the control centers of digestive function. Heart rate variability has 
been measured extensively as a surrogate of sympathetic and parasympathetic activities to evaluate 
autonomic nervous system in patients with functional dyspepsia, and decreased parasympathetic 
activation [41] and vagal activity [42] were reported. However, we do not yet know whether the 
altered autonomic nervous system in patients cause dyspeptic symptoms or impaired 
gastrointestinal functions [43].  
 
1.4. Changes in the gastrointestinal tracts 
Impaired motor function, gastric accommodation, and emptying time  
The gastrointestinal tract processes ingested food by motor functions of the proximal and 
the distal part of the stomach. A dysfunction of the proximal stomach as well as disturbances of 
gastric motor function, impaired gastric accommodation, and abnormal distribution of food in the 
stomach have been studied from an early stage of research in functional dyspepsia patients. The 
proximal stomach relaxes to allow an increase in intragastric volume without an increase of 
pressure. Patients showed a lower antral motor response and gastric relaxation to a test meal than 
healthy volunteers [44, 45]. The hypomotility of fundus may be involved in delaying the gastric 
emptying [46] and impaired accommodation [47]. This remains a controversial issue. Impaired 
gastric accommodation was associated with early satiation in the studies using barostat [48] and 
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scintigraphy [49]. However, other studies found neither impaired accommodation in patients [50] 
nor any association with the symptoms [51].  
Impaired gastric accommodation may be caused by abnormal vago-vagal reflex since the 
accommodation reflex consists of a vago-vagal reflex pathway that affects smooth muscle tone in 
the proximity of the stomach [52]. Since motor neurons within the enteric plexuses control gastric 
motility, the inhibitory innervation may also be related to gastric accommodation. For instance, 
activation of Nitroxidergic pathways and inhibition of cholinergic pathways both contribute to 
gastric accommodation. Moreover, the central nervous system may affect gastric motility, for 
example, anxiety negatively affects the accommodation reflex [53].   
The distal part of the stomach regulates the gastric emptying of food in cooperation with 
the proximal stomach and the small intestine. In a meta-analysis, the gastric emptying is slowed 
down in almost 40% of functional dyspepsia patients [54]. Moreover, fat in the stomach releases 
hormones such as cholecystokinin that increases pyloric sphincter tone and inhibits gastric 
emptying [55]. However, inconsistent results have been reported with regard to the relationship 
between dyspeptic symptoms and delayed gastric emptying in patients. Nevertheless, it is 
conceivable that fullness, nausea, and vomiting are mainly related to gastric emptying [56, 57]. 
Delayed gastric emptying is more frequent in female and low-weighted patients.   
For the assessment of gastric accommodation, the barostat was developed to evaluate 
changes of pressure. Using single-photon emission-computed tomography, a three dimensional 
image of the stomach and its volume could be obtained. Gastric accommodation is determined by 
comparing fasting and postprandial volumes of the stomach. Magnetic resonance imaging and 
ultrasound are also available. The standard method of measuring gastric emptying is using 
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radioactive isotope method (scintigraphy). However, acid breath tests are now more widely used 
since these are non-invasive and without exposure to radiation [56].  
 
Visceral hypersensitivity  
 Visceral hypersensitivity is an increased visceral sensation or a decreased threshold to 
mechanical or chemical stimuli. In functional dyspepsia patients, visceral hypersensitivity has been 
well established in gastric distension or nutrient infusion conditions. Expanding the balloon-type 
barostat in the gastrointestinal tracts, and infusion tests of lipid or acid are the most frequently used 
methods for mechanical and chemical stimuli, respectively. Both the volume of the meal 
(mechanical stimuli) and the absorption of nutrients in the meal (chemical stimuli) may be the main 
factors in meal-related dyspeptic symptoms, activating the mechanoreceptors and nutrient 
receptors responsible for the distension of gastric muscles, feeling of hunger/fullness/satiation, and 
secretion of hormones. A large-scale study using barostat distension showed that 34% of functional 
dyspepsia patients were suffereing from gastric hypersensitivity which was associated with pain, 
weight loss, belching [58] as well as with impaired accommodation [59].  
Multiple studies have shown that functional dyspepsia patients showed higher visceral 
symptoms to the balloon or barostat distension [59, 60], altered brain activities during the balloon 
or barostat distension [61-63], higher nausea symptoms to the acid perfusion in duodenum [64, 65], 
and increased sensitivity to gastric distension after lipid infusion in duodenum [66, 67] than healthy 
controls.  
Since barostat distension technique is invasive, it is unlikely to be used in clinics and is 
more suitable for pre-clinical research. Another point is that the somatic hypersensitivity to 
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cutaneous heat pain stimuli applied to the hand and foot was demonstrated, as well as the visceral 
hypersensitivity, in patients with irritable bowel syndrome [68]. Hyperalgesia to external pain 
stimuli has never been studied in functional dyspepsia. However, it is conceivable that the 
dysfunction of the central nervous system in pain processing leads to the somatic hypersensitivity 
in the functional gastrointestinal disorders. Further studies with regard to the origin of 
hypersensitivity in patients at the level of peripheral neurons in the gastrointestinal tracts, afferent 
neurons in the spinal cord, and subcortical or cortical neurons involved in processing pain signal 
may reveal the pathogenesis of visceral hypersensitivity in functional dyspepsia patients. 
Lipid, carbohydrate, and acid have been infused in gastrointestinal tracts in functional 
dyspepsia patients to measure changes of visceral symptoms and plasma hormone levels after 
infusion. Functional dyspepsia patients showed more prevalent moderate to severe symptoms 
(particularly abdominal pain and distress) during intra-duodenal lipid and dextrose infusions than 
healthy controls, and they were associated with greater plasma level of Glucagon-like peptide-1 
hormone [69]. Several studies have shown greater upper abdominal symptoms in response to lipid 
infusion [66, 70, 71]. However, infusions of nutrient might not induce the same kind of 
physiological responses as oral meal ingestion. Thus, a more recent study used standard meals of 
high fat and high carbohydrate and demonstrated the increased pain and nausea after high fat meal 
ingestion, as well as increased cholecystokinin and decreased peptide-YY in functional dyspepsia 
patients compared to healthy controls [72]. Furthermore, higher nausea symptom and lower motor 
response to duodenal infusion of hydrochloric acid were found in patients with functional 
dyspepsia than in healthy controls [64, 73]. 
 
Secretion of hormones 
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 In response to food, the gastrointestinal tracts produce several hormones and peptides which 
are essential for the digestion of food. Ghrelin is a peptide secreted from the stomach mucosa. 
Secretion of ghrelin is maximized in the fasted state and suppressed by fat and carbohydrate 
ingestion, but not protein. Acylated ghrelin, a biologically active form of ghrelin, increases the 
sensation of hunger and initiates eating behavior by accelerating gastric contraction and emptying 
[74]. The relationship between the acylated ghrelin in plasma level and dyspeptic symptoms was 
significantly correlated [75, 76]. Furthermore, intra-venous injection of ghrelin twice a day for two 
weeks increased daily food intake in a small number of functional dyspepsia patients [77]. 
 Ever since the fat-specific responses in functional dyspepsia have been revealed, scientists 
have been showing increasing interest in the role of cholecystokinin. Cholecystokinin is released 
from entero-endocrine cells by the presence of fat and protein in the small intestine and is regarded 
as the satiety hormone which regulates food intake. Intra-venous injection of cholecystokinin 
produced significantly higher bloating, fullness, and nausea symptoms in functional dyspepsia 
patients than in healthy controls. Furthermore, oral administration of loxiglumide, a 
cholecystokinin-A receptor antagonist, relieved dyspeptic symptoms by intravenous administration 
of cholecystokinin in functional dyspepsia patients [78]. Plasma cholecystokinin level is 
significantly higher before meal ingestion and also increases more significantly after high-fat meal 
ingestion in functional dyspepsia patients than in healthy controls [72]. These findings suggest that 
the enhanced cholecystokinin secretion at the fasted condition and increased release of 
cholecystokinin in response to fat contributes to the pathophysiology of functional dyspepsia. 
 
Infection and inflammation 
 Dysfunction of immune system has been investigated in functional dyspepsia due to the 
fact that a small number of patients develop their symptoms after a gastrointestinal infection. This 
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is known as post-infectious functional dyspepsia. The potential role of an infectious agent in 
functional dyspepsia initially focused on Helicobacter pylori. Although its role in the pathology of 
functional dyspepsia is unclear, Helicobacter pylori infection [56, 79] is still under consideration. 
It causes chronic inflammation in gastric mucosa and affects the production of ghrelin and mast 
cells in infected functional dyspepsia patients [80]. However, the relationship between the infection 
and gastric symptoms in functional dyspepsia patients does not seem to be significant [81]. 
Although the impact of Helicobacter pylori eradication in functional dyspepsia remains a 
contentious issue, it provides symptomatic relief in a small number of patients [82]. A recent 
systematic review reported small effect size of Helicobacter pylori eradication therapy which 
showed no short term benefit. Histologic changes of chronic gastritis did, however, appear to be 
relieved after therapy [83].  
The prevalence of functional dyspepsia was significantly higher in patients with salmonella 
gastroenteritis than in the non-infected population [84], and a recent systematic review showed that 
diverse bacteria and viruses such as Salmonella spp., Escherichia coli O157, Campylobacter jejuni, 
Giardia lamblia, and Norovirus were associated with post-infectious dyspeptic symptoms [85]. 
Post-infectious functional dyspepsia patients showed focal aggregates of T cells and CD8+, 
reduced number of CD4+ T cells, and higher macrophage counts in the duodenum than functional 
dyspepsia patients with unspecific onset [86]. Furthermore, epigastric burning symptom was 
significantly correlated to the degree of histological duodenitis in post-infectious functional 
dyspepsia patients [87]. Changes of inflammatory cells were also reported in non-infected 
functional dyspepsia patients. Increased degranulation and clusters of eosinophils [87-90] and mast 
cells [89, 91, 92] in the duodenum of functional dyspepsia patients have been reported consistently 
in several studies. Investigation of immune cells in functional dyspepsia is a meaningful approach 
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as it shows the possibility of developing the objective measurement for the diagnosis and treatment 
of functional dyspepsia in the future.  
 
1.5. Psychological and cognitive characteristics  
 The psychological aspects of functional gastrointestinal disorders have been reported from 
the mid-1980s and discussed vigorously since the 1990s. Of the many psychological factors 
involved in functional dyspepsia, anxiety and depression have been studied most often. In almost 
all studies, both were found to be more severe in functional dyspepsia patients than in healthy 
controls. Moreover, stress and coping style, psychological distress, sleep dysfunction and 
somatization, history of abuse, and traits such as perfectionism, hostility, and neuroticism have 
been studied in functional dyspepsia [37, 93-100]. Physical abuse history and somatization were 
associated with gastric discomfort threshold and gastric emptying time [101]. Moreover, both acute 
and chronic comorbid anxiety were associated with impaired accommodation in functional 
dyspepsia [102]. Epigastric pain was associated with neuroticism, somatization and abuse [103]. 
However, most of the studies used self-report questionnaires for assessment of psychosocial 
characteristics or the presence of psychiatric disorders rather than structured interviews or clinical 
decision process by well-trained psychologists. 
The cognitive aspect is also involved in the development of dyspeptic symptoms. In an 
early study with a small number of patients, dyspepsia patients were served different muffins with 
or without high fat. Patients could not distinguish between the different muffins by taste and 
dyspepsia did not differ either. [104]. A more recent study also showed the effect of information 
about calorie (high or low calorie) on the level of plasma ghrelin and subjective satiety rating in 
healthy controls [105]. Another study with functional dyspepsia patients showed that a low fat meal 
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– under the pretense that it was high fat meal –caused more severe fullness and bloating symptoms 
than a low fat meal served with the correct fat information in FD patients [106]. This suggests that 
modified information about fat plays a prominent role in causing perceptual dyspeptic symptoms. 
These findings suggest that the effect of fat in gastric symptoms and functions in patients may be 
psychologically mediated and affected by the perception of fat rather than the ingested amount of 
fat. However, the size of impact of the cognitive perception of fat and the ingested amount of fat 
on symptom development needs to be studied further.  
 
1.6. The brain-gut axis 
The enteric nervous system 
The enteric nervous system, also known as the second brain, is located in the walls of the 
gastrointestinal tracts and communicates with the central nervous system via autonomic nervous 
system and vagus nerve. It contains 200-600 millions of sensory, interneurons, muscle motor, and 
secreto-motor neurons [107, 108]. However, its function is highly independent of the central 
nervous system and the autonomic nervous system. It regulates gastric motility [109], exocrine and 
endocrine secretion, and immune system [108, 110]. More than 30 neurotransmitters comprised of 
small molecules (norepinephrine, 5-hydroxytryptamine, etc.), peptides, nitric oxide, carbon 
monoxide, and acetylcholine [108] are involved in this system. It is therefore one of the targets of 
pharmacological treatments in functional dyspepsia. For example, acotiamide, an 
acetylcholinesterase inhibitor that increases acetylcholine release in the enteric nervous system, is 
efficacious for postprandial distress syndrome by enhancing gastric contractility and accelerating 
delayed gastric emptying [111, 112]. Moreover, the gut microbiota, an ecological community of 
commensal, symbiotic and pathogenic microorganisms with a great impact on the gut functions, 
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regulates neuronal functions of the enteric nervous system [113]. Paroxetine enhanced the meal-
induced relaxation of fundus, suggesting that selective serotonin reuptake inhibitor may be 
beneficial to patients with impaired postprandial fundus relaxation [114]. In a recent study of 
changes of neuronal function and structure of enteric nervous system, functional dyspepsia patients 
showed impaired neuronal activity (decreased calcium responses and lower peak amplitude) while 
healthy controls did not. FD also had a higher number of eosinophils and mast cells in submucosa 
plexus than healthy controls [115].  
 
The central nervous system 
Neuroimaging techniques and a growing interest in the psychosocial factors in functional 
disorders have accelerated the studies on the brain-gut axis in functional gastrointestinal disorders 
[116]. In irritable bowel syndrome, the most prevalent functional gastrointestinal disorder, changes 
of prefrontal cortex, somatosensory cortex, anterior cingulate cortex, insula, hippocampus, and 
amygdala activities are known to be associated with clinical phenotypes and symptom severity 
[117]. However, only very few studies have explored the structural and functional changes of the 
brain in functional dyspepsia patients, and conflicting results prevent us from achieving an 
integrative understanding [36]. Furthermore, the neuroimaging technique is an expansive, time-
consuming, labor-intensive experimental tool that requires profound knowledge in physiology, 
pathology, neurology, physics, and program coding skills. As a matter of fact, the methods and 
results of functional neuroimaging studies are practically incomprehensible to people outside the 
field. Since it should provide novel methods of diagnosing and treating patients and improve our 
understanding on the features of the central nervous system in functional dyspepsia patients, it is 
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vital that clinicians and scientists from various fields cooperate with each other to conduct and 
interpret the results of neuroimaging studies [118].   
 
The brain-gut interaction 
 A highly influential hypothesis to explain the functional gastrointestinal disorders is that 
the dysfunction of brain-gut signaling may contribute to these problems. The brain-gut axis is part 
of an interoceptive and homeostatic system and consists of the reward, affective, cognitive, 
sensorimotor systems in the central nervous system, enteric nervous system, autonomic nervous 
system, and vagus nerve. Ascending transmission of the information of visceral sensation and 
environment from the gut through the afferent pathway and descending modulation signals of 
psychological factors from the brain are responsible for gastrointestinal functions and symptoms. 
For instance, satiety and eating behavior [119], and gastric motility [120] are controlled by brain-
gut axis.  
In the neuronal pathways of brain-gut axis, the efferent pathway, consists of preganglionic 
parasympathetic fibers, travels along vagus and pelvic nerves and projects to the smooth muscles 
and enteroendocrine glands in the gut. The afferent pathway transmits the mechanical, chemical, 
and thermal information from the gastrointestinal tracts to the hypothalamus. After the information 
is integrated in hypothalamus, it is projected to several subcortical and cortical regions of brain 
such as thalamus, anterior and posterior cingulate cortices, amygdala, insula, somatosensory cortex, 
and frontal cortex [120].  
The brain-gut pathway may explain how psychological states affect gastric symptoms and 
vice versa. A large scale longitudinal population-based study with a follow-up of more than 10 
years revealed that anxiety was associated with the new onset of functional dyspepsia at follow-up 
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[121], and depression at baseline in a population without functional dyspepsia independently 
predicted dyspepsia symptoms at follow-up [122].  
Recent studies have ascertained that the pathological changes of microbiota in the gut can 
even affect immune system, mind, emotion (especially anxiety and depression, the most common 
psychological problems in functional dyspepsia), cognitive development, and even human 
behavior through the brain-gut axis [123]. The alterations in the microbiota compositions in 
irritable bowel syndrome patients compared to healthy controls have been demonstrated. The 
microbiota may synergistically interact with infection and inflammation and enhance abdominal 
symptoms [124, 125] indicating the possible role of microbiota in functional dyspepsia. This theory 
requires further investigation.  
 
1.7. Food, nutrition, and dietary behavior  
Food is responsible for diverse changes in gastrointestinal tracts including visceral 
sensation, gastric motility, gastric volume, and hormonal release and also induces several 
gastrointestinal symptoms. Furthermore, a long-term negative experience with certain foods in 
functional dyspepsia patients may change the cognitive response to food by operant conditioning 
of food and symptoms.  
The effect of fat in the impaired gastrointestinal sensitivity and symptoms is one of the 
well-known pathophysiological features in functional dyspepsia patients. Following ingestion of a 
high fat meal, nausea and pain symptoms were greater than after a high carbohydrate meal [72]. 
Food diaries revealed that functional dyspepsia patients consumed less fat and that their bloating 
symptoms were related to the amount of ingested fat [126].  
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Eating patterns of functional dyspepsia patients including size and frequency of meals, 
energy intake, and food intolerance have received little attention so far. Evidence showed that a 
smaller percentage of functional dyspepsia patients consumed three regular meals per day. They 
had a lower prevalence of eating large meals, ate snacks more frequently, and had a lower 
consumption of fiber and fat than healthy controls [126-129]. With regard to food intolerance, 
functional dyspepsia patients reported that high fat meals induced or exacerbated their symptoms. 
They exhibited more intolerance towards alcohol, fatty foods, fruits, spices, coffee, etc., than 
healthy controls [128-130].  
However, conflicting results, lack of consented definition of ‘meal’, ‘snack’, ‘frequency’, 
and dyspeptic symptoms, and usage of diaries or questionnaires instead of in-depth interviews are 
the limitations of previous studies. To overcome these limitations, a few studies served fixed 
amounts of real meals to functional dyspepsia patients and investigated the gastric changes and 
meal-related dyspeptic symptoms [18, 131-133]. Furthermore, visual food images are a validated 
experimental tool that has been used to investigate food-related behavior in patients with obesity 
[134], anorexia nervosa [135], and binge eating disorder [136]. In general, food images are 
delivered as reward-related stimuli eliciting positive responses [137]. However, the evaluation of 
the reward value of food and food images, emotional and physiological responses to food and food 
images, and the effect of modification of eating behavior have yet to be demonstrated in functional 
dyspepsia patients.  
 
1.8. Treatment and placebo response 
 Treatment of functional dyspepsia is still unsatisfactory due to the insufficient awareness 
of the disease on the part of both patients and physicians, difficulty in diagnosis, and lack of 
standard treatment guidelines. Therapies for functional dyspepsia have focused mainly on gastric 
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functions and relief of symptoms. Current treatment options include an eradication of Helicobacter 
pylori, prokinetic agents, histamine H2 receptor antagonists and proton pump inhibitors (acid 
suppression medications), tricyclic antidepressants, selective serotonin reuptake inhibitors, 
analgesics, complementary and alternative medicine (acupuncture and herbal medicine), and 
psychotherapies [138].  
Pharmacological treatments which have been tested with regard to their efficacy and safety 
are currently not available for patients with impaired gastric accommodation. However, several 
options may be worth considering. Administration of sublingual glyceryl trinitrate improved 
proximal gastric accommodation and reduced pain, nausea, and total symptom score [139]. 
Sildenafil (used for smooth muscle relaxation) [140], paroxetine (a selective serotonin reuptake 
inhibitor) [141], and buspirone (5-hydroxytryptamine 1A receptor agonist) [142] have been tested 
and proved to increase gastric volume and enhance gastric accommodation, but only in healthy 
controls.  
Current treatment options for functional dyspepsia do not take into account that dyspeptic 
symptoms are induced by food ingestion. To enhance the conventional therapies, a detailed 
interview of their eating patterns should first be conducted by physicians. If required, physicians 
might use the nutrient challenge test to measure meal-related symptoms in patients. On the basis 
of these data, physicians and patients could then discuss their eating behavior and decide how to 
modify it to alleviate their symptoms.  
 Placebo response in functional dyspepsia has been observed in clinical practice and clinical 
trials show that a substantial number of patients, ranging from 13-73%, respond to placebo 
treatment [143]. In an earlier study to determine predictors and contributing factors to the placebo 
response in functional dyspepsia patients, body mass index and the consistency of the most 
undesirable symptoms were found as predictors [1]. In a later study, lower baseline gastrointestinal 
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symptoms and increase of symptoms during the trial, and higher body mass index were found in 
placebo responders than in non-responders [144]. The relatively high response rate to placebo 
treatment in functional dyspepsia patients also shows the possibility of psychotherapies in symptom 
relief.  
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2. Functional neuroimaging studies in functional dyspepsia (Paper I, II) 
Only a small number of studies have addressed the functional brain alterations of functional 
dyspepsia patients and conflicting results have been reported. We aimed to integrate the previous 
neuroimaging results in functional dyspepsia patients and present the important technical and 
practical issues of functional neuroimaging technique to clinicians. This might prompt functional 
neuroimaging studies in functional dyspepsia patients.  
The systematic review (paper I) aimed to 1) find the brain regions assumed to be related to 
functional dyspepsia; and 2) establish a hypothesis of how altered brain activities are derived and 
interact with various factors in functional dyspepsia.  
Sixteen articles were reviewed, and we found functional abnormalities of frontal cortex, 
somatosensory cortex, insula, anterior cingulate cortex, thalamus, hippocampus, and amygdala in 
functional dyspepsia patients. With behavior results, it is conceivable that the changes of brain 
activity of functional dyspepsia patients are induced from the repeated afferent signal from the gut 
and failure of central pain modulation.  
In a second technical review study (paper II), we introduced the basic understanding of 
functional magnetic resonance imaging including the blood oxygen level dependent signal, 
hemodynamic response function, design, analysis procedure and software, and the technical 
terminology.  
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3. Physiological processing of and attentional bias to food images (paper III) 
Chronic negative experience with food in functional dyspepsia patients may have a negative 
influence on the reward value of food and alter the autonomic and emotional response to it. 
Furthermore, food eating behavior and nutrient consumption have been studied in functional 
dyspepsia patients using diaries and questionnaires and need to be examined with the meal 
challenge test.  
Visual food stimuli and the eye-tracking technique, which measures either the fixation of 
gaze or the path of gaze [145], have been used to investigate food-related attentional bias. 
Autonomic response and emotional state might change in functional dyspepsia patients: Attention 
might also be distorted while watching visual food cues. Activity of the autonomic nervous system 
and facial muscle contraction could be measured using skin conductance response, heart rate 
variability, and electromyography. Skin conductance response refers to changes in skin resistance 
in accordance with the activity of sweat glands. Since sweat glands are controlled by the 
sympathetic nervous system, it refers to the activity of sympathetic nervous system. Heart rate 
variability parameters are suitable for measuring different aspects of the autonomous nervous 
system. Face muscles are related to emotional response and several studies have shown that the 
pictures of positive and negative emotion are related to the greater activity of the zygomatic or 
corrugator muscle, respectively [146, 147]. In general, food images are positive reward cues [137].  
We therefore aimed to determine the physiological and emotional responses and visual 
attention to food images after taking an ad-libitum meal. For this purpose, after a standard breakfast 
at which the participants could eat as much as they wished, five sets of high fat food, low fat food, 
positive, negative, and neutral images were presented with skin conductance response, heart rate, 
and facial electromyography measurements. Gaze data was also obtained during the presentation 
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of pairs of images of food and non-food images in functional dyspepsia patients and in healthy 
controls.  
We observed that, in comparison to healthy controls, functional dyspepsia patients 1) had 
a higher food craving, depression, and anxiety score, 2) consumed smaller amounts of food (bread) 
and less calories and reported higher dyspeptic symptoms afterwards, 3) rated less pleasantness to 
both high and low fat food images, 4) showed lower sympathetic activation (ratio between low and 
high frequency components), and 5) fixated less time on food images than non-food images.  
The results show that, despite the increased craving for food, functional dyspepsia patients 
can tolerate only small amounts of food. Decreased visual attention and pleasantness rating to food 
might reflect their disturbed perception of food.  
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4. Neuronal processing of fat and fat label (paper IV)   
Due to the methodological difficulties of delivering a meal during scanning and matching the 
central response with the slow digestive process, the central responses following regular food ingestion 
have rarely been recorded [148]. In functional dyspepsia patients, fat content of food and modified 
information of fat content [106] as well as psychological factors such as anxiety, depression, and abuse 
history [34] influence dyspeptic symptoms. However, previous functional neuroimaging studies have 
discussed the resting state brain activity, brain response to visceral pain stimulation or acupuncture [36], 
and only very few of them examined the effects of anxiety, depression, and abuse history [62, 63, 149-
151]. To date, no neuroimaging studies have been conducted on how the brain processes food and food-
related information and how psychological/cognitive factors influence brain activity in functional 
dyspepsia patients.  
In this study, we used functional magnetic resonance imaging to investigate how cognitive 
modulation of fat information and the amount of fat ingested influences the induction of dyspeptic 
symptoms and brain activities in functional dyspepsia patients. The resting state blood oxygen level 
dependent signal was recorded before and after the four types of yogurt ingestion. Functional dyspepsia 
patients and healthy controls were given a 200ml of high fat yogurt labeled ‘high fat’ or ‘low fat’, low 
fat yogurt labeled ‘low fat’ or ‘high fat’ during each visit (high fat=10%, low fat=0.1% fat). Dyspeptic 
symptoms were measured 4 times using a visual analog scale (to what extent do you feel 
fullness/satiety/epigastric pain/burning/nausea/vomiting).  
We observed that 1) the low fat information relieved the abdominal pain, burning, and 
discomfort symptoms, in both high fat or low fat yogurt condition, 2) the resting state brain activity 
increased in the prefrontal, occipital and decreased in cingulate before yogurt ingestion, 3) resting 
state activity increased after yogurt ingestion in the cerebellum and occipital cortices, 3) functional 
connectivity of the insula-inferior occipital gyrus was higher in high fat condition than in low fat 
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condition and correlated with nausea symptom in functional dyspepsia patients, 4) functional 
connectivity of the insula-precuneus was higher in low fat label condition in patients than in healthy 
controls, 4) the bidirectional influences between the degree depression and disease-related quality 
of life which are mediated by dyspeptic symptoms, 5) there is a mediation effect of depression on 
the influence of food craving to the middle frontal gyrus activity in functional dyspepsia patients.  
The results imply that the fat label has a significant effect on symptom aggravation, food 
craving on the higher cognitive brain region mediated by depression, and symptom (nausea) related 
functional connectivity from the insula to the occipital gyrus as well as on the reward context 
involved in the functional connectivity from the insula to the precuenus. The role of expectation of 
fat content in meals and psychological factors, particularly food craving and depression, may be 
crucial in the somatic symptoms induction and in the altered brain activity in functional dyspepsia 
patients.  
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5. Paper I. Functional neuroimaging studies in functional dyspepsia patients: 
a systematic review 
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Key Points
• By summarizing earlier functional neuroimaging studies, this systematic review proposes the FD-related brain
regions and direction of future research.
• The functional abnormalities of frontal cortex, somatosensory cortex, insula, ACC, thalamus, hippocampus,
and amygdala were reported in FD.
• Various neuroimaging tasks, interventions, precise diagnosis, and measurement of psychological factors could
improve our understanding of FD.
Abstract
Background There is increasing evidence in support of
the presence of abnormal central changes (compared
to healthy controls) in functional dyspepsia (FD) in
addition to the peripheral changes in gastrointestinal
tract. Purpose This systematic review aims to provide
an integrative understanding of the abnormal func-
tional brain activity, visceral sensation, dyspeptic
symptoms, and psychological changes of FD. Elec-
tronic and hand searches were conducted to identify
functional neuroimaging studies involving FD
patients. Sixteen studies were selected and divided
into three categories: 10 resting state studies, three
visceral distention studies, and three acupuncture
studies. Changes were reported in several brain areas
in FD patients including the frontal cortex,
somatosensory cortex, insula, anterior cingulate cor-
tex, thalamus, hippocampus, and amygdala. These
brain activity changes were associated with visceral
hypersensitivity, dyspeptic symptoms, poorer quality
of life, anxiety, and depression. The results show that
FD is associated with functional abnormalities in
sensory and pain modulation, emotion, saliency, and
homeostatic processing regions. The diversity of con-
ditions, heterogeneous results, poorly standardized
diagnoses of FD, and various comorbidities may be
responsible for the variability in the results.
Keywords brain imaging, fMRI, functional dyspepsia,
PET, systematic review.
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INTRODUCTION
Functional dyspepsia (FD) is defined as the presence of
symptoms believed to originate in the gastroduodenal
regionwithout the evidence of any organic, systemic, or
metabolic disease that might explain the symptoms.1
Functional dyspepsia patients suffer from postprandial
fullness, early satiation, epigastric pain, and burning.2
This problem has now come into focus due to its high
prevalence in the general population (11–29.2%),3
unknown mechanism, heterogeneity of pathogenic
factors and symptoms, poorer quality of life (QOL),
and absence of management strategies. In addition to
the studies on peripheral abnormalities (hypersensitiv-
ity, abnormal accommodation, gastric dysmotility), a
hypothesis from the early 1990s proposed that abnor-
malities of the brain-gut axis (biochemical/neural
communication system between the gut and brain) are
one of the driving mechanisms behind FD.4 The
development of neuroimaging techniques and emerging
evidence of the importance of psychosocial factors have
also contributed to the study of the brain-gut axis
impairment in functional gastrointestinal diseases.5
The thalamus, secondary somatosensory cortex (SII),
prefrontal cortex (PFC), insula, and anterior cingulate
cortex (ACC) all receive signals from the gastrointesti-
nal tract via spinal or vagal afferents and process the
sensory, affective, and cognitive information of visceral
sensation.6 The thalamus receives signals from the
periphery and relays them to the insula, PFC, motor,
and somatosensory area, the so-called visceral pain
network.7 Unlike the somatic sensation with its clear
representation in the primary somatosensory cortex
(SI), the visceral sensation is vaguely localized and
diffused8 and may be more strongly associated with the
SII.6 Furthermore, visceral sensation is closely related
to the insula; a hub region responsible for the intero-
ceptive function.9,10 Insula, a monitoring center of our
cognitive, affective, and homeostatic systems, is also
considered to be a key region of salience network (the
brain network of identifying the item among several
stimuli to guide behavior11) with ACC.12 Anterior
cingulate cortex is involved in the motivation and
motor aspect of visceral sensation, while insula is
involved in the sensory part,10 and pain modulation.13–
15 Prefrontal cortex is implicated in the attention and
appraisal of stimuli and located in the highest hierarchy
of visceral sensory network.6,16 In short, thalamus and
somatosensory cortex (SI and SII) are mainly associated
with the first-order process of sensory information,
whereas PFC, insula, and ACC tend to be rather
associated with the higher order process of cognitive
evaluation, attention, sensory-motor integration, and
affective response.6,16 In irritable bowel syndrome (IBS),
one of the functional gastrointestinal disorders, changes
of PFC, somatosensory cortex, insula, hippocampus,
and amygdala activity are known to be associated with
clinical phenotypes and symptom severity,17 and vari-
ous brain networks, including sensory and salience
networks might be relevant.18 However, only a small
number of studies have addressed the functional brain
alterations of FD patients, and conflicting results hinder
the development of an integrative understanding.
This systematic review aims to (i) provide a com-
prehensive survey of the core brain regions assumed to
be related to FD, (ii) establish a brain-gut axis model of
how altered brain activities are derived and interact
with various factors and clinical changes, and (iii)
propose the direction of future research by summariz-
ing current functional neuroimaging studies.
METHODS
Paper search
We used a systematic search strategy that followed the PRISMA
guidelines for systematic reviews. Electronic searches were
conducted in PubMed, EMBASE, MEDLINE, and Cochrane
Library using the keywords ‘FD’, ‘neuroimaging’, ‘functional
magnetic resonance imaging (fMRI)’, and ‘positron emission
tomography (PET)’. Search terms and methods were modified for
individual databases (Table S1). Hand searching was performed by
screening the reference lists of articles that met the inclusion
criteria. The literature search was completed in October 2015.
Study selection and data extraction
Search results were screened on the basis of the title and abstract
before the full text was assessed. Neuroimaging studies, including
FD patients regardless of their characteristics (e.g. diagnosis,
symptoms, age, gender, etc.) and imaging conditions (e.g. resting,
distention, medical intervention, etc.), were incorporated.
We retrieved the first author’s name, year of publication,
characteristics and number of participants studied, subgroups of
FD patients, imaging modality and conditions, analysis methods,
behavioral outcomes (Table 1), and results of the brain imaging
data (Tables 2 and S2). Results of behavioral and clinical out-
comes are summarized in the text.
RESULTS
Study selection and description
Our research strategy retrieved a total of 314 articles,
104 of which were duplicates. These were discarded
together with a further 194 after screening the title and
abstract. Sixteen articles met the inclusion criteria and
were incorporated in the systematic review (Fig. 1).
All articles19–34 were published between 2007 and
October 2015 (Table 1). We distinguished two research
© 2016 John Wiley & Sons Ltd2
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groups (Group 1: Studies 1, 3, 4; Group 2: Studies 2, 5–
16), on the basis of authors and affiliations. Group 1
focused on the central processing of visceral stimuli (by
distention of a gastric balloon) in FD patients using
PET in comparison to healthy controls (HC). The
influence of moderating variables (anxiety, gastric
sensitivity, and abuse history) on brain activity in FD
subgroups (normosensitive/hypersensitive and abused/
non-abused) was also investigated. Group 2 reported
resting state activity (n = 10) and brain activity fol-
lowing acupuncture (n = 3) with fMRI. Group 2 applied
several analysis methods for resting state activity,
including whole brain, region of interest, correlation
analysis with behavioral outcomes, functional connec-
tivity, (functional) amplitude of low-frequency fluctu-
ations ((f)ALFF), independent component analysis
(ICA), multivariate pattern analysis (MVPA), regional
homogeneity (ReHo), and topological brain network
analysis. They also measured the resting state brain
response before and after the acupuncture treatment,
and during the acupuncture stimulation.
Participants
A total of 504 FD patients (460 of whom participated in
the neuroimaging scan, 181 males) and 294 HC (120
males) were investigated. Twelve studies included FD
patients between 20 and 30 years of age only, and the
mean age of patients in the other four studies (in which
the inclusion criteria for the age was not stated) ranged
from 22.5 to 35.1 years. The mean duration of FD
symptoms or diagnosis ranged from 15.25 to
82.78 months. Thirteen studies (all by Group 2)
included FD patients who met the Rome III diagnostic
criteria for functional gastrointestinal disorders,2 and
10 of these studies contained postprandial distress
syndrome patients only (one of the subgroups of FD
patients in accordance with the Rome III criteria).
Five studies divided FD patients into subgroups
(Studies 4–6, 13, 15). Among the three gastric disten-
tion studies, Study 1 included FD patients with
visceral hypersensitivity, and Study 4 divided FD
patients into normo- and hypersensitive or abused
and non-abused groups. To identify the symptom-
related functional brain activity, patients were divided
into milder (or less severe) and severe (or more severe)
groups in Study 5 and 13. In Studies 6 and 15, patients
were divided by the score of anxiety and depression
(AD). In Study 7, FD patients were randomly assigned
into two groups for acupuncture and sham acupunc-
ture treatment.
With the exception of Studies 1, 3, 4, 6, and 7,
healthy volunteers were used in the other studies asT
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the control group for FD patients. In Study 1 and 3, the
demographic, behavioral, and brain data of FD patients
were compared with the HC of a previous study.35 In
Studies 4, 6, and 7, the data of FD subgroups without
HC group were compared.
Imaging modality, analysis, and conditions
Functional magnetic resonance imaging is the most
frequently applied brain recording technology (n = 8).
This is followed by PET-CT (n = 5) and PET imaging
(n = 3). PET and PET-CT studies conducted whole
brain analysis and correlation analysis with behavioral
data. Functional magnetic resonance imaging studies
performed analyses of the whole brain, functional
connectivity, (f)ALFF, ICA, MVPA, ReHo, and topo-
logical brain network analysis.
Behavioral and clinical outcomes
Fourteen studies reported behavioral and clinical out-
comes, while two acupuncture studies (Studies 2, 14)
reported brain imaging data only. The behavioral
outcomes were classified into three categories: somatic
symptom, FD symptom, and psychological outcomes.
Somatic symptom outcomes Somatic symptom out-
comesweremeasured in three distention studies (Studies
1, 3, 4) as balloon distention threshold (pain or unpleas-
antness), gastric sensation, or on a visual analog scale for
pain, discomfort, nausea, and bloating during distention.
Gastric sensation during baseline, distention, and sham
distention were higher in FD patients than in HC in one
study, with lower distention pressure (Study 3). Gastric
sensation was higher in the hypersensitive and the
abused group than in the normosensitive and the non-
abused group, respectively (Study 4). Distention pressure
thresholdwasalso lower in thehypersensitive than in the
normosensitive group, but did not differ between the
abused and non-abused groups.
FD symptom outcomes Functional dyspepsia symp-
toms were measured in twelve studies. The Nepean
dyspepsia index (NDI) was reported in six studies (Study
Table 2 Brain imaging data of frequently reported brain areas
FD vs HC FD subgroups
Resting
Sham
distention Other conditions Resting Distention>baseline
SI/SII ↑(5, 15)
Interhemi FC↑(8)
↓(3) ↓Distention>baseline(3) – Normosensitive>
hypersensitive(4)
PFC ↑(5, 10, 15)
Interhemi FC↑(8)
ReHo↑(13)
↓(3) ↓acupuncture(14) Abused>non-abused(4)
Severe>milder(5)
AD>non-AD(6, inf)
Non-AD>AD(6, sup/med)
Non-abused>abused(4)
OFC ↑(5, 15)
↓(2, 10)
ReHo↑(13)
↓(3) ↓acupuncture(14) –
Insula ↑(5, 10, 15)
Interhemi FC↑(8)
fALFF↑(9)
↓(3) ↑acupuncture(14) Severe>milder(5)
AD>non-AD(6)
ACC ↑(5, 10, 15)
↓(2)
Interhemi FC↑(8)
ReHo↑(13)
FC with OFC↑(13)
FC with insula, PFC↓(13)
– ↓acupuncture(14) Severe>milder(5)
Thalamus ↑(5, 10, 15)
Interhemi FC↑(8)
ReHo↓(13)
FC with cerebellum(9),
PFC(med, 13)↑
FC with insula, PFC
(inf/mid/sup)↓(13)
– Severe>milder(5)
AD>non-AD(6)
Hippo/amygdala ↑(15) – ↑Sham>baseline(3) Non-abused>abused(4) Abused>non-abused(4)
ACC, anterior cingulate cortex; AD, anxiety and depression; fALFF, functional amplitude of low-frequency fluctuations; FC, functional connectivity;
FD, functional dyspepsia patients; HC, healthy controls; Hippo, hippocampus; inf, inferior; intermehi, interhemispheric; med, medial; mid, middle;
OFC, orbitofrontal cortex; PFC, prefrontal cortex; ReHo, regional homogeneity; sham, sham distention; SI(II), primary (secondary) somatosensory
cortex; sup, superior; (), study number; ↑, greater than healthy controls; ↓, lower than healthy controls.
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8–13), dyspepsia symptom score (DSS) in four studies
(Studies 3, 4, 6, 16), the symptom index of dyspepsia
(SID) in two studies (Studies 5, 7), and one study
reported symptoms on a 4-item custom score (Study
15). Somatization severity was also measured with the
Patient Health Questionnaire (PHQ-15) in Study 4. The
NDI questionnaire, whichwas themost frequently used
questionnaire for FD symptom assessment in this
review, could record both FD symptoms and FD-specific
QOL and was validated.36,37
Functional dyspepsia symptom scores were higher in
FD patients than in HC. Functional dyspepsia symp-
tom scores were also higher in the severe (or more
severe) groups than in the milder (or less severe) groups
and in the AD group than in the non-AD group,
respectively (Studies 5, 6, 13). Both the AD and the
non-AD groups showed higher symptom scores than
HC (Study 15). The DSS and PHQ-15 scores correlated
with gastric sensation during baseline, distention, and
sham distention. PHQ-15 scores—but not DSS—were
higher in the hypersensitive than in the normosensi-
tive group (Study 4).
Functional dyspepsia symptom scores before and
after acupuncture treatment are shown in Study 7.
Symptom index of dyspepsia scores for postprandial
symptoms and NDI-QOL scores improved after both
acupuncture and sham acupuncture treatments,
whereas SID scores for early satiety improved in the
acupuncture group only.
Psychological outcomes The influence of psychologi-
cal factors in FD symptoms was reported in all but the
three acupuncture studies. Zung self-rating anxiety
scale (SAS) and Zung self-rating depression scale (SDS,
Studies 5, 6, 8–13, 15, 16), state-trait anxiety inventory
(STAI, Studies 3, 4), PHQ-9 (Study 4), and the level of
anxiety and tension during distention (Study 1) were
reported. Quality of life (NDI-QOL, Studies 5–11, 13,
15), abuse history, and somatization (PHQ-15, Study 4)
were also measured.
Although anxiety and depression scores were higher
in FD patients than in HC (Studies 5, 8–12, 16), no
differences were found between normosensitive and
hypersensitive, or between abused and non-abused
groups (Study 4). No differences were detected between
the milder FD and severe FD patients in Study 5, but
higher scores were observed in the more severe than in
the less severe group (Study 13). Quality of life scores
were higher in HC than in FD patients (Studies 10, 11),
in the milder (or less severe) than in the severe (or more
severe) group (Studies 5, 13), in HC than in the non-
AD, and, finally, in the non-AD than in the AD group
(Studies 6, 15).
Brain imaging data
Brain data can be divided into three main categories:
resting state activity, activity following gastric disten-
tion, and activity with acupuncture. Resting state activ-
ity includes the results of resting state or baseline
conditions in studies except Study 3, due to the balloon
in the stomach during baseline. Activity following
gastric distention includes brain response during the
distention of a balloon in the stomach and sham
distention (information about distention without actual
distention).Activitywith acupuncture refers to thebrain
activity before and after, or during the acupuncture and
sham acupuncture. The activation of the most fre-
quently reported brain areas, frontal cortex, somatosen-
sory cortex, insula, ACC, thalamus, hippocampus, and
amygdala, are summarized in Table 2. We made no
distinction between the data of PET/PET-CT and fMRI,
and the statistically significant results of each study are
described with the corresponding p-values.
Resting state brain activities Ten studies (Studies 5, 6,
8–13, 15, 16) performed resting state brain imaging and
one study (Study 2) reported baseline data. According to
the resting state brain analyses, the activation of the
PFC, somatosensory cortex, insula, and thalamus was
Figure 1 Flow diagram of literature search.
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consistently greater in FD patients than in HC, while
brain activities of the orbitofrontal cortex (OFC) and
the ACC are inconsistent. The severe FD group showed
higher activity in ACC, midcingulate cortex (MCC),
insula, thalamus, and cerebellum than the milder FD
group (Study 5). The AD group showed higher activity
in SI, insula, thalamus, and parahippocampal gyrus,
and lower activity in frontal cortices and MCC than
the non-AD group (Study 6).
Functional dyspepsia patients showed higher inter-
hemispheric connectivity (synchronized activity
between the same brain areas in opposite hemispheres)
of ACC, insula, thalamus, and cerebellum than HC
(Study 8). Pattern classification analyses were also
applied to distinguish FD patients from HC. Classifica-
tion accuracy was sufficiently high, and discriminative
regions were the medial PFC, OFC, ACC, MCC, insula,
thalamus, hippocampus, and cerebellum based on
MVPA pattern classification. Anterior cingulate cortex
and thalamus distinguished FD from HC, or less severe
from more severe FD, respectively (Studies 11–13). In a
recent study (Study 16), a new approach to topological
changes of the brain network revealed a higher cluster-
ing coefficient and local efficiency in FDpatients than in
HC. Furthermore, nodal efficiency in the ACC was
found to be positively correlated with dyspeptic symp-
tom and duration.
Seven studies performed correlation analyses
between resting state brain activity and behavioral
measures (Studies 5, 9–13, 15). A positive correlation
between ACC activity and symptom score was
observed in four studies (Studies 5, 10, 12, 13). Anxiety
scores positive correlated with ACC, MCC, and insula
in Study 15 only. Depression score and FD duration
correlated poorly with brain activity in five studies
(Studies 9–12 and 15).
Distention-related brain activities The three disten-
tion studies were conducted by Group 1 and therefore
had similar balloon distention procedures (Studies 1, 3,
4). The ventral PFC, OFC, SI, and temporal lobe were
commonly activated during the balloon distention.
Significant correlations of upper abdominal sensations
with these areas were reported (Study 1). Study 3
reported a deactivation during distention in dorsal PFC,
medial OFC, ACC, hippocampus, amygdala, and sev-
eral regions in the parietal, temporal, and occipital
lobes in FD patients.
Group comparison of [distention>baseline] condition
revealed that activity in the mid brain, cerebellum, and
dorsal pons was greater, and activity in SI and SII was
lower in FD patients than in HC (Study 3). The
normosensitive group showed greater activation in
SII, MCC, and precuneus than the hypersensitive
group. Functional dyspepsia patients with an abuse
history showed greater activation of the hippocampus,
parahippocampal gyrus, and amygdala, and lower acti-
vation of dorsal PFC, insula, caudate, and cerebellum
than the non-abused group (Study 4).
Sham distention did not elicit any brain (de)activa-
tion in FD patients (sham distention vs baseline), but
in comparison with HC, FD patients showed higher
hippocampus and amygdala activity under [sham dis-
tention>baseline] condition (Study 3).
Acupuncture-related brain activities The initial
acupuncture study (Study 2) compared the resting state
of FD patients before and after the acupuncture
treatment. The second study (Study 7) compared the
influence of acupuncture and sham acupuncture, while
the third study (Study 14) compared the brain response
during acupuncture stimulation in FD patients and
HC.
After five sessions of manual acupuncture, brain
activity in FD patients increased in PFC and pre-
cuneus, but decreased in SI, pons, and cerebellar tonsil
(Study 2). After 20 sessions of electro-acupuncture,
brain activity in FD patients increased in SI and
precuneus, but decreased in anterior/mid/posterior
cingulate cortex, insula, thalamus, putamen,
hippocampus, and cerebellum (Study 7). The inconsis-
tent results from these two studies might be due to the
different characteristics of FD patients, stimulation
type (manual or electro-), number of sessions, or
comparatively small sample size. Correlation analysis
showed that changes of ACC, insula, thalamus,
hypothalamus are positively correlated with changes
of symptom score, and negatively correlated with
changes of QOL score in the acupuncture group. In
the sham acupuncture group, changes of QOL score
were negatively correlated with fewer areas than the
acupuncture group that included thalamus and brain-
stem (Study 7).
During manual acupuncture stimulation at the
acupoint ST36, FD patients showed greater brain
activity in SI and insula, and lower activity in PFC,
OFC, and ACC than HC (Study 14).
DISCUSSION
Sixteen articles were taken into consideration in this
review and functional brain activity (resting state,
visceral distention, acupuncture conditions) and
behavioral/clinical outcomes were measured. The
abnormal brain activity was frequently found in SI,
PFC, insula, ACC, thalamus, hippocampus, and amyg-
© 2016 John Wiley & Sons Ltd 7
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dala. When compared to HC, FD patients showed
greater activation in PFC, insula, cingulate cortex, and
thalamus during the resting state, and altered activa-
tion in the somatosensory cortex, OFC, hippocampus,
and amygdala during distention and acupuncture-
related conditions. According to the pattern classifica-
tion analysis, FD patients and HC could be distin-
guished using the activity pattern of ACC and
thalamus. The behavioral data showed that FD
patients experienced visceral hypersensitivity (low
balloon distention threshold with higher gastric sen-
sation/pain) during the balloon distention. Further-
more, the anxiety and depression scores were higher in
FD patients than in HC, and QOL scores varied on the
FD symptom severity, anxiety, and depression scores.
Visceral sensations are involved in the ascending
visceral pain pathway and processed in the somatosen-
sory cortex.6,38,39 The somatosensory cortex activity
during both the resting state and visceral distention
was higher in FD patients than in HC. Moreover, brain
activity during acupuncture (external somatic stimu-
lation) also showed a greater increase in SI activity in
FD patients than in HC, implying that the hypersen-
sitive to somatic stimulation like IBS patients.40 The
increased activity of somatosensory cortex—even in
the absence of visceral stimulation—could support the
hypothesis of cortical sensitization in FD patients.41,42
Central sensitization, increased brain response to
various stimuli, may be one of the underlying patho-
physiologic features in fibromyalgia, migraine, IBS, and
FD patients.42 Since FD is a chronic disease,
somatosensory cortex receives afferent ascending vis-
ceral pain signals from internal organs repeatedly and
consequent sensitization of the brain could result in an
abnormal central modulation of sensory information
and peripheral abnormalities such as visceral hyper-
sensitivity. However, FD symptoms during resting
state measurement, which could affect the brain
activity, were not reported in any studies. The sensi-
tization hypothesis therefore still requires further
confirmation. Unlike the resting state activities, HC
showed a higher somatosensory cortex activation than
FD patients in [distention>baseline] and [sham disten-
tion>baseline] conditions. This could be due to the
increased activity in resting state (ceiling effect),
attenuated increase from chronic visceral sensation
in FD patients, or different visceral distention pressure
between groups (lower in FD patients). Although
visceral distention pressure was lower in FD patients
than in HC, this is not enough to explain the increase
in somatosensory cortex activation in HC in [sham
distention>baseline] condition. This is worth bearing
in mind as evidence of abnormal sensory processing in
FD patients. Further research on the sensitization or
attenuation of brain activity during resting or internal/
external stimuli is required to gain an understanding of
sensory processing in FD patients.
The frontal cortex is associated with executive and
integrative control functions. The integration of infor-
mation from peripheral, cognitive modulation of pain
(medial, dorsolateral), and appraise or response to
affective aspect of pain sensation (medial, ventrolat-
eral) are processed in the PFC.5,43,44 Orbitofrontal
cortex is also involved in cognitive pain modulation,
inhibition of pain-related emotional response, sensory
discrimination, and monitoring,45–47 and is closely
related to psychological disorders such as anxiety48
and depression.49 It is also associated with the
endogenous opioid analgesia systems in conjunction
with ACC.15 The activation pattern of PFC is similar
with somatosensory cortex during resting (FD>HC)
and sham distention conditions (HC>FD), whereas
PFC activity did not differ from HC during distention
despite low distention pressure in FD patients. One
may speculate that this is due to an overlapping
influence of chronic ascending sensory processing,
cognitive and descending pain modulation, attention,
and anticipation for visceral sensation on the frontal
cortex activity in FD patients. However, in contrast to
the previous studies which showed the close connec-
tion between OFC and anxiety or depression,48,49 the
relation between psychological factors and OFC activ-
ity was not observed in the current review.
Insula, ACC, and thalamus were already in the focus
of early functional gastrointestinal disease studies. The
insula is involved in interoceptive processing, homeo-
static function, emotion, affective state, and aware-
ness.10,50 In our review, the insula is activated during
visceral distention in FD patients ([distention>base-
line]), where it showed greater activation than in HC
during baseline and sham distention in all but one
study. This implies that the abnormal excitement of
the insula could be derived by the residual influence of
chronic visceral sensation, psychological state, home-
ostatic imbalance (supported by greater brain activa-
tion in FD than in HC in the baseline condition), and
anticipation of distention (supported by comparison in
the sham distention condition) in FD patients. ACC,
one of the core regions of medial pain system, is
particularly important for cognitive pain modulation,
attention to pain, endogenous opioid system-related
placebo analgesia, and regulating the affective compo-
nent of pain experience.13–15 Various analyses, includ-
ing whole brain, interhemispheric functional
connectivity, topological brain network, ReHo, classi-
fication, and correlation analysis reported the abnor-
© 2016 John Wiley & Sons Ltd8
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mal functional activity of ACC in FD patients. It is
feasible that the altered activity of ACC causes
diminished central pain modulation and subsequent
hypersensitivity in FD patients. Although various
functions and distinct neuroanatomical regions within
the insula and the ACC are not covered in this review,
it is still important to note that the insula is not a
homogeneous region,51 and neither is the ACC.52
The role of the limbic area (hippocampus, amygdala,
hypothalamus, parahippocampal gyrus, etc.) has been
discussed in termsof pain sensitivity, stress, andanxiety
in IBS patients.53,54 In particular, the studies evaluated
in this review reported a coactivation of hippocampus
and amygdala in FD patients. Amygdala is associated
with the emotional memories with hippocampus, emo-
tional evaluation of sensory stimuli, recognition of
emotion, and nociceptive pathway.55–58 In FD patients,
the activity of amygdala and hippocampus could be
interpreted as the anticipationor response to thevisceral
stimuli, and the recall of previous negative memories
(pain, unpleasant, anxiety, etc.). Furthermore, the vol-
ume and synaptic changes of hippocampus and amyg-
dala by chronic pain59,60 could also affect the functional
activity in FD patients. Greater activity is recorded in
these regions in FD patients than in HC during both
sham distention and [distention>baseline] condition
and in abused than in non-abused group, supporting
the hypothesis that negative emotional memory influ-
ences brain activity in FD patients.
On the basis of our results, it can be assumed that
the changes of brain activity, response to visceral
stimulation, and cognitive state of FD patients are due
to the repeated afferent signal from the periphery and
failure of central pain modulation leading to the
dysfunction of the pain (SI, SII, ACC, insula, thalamus,
amygdala) and salience network (ACC and insula). The
evaluation, integration, and response to salient stimuli
were altered in chronic pain and IBS patients.11,61–63
Moreover, a saliency of stimuli varies according to the
emotional state and pathological condition. We can
therefore also assume that the visceral sensation,
dyspeptic symptoms, emotion, and cognitive process-
ing of dyspeptic symptoms have different saliency in
FD patients than in HC. In summary, we propose that
FD, like IBS, can also be considered as the functional
chronic pain syndrome in which pain and salience
processing are impaired64,65 and that the ACC and
insula play critical roles in FD.66 Constant sensory
signal from the gut (bottom-up) and abnormal central
modulation (top-down) of pain and gut functions might
be key features of FD, showing that peripheral changes
could originate from abnormal brain activities through
the brain-gut axis (Fig. 2).
By summarizing previous neuroimaging studies, we
also suggest further research of FD. Since only two
research groups have performed functional neuroimag-
ing studies in FD patients, this review could poten-
tially be biased. In addition to the limited number of
research groups, there is still a lack of appropriate
tasks. In early studies, visceral distention was applied
to patients and healthy participants to investigate the
visceral sensitivity-related activation of the brain.
However, balloon distention is invasive and further
peripheral changes are also related to the FD. Differ-
ent kinds of tests such as water load test or real food
intake are therefore required. Although FD patients
have increased dyspeptic symptoms after eating
food,67 neuroimaging studies during or after food
ingestion are relatively rare compared to those on
obesity or IBS patients. New paradigms to overcome
the practical problems involved (e.g. discomfort and
dyspeptic symptoms of patients during food ingestion,
amount and type of food) could augment our under-
standing of FD. Furthermore, the only intervention in
which neuronal mechanism in FD has been investi-
gated is acupuncture, and careful interpretation is
necessary due to the poor reliability and validity of
sham acupuncture.68 Although acid-suppressive
drugs, prokinetic agents, antidepressants, and psy-
chotherapy are prescribed for FD patients, various
phenotypes of patients and unknown underlying
mechanisms often disrupt the standardized treatment
strategy. Neuronal mechanism studies could therefore
be helpful. Moreover, the improved and unified
methods of measuring the psychological factors in
FD, such as more specific definition (e.g. trait or state
anxiety, anxiety for symptom or experimental envi-
ronment, anxiety of present or previous week) and
well-structured interviews rather than self-rating
questionnaires are also important.69 It is also worth
investigating further psychological, behavioral, and
lifestyle factors, including somatization,42,70
stress,71,72 fatigue,73 food behavior,74 sleep behavior,
and comorbidities (IBS, other functional pain syn-
drome diseases, anxiety, depression). Finally, a more
representative sample of FD patients should be
included in further studies. In this review, although
diagnoses of FD usually depend on Rome III criteria, a
number of studies did not describe the diagnostic
procedure. Although the peak prevalence of FD is
distributed around the middle age,3 many studies
included only patients in their twenties. Representa-
tive and homogenous sample recruitment, where age,
symptom severity, comorbidities, and gender are
taken into consideration, could improve the reliability
of the research.75
© 2016 John Wiley & Sons Ltd 9
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In summary, in comparison to the body of research
in patients with IBS, where much more data on both
central and peripheral functions and genetic and
microbiotic contributions allow to draw a complex
network theory of the disease,18 our current knowledge
about brain activity in FD patients is still fragmentary.
Whether brain activation is similar or different (in
extent and brain areas activated/deactivated) between
IBS and FD has never been studied (nor is it studied
here). However, given the different symptoms between
both functional gastrointestinal disorders, differences
are liable to exist and even similar activations may be
based on different peripheral or central processes.
CONCLUSIONS
The results of this review show the functional abnor-
malities of frontal cortex, somatosensory cortex, insula,
ACC, thalamus, hippocampus, and amygdala, demon-
strating the altered pain and salience network in FD
patients. The chronic suffering from gastrointestinal
symptoms, psychological problems, and subsequent
abnormal brain functions could be the key clinical
features of FD. Asmany pathogenic factors and physical
changes of FD remain to be discovered, more diverse
neuroimaging tasks, state-of-the-art interventions, pre-
cise diagnosis and measurement of psychological fac-
tors could improve our understanding of FD.
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Figure 2 Pathological mechanisms of functional dyspepsia. Various factors involved in the brain, gut, and brain-gut axis in functional dyspepsia
patients. Sensory, cognitive, and affective related brain regions showed altered functional activities in functional dyspepsia patients compared to
healthy controls. Repeated visceral sensory signal from the gut (bottom-up) and abnormal central modulation (top-down) of pain and gut functions
might be involved in functional dyspepsia. It also suggests that peripheral changes could be derived from abnormal brain functions through the brain-
gut axis. ACC, anterior cingulate cortex; OFC, orbitofrontal cortex; PFC, prefrontal cortex; SI (II), primary (secondary) somatosensory cortex.
© 2016 John Wiley & Sons Ltd10
I.-S. Lee et al. Neurogastroenterology and Motility
38
REFERENCES
1 Tack J, Talley NJ, Camilleri M, Holt-
mann G, Hu P, Malagelada JR, Stan-
ghellini V. Functional gastroduodenal
disorders. Gastroenterology 2006;
130: 1466–79.
2 Drossman DA, Dumitrascu DL.
Rome III: new standard for functional
gastrointestinal disorders. J Gastroin-
testin Liver Dis 2006; 15: 237–41.
3 Mahadeva S, Goh KL. Epidemiology
of functional dyspepsia: a global per-
spective. World J Gastroenterol 2006;
12: 2661–6.
4 Mearin F, Cucala M, Azpiroz F,
Malagelada JR. The origin of symp-
toms on the brain-gut axis in func-
tional dyspepsia. Gastroenterology
1991; 101: 999–1006.
5 Mayer EA, Naliboff BD, Craig AD.
Neuroimaging of the brain-gut axis:
from basic understanding to treat-
ment of functional GI disorders. Gas-
troenterology 2006; 131: 1925–42.
6 Aziz Q, Schnitzler A, Enck P. Func-
tional neuroimaging of visceral sen-
sation. J Clin Neurophysiol 2000; 17:
604–12.
7 Moisset X, Bouhassira D, Denis D,
Dominique G, Benoit C, Sabate JM.
Anatomical connections between
brain areas activated during rectal
distension in healthy volunteers: a
visceral pain network. Eur J Pain
2010; 14: 142–8.
8 McMahon SB. Are there fundamental
differences in the peripheral mecha-
nisms of visceral and somatic pain?
Behav Brain Sci 1997; 20: 381–91;
discussion 435-513.
9 Dunckley P, Wise RG, Aziz Q, Pain-
ter D, Brooks J, Tracey I, Chang L.
Cortical processing of visceral and
somatic stimulation: differentiating
pain intensity from unpleasantness.
Neuroscience 2005; 133: 533–42.
10 Craig AD. How do you feel? Intero-
ception: the sense of the physiological
condition of the body. Nat Rev Neu-
rosci 2002; 3: 655–66.
11 Seeley WW, Menon V, Schatzberg AF,
Keller J, Glover GH, Kenna H, Reiss
AL,GreiciusMD.Dissociable intrinsic
connectivity networks for salience pro-
cessing and executive control. J Neu-
rosci 2007; 27: 2349–56.
12 Menon V, Uddin LQ. Saliency,
switching, attention and control: a
network model of insula function.
Brain structure & function 2010; 214:
655–67.
13 Zubieta JK, Smith YR, Bueller JA, Xu
Y, Kilbourn MR, Jewett DM, Meyer
CR, Koeppe RA et al. Regional mu
opioid receptor regulation of sensory
and affective dimensions of pain.
Science 2001; 293: 311–5.
14 Zubieta JK, Bueller JA, Jackson LR,
Scott DJ, Xu Y, Koeppe RA, Nichols
TE, Stohler CS. Placebo effects medi-
ated by endogenous opioid activity on
mu-opioid receptors. J Neurosci 2005;
25: 7754–62.
15 Petrovic P, Kalso E, Petersson KM,
Ingvar M. Placebo and opioid analge-
sia– imaging a shared neuronal net-
work. Science 2002; 295: 1737–40.
16 Van Oudenhove L, Coen SJ, Aziz Q.
Functional brain imaging of gastroin-
testinal sensation in health and dis-
ease. World J Gastroenterol 2007; 13:
3438–45.
17 Coss-Adame E, Rao SS. Brain and gut
interactions in irritable bowel syn-
drome: new paradigms and new
understandings. Curr Gastroenterol
Rep 2014; 16: 379.
18 Mayer EA, Labus JS, Tillisch K, Cole
SW, Baldi P. Towards a systems view
of IBS. Nat Rev Gastroenterol Hepa-
tol 2015; 12: 592–605.
19 Vandenberghe J, Dupont P, Van
Oudenhove L, Bormans G, Demytte-
naere K, Fischler B, Geeraerts B,
Janssens J et al. Regional cerebral
blood flow during gastric balloon dis-
tention in functional dyspepsia. Gas-
troenterology 2007; 132: 1684–93.
20 Zeng F, Song WZ, Liu XG, Xie HJ,
Tang Y, Shan BC, Liu ZH, Yu SG
et al. Brain areas involved in
acupuncture treatment on functional
dyspepsia patients: a PET-CT study.
Neurosci Lett 2009; 456: 6–10.
21 Van Oudenhove L, Vandenberghe J,
Dupont P, Geeraerts B, Vos R, Dirix
S, Bormans G, Vanderghinste D et al.
Abnormal regional brain activity dur-
ing rest and (anticipated) gastric dis-
tension in functional dyspepsia and
the role of anxiety: a H(2)(15)O-PET
study. Am J Gastroenterol 2010; 105:
913–24.
22 Van Oudenhove L, Vandenberghe J,
Dupont P, Geeraerts B, Vos R, Dirix
S, Van Laere K, Bormans G et al.
Regional brain activity in functional
dyspepsia: a H(2)(15)O-PET study on
the role of gastric sensitivity and
abuse history. Gastroenterology
2010; 139: 36–47.
23 Zeng F, Qin W, Liang F, Liu J, Tang Y,
Liu X, Yuan K, Yu S et al. Abnormal
resting brain activity in patients with
functional dyspepsia is related to
symptom severity. Gastroenterology
2011; 141: 499–506.
24 Liu ML, Liang FR, Zeng F, Tang Y,
Lan L, Song WZ. Cortical-limbic
regions modulate depression and anx-
iety factors in functional dyspepsia: a
PET-CT study. Ann Nucl Med 2012;
26: 35–40.
25 Zeng F, Qin W, Ma T, Sun J, Tang Y,
Yuan K, Li Y, Liu J et al. Influence of
acupuncture treatment on cerebral
activity in functional dyspepsia
patients and its relationship with
efficacy. Am J Gastroenterol 2012;
107: 1236–47.
26 Liu P, QinW,Wang J, Zeng F, ZhouG,
WenH, vonDeneenKM, Liang F et al.
Identifying neural patterns of func-
tional dyspepsia using multivariate
pattern analysis: a resting-state FMRI
study. PLoS ONE 2013; 8: e68205.
27 Liu P, Zeng F, Zhou G, Wang J, Wen
H, von Deneen KM, Qin W, Liang F
et al. Alterations of the default mode
network in functional dyspepsia
patients: a resting-state fmri study.
Neurogastroenterol Motil 2013; 25:
e382–8.
28 Nan J, Liu J, Li G, Xiong S, Yan X, Yin
Q, Zeng F, von Deneen KM et al.
Whole-brain functional connectivity
identification of functional dyspepsia.
PLoS ONE 2013; 8: e65870.
29 Zhou G, Liu P, Wang J, Wen H, Zhu
M, Zhao R, von Deneen KM, Zeng F
et al. Fractional amplitude of low-
frequency fluctuation changes in
functional dyspepsia: a resting-state
fMRI study. Magn Reson Imaging
2013; 31: 996–1000.
30 Zhou G, Liu P, Zeng F, Yuan K, Yu D,
von Deneen KM, Liang F, Qin W
et al. Increased interhemispheric
resting-state functional connectivity
in functional dyspepsia: a pilot study.
NMR Biomed 2013; 26: 410–5.
31 Li Z, Zeng F, Yang Y, Chen Y, Zhang
D, Sun J, Qin W, Yang J et al. Differ-
ent cerebral responses to puncturing
at ST36 among patients with func-
tional dyspepsia and healthy subjects.
Forsch Komplementmed 2014; 21:
99–104.
32 Nan J, Liu J, Zhang D, Yang Y, Yan X,
Yin Q, Xiong S, von Deneen KM
et al. Altered intrinsic regional activ-
ity and corresponding brain pathways
reflect the symptom severity of func-
tional dyspepsia. Neurogastroenterol
Motil 2014; 26: 660–9.
© 2016 John Wiley & Sons Ltd 11
Functional imaging in functional dyspepsia
39
33 Nan J, Liu J, Mu J, Dun W, Zhang M,
Gong Q, Qin W, Tian J et al. Brain-
based correlations between psycho-
logical factors and functional dyspep-
sia. J Neurogastroenterol Motil 2015;
21: 103–10.
34 Nan J, Zhang L, Zhu F, Tian X, Zheng
Q, Deneen KM, Liu J, Zhang M.
Topological alterations of the intrin-
sic brain network in functional dys-
pepsia patients. J Neurogastroenterol
Motil 2016; 22: 118–28.
35 Vandenbergh J, Dupont P, Fischler B,
Bormans G, Persoons P, Janssens J,
Tack J. Regional brain activation
during proximal stomach distention
in humans: a positron emission
tomography study. Gastroenterology
2005; 128: 564–73.
36 Talley NJ, Verlinden M, Jones M.
Validity of a new quality of life scale
for functional dyspepsia: a United
States multicenter trial of the Nepean
Dyspepsia Index. Am J Gastroenterol
1999; 94: 2390–7.
37 Talley NJ, Haque M, Wyeth JW, Stace
NH, Tytgat GN, Stanghellini V, Holt-
mann G, Verlinden M et al. Develop-
ment of a new dyspepsia impact
scale: the Nepean Dyspepsia Index.
Aliment Pharmacol Ther 1999; 13:
225–35.
38 Jones MP, Dilley JB, Drossman D,
Crowell MD. Brain-gut connections
in functional GI disorders: anatomic
and physiologic relationships. Neu-
rogastroenterol Motil 2006; 18: 91–
103.
39 Van Oudenhove L, Dupont P, Van-
denberghe J, Geeraerts B, van Laere K,
Bormans G, Demyttenaere K, Tack J.
The role of somatosensory cortical
regions in the processing of painful
gastric fundic distension: an update of
brain imaging findings. Neurogas-
troenterol Motil 2008; 20: 479–87.
40 Verne GN, Robinson ME, Price DD.
Hypersensitivity to visceral and cuta-
neous pain in the irritable bowel
syndrome. Pain 2001; 93: 7–14.
41 Moshiree B, Zhou Q, Price DD, Verne
GN. Central sensitisation in visceral
pain disorders. Gut 2006; 55: 905–8.
42 Wilhelmsen I. Somatization, sensiti-
zation, and functional dyspepsia.
Scand J Psychol 2002; 43: 177–80.
43 Lu HC, Hsieh JC, Lu CL, Niddam
DM, Wu YT, Yeh TC, Cheng CM,
Chang FY et al. Neuronal correlates
in the modulation of placebo analge-
sia in experimentally-induced eso-
phageal pain: a 3T-fMRI study. Pain
2010; 148: 75–83.
44 Wiech K, Ploner M, Tracey I. Neu-
rocognitive aspects of pain perception.
Trends Cogn Sci 2008; 12: 306–13.
45 Wager TD, Rilling JK, Smith EE,
Sokolik A, Casey KL, Davidson RJ,
Kosslyn SM, Rose RM et al. Placebo-
induced changes in FMRI in the
anticipation and experience of pain.
Science 2004; 303: 1162–7.
46 Ochsner KN, Ludlow DH, Knierim K,
Hanelin J, Ramachandran T, Glover
GC, Mackey SC. Neural correlates of
individual differences in pain-related
fear and anxiety. Pain 2006; 120: 69–
77.
47 Kringelbach ML. The human orbito-
frontal cortex: linking reward to
hedonic experience. Nat Rev Neu-
rosci 2005; 6: 691–702.
48 Milad MR, Rauch SL. The role of the
orbitofrontal cortex in anxiety disor-
ders. Ann N Y Acad Sci 2007; 1121:
546–61.
49 Drevets WC. Orbitofrontal cortex
function and structure in depression.
AnnNYAcadSci2007;1121: 499–527.
50 Craig AD. How do you feel–now? The
anterior insula and human awareness.
Nat Rev Neurosci 2009; 10: 59–70.
51 Nieuwenhuys R. The insular cortex:
a review. Prog Brain Res 2012; 195:
123–63.
52 Gasquoine PG. Localization of func-
tion in anterior cingulate cortex: from
psychosurgery to functional neu-
roimaging. Neurosci Biobehav Rev
2013; 37: 340–8.
53 Lackner JM, Lou Coad M, Mertz HR,
Wack DS, Katz LA, Krasner SS, Firth
R, Mahl TC et al. Cognitive therapy
for irritable bowel syndrome is asso-
ciated with reduced limbic activity,
GI symptoms, and anxiety. Behav Res
Ther 2006; 44: 621–38.
54 Mertz H. Role of the brain and sen-
sory pathways in gastrointestinal sen-
sory disorders in humans. Gut 2002;
51 (Suppl. 1): i29–33.
55 Phelps EA. Human emotion and
memory: interactions of the amyg-
dala and hippocampal complex. Curr
Opin Neurobiol 2004; 14: 198–202.
56 Hamann SB, Ely TD, Grafton ST,
Kilts CD. Amygdala activity related
to enhanced memory for pleasant and
aversive stimuli. Nat Neurosci 1999;
2: 289–93.
57 Zald DH. The human amygdala and
the emotional evaluation of sensory
stimuli. Brain Res Brain Res Rev
2003; 41: 88–123.
58 Adolphs R, Tranel D, Damasio H,
Damasio A. Impaired recognition of
emotion in facial expressions follow-
ing bilateral damage to the human
amygdala. Nature 1994; 372: 669–72.
59 Han JS, Neugebauer V. Synaptic plas-
ticity in the amygdala in a visceral
pain model in rats. Neurosci Lett
2004; 361: 254–7.
60 Mutso AA, Radzicki D, Baliki MN,
Huang L, Banisadr G, Centeno MV,
Radulovic J, Martina M et al. Abnor-
malities in hippocampal functioning
with persistent pain. J Neurosci 2012;
32: 5747–56.
61 Naliboff BD, Berman S, Suyenobu B,
Labus JS, Chang L, Stains J, Mandelk-
ern MA, Mayer EA. Longitudinal
change in perceptual and brain acti-
vation response to visceral stimuli in
irritable bowel syndrome patients.
Gastroenterology 2006; 131: 352–65.
62 Legrain V, Iannetti GD, Plaghki L,
Mouraux A. The pain matrix
reloaded: a salience detection system
for the body. Prog Neurobiol 2011; 93:
111–24.
63 Borsook D, Edwards R, Elman I,
Becerra L, Levine J. Pain and analge-
sia: the value of salience circuits.
Prog Neurobiol 2013; 104: 93–105.
64 Wessely S, Nimnuan C, Sharpe M.
Functional somatic syndromes: one
or many? Lancet 1999; 354: 936–9.
65 Mayer EA, Bushnell MC. Functional
Pain Syndromes: Presentation and
Pathophysiology. Seattle, WA: IASP
Press, 2009.
66 Uddin LQ. Salience processing and
insular cortical function and dysfunc-
tion.NatRevNeurosci2015;16:55–61.
67 Bisschops R, Karamanolis G, Arts J,
Caenepeel P, Verbeke K, Janssens J,
Tack J. Relationship between symp-
toms and ingestion of a meal in
functional dyspepsia. Gut 2008; 57:
1495–503.
68 Moffet HH. Sham acupuncture may
be as efficacious as true acupuncture:
a systematic review of clinical trials. J
Altern Complement Med 2009; 15:
213–6.
69 First MB, Spitzer RL, Gibbon M, Wil-
liams J. Structured Clinical Interview
for Axis I DSM-IV Disorders: Patient
Edition (SCID-I/P, vs 2.0). New York:
Biometrics Research, New York State
Psychiatric Institute, 2002.
70 Anand P, Aziz Q, Willert R, van
Oudenhove L. Peripheral and central
mechanisms of visceral sensitization
in man. Neurogastroenterol Motil
2007; 19 (1 Suppl.): 29–46.
71 Monnikes H, Tebbe JJ, Hildebrandt
M, Arck P, Osmanoglou E, Rose M,
I.-S. Lee et al. Neurogastroenterology and Motility
© 2016 John Wiley & Sons Ltd12
40
Klapp B, Wiedenmann B et al. Role of
stress in functional gastrointestinal
disorders. Evidence for stress-induced
alterations in gastrointestinal motil-
ity and sensitivity. Dig Dis 2001; 19:
201–11.
72 Camilleri M, Malagelada JR, Kao PC,
Zinsmeister AR. Gastric and auto-
nomic responses to stress in func-
tional dyspepsia.Dig Dis Sci 1986; 31:
1169–77.
73 Van Oudenhove L, Vandenberghe J,
Vos R, Holvoet L, Tack J. Factors
associated with co-morbid irritable
bowel syndrome and chronic fatigue-
like symptoms in functional dyspep-
sia. Neurogastroenterol Motil 2011;
23: 524–e202.
74 Feinle-Bisset C, Azpiroz F. Dietary
and lifestyle factors in functional
dyspepsia. Nat Rev Gastroenterol
Hepatol 2013; 10: 150–7.
75 Lee IS, Wang H, Chae Y, Preissl H,
Braun C, Enck P. Functional neu-
roimaging studies in functional dys-
pepsia patients: a systematic review.
Neurogastroenterol Motil 2015; 27
(Suppl. 2): 80.
SUPPORTING INFORMATION
Additional supporting information may be found in the online version of this article at the publisher’s web site:
Table S1 Search terms used in each database.
Table S2 Brain imaging data of functional neuroimaging in FD
© 2016 John Wiley & Sons Ltd 13
Functional imaging in functional dyspepsia
41
 
42 
 
6. Paper II. How to perform and interpret functional magnetic resonance imaging 
studies in functional gastrointestinal disorders 
 
 
 
 
 
 
 
 
 
Author contributions 
The material of this chapter was published in journal of neurogastroenterology and 
motility (Lee et al., 2017). In-Seon Lee wrote the manuscript and Hubert Preissl and Paul Enck 
revised the manuscript. 
 
Acknowledgement 
Writing of this review was funded by the People Programme of the European Union’s 
Seventh Framework Programme under REA grant agreement No. 607652 (NeuroGUT).
197
How to Perform and Interpret Functional 
Magnetic Resonance Imaging Studies in 
Functional Gastrointestinal Disorders 
In-Seon Lee,1,2 Hubert Preissl,3,4 and Paul Enck1*
1Psychosomatic Medicine and Psychotherapy Department, University of Tübingen, Tübingen, Germany; 2Graduate Training Centre of 
Neuroscience, International Max Planck Research School, University of Tübingen, Tübingen, Germany; 3Institute for Diabetes Research and 
Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, German Center for Diabetes Research (DZD e.V.), Tübingen, 
Germany; and 4Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany
Functional neuroimaging studies have revealed the importance of the role of cognitive and psychological factors and the dysregulation 
of the brain-gut axis in functional gastrointestinal disorder patients. Although only a small number of neuroimaging studies have 
been conducted in functional gastrointestinal disorder patients, and despite the fact that the neuroimaging technique requires a high 
level of knowledge, the technique still has a great deal of potential. The application of functional magnetic resonance imaging (fMRI) 
technique in functional gastrointestinal disorders should provide novel methods of diagnosing and treating patients. In this review, 
basic knowledge and technical/practical issues of fMRI will be introduced to clinicians.
(J Neurogastroenterol Motil 2017;23:197-207)
Key Words
Brain; Functional magnetic resonance imaging; Functional neuroimaging; Gastrointestinal diseases
Received: November 8, 2016    Revised: None    Accepted: December 19, 2016
  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. 
org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work 
is properly cited.
*Correspondence:  Paul Enck, PhD 
University Hospital, Department of Internal Medicine VI, Osianderstr. 5, 72076 Tübingen, Germany 
Tel: +49-07071-29-89118, Fax: +49-07071-29-4382, E-mail: paul.enck@uni-tuebingen.de
JNM
J Neurogastroenterol Motil,  Vol. 23  No. 2   April,  2017
pISSN: 2093-0879   eISSN: 2093-0887
https://doi.org/10.5056/jnm16196
Technique ReviewJournal of Neurogastroenterology and Motility 
ⓒ 2017 The Korean Society of Neurogastroenterology and Motility
J Neurogastroenterol Motil, Vol. 23  No. 2   April,  2017
www.jnmjournal.org
Introduction  
Functional gastrointestinal disorders (FGIDs) are associated 
with functional and histological changes of gastrointestinal com-
partments such as gastric motility, visceral sensitivity, and inflam-
mation. Our understanding of the underlying pathophysiological 
mechanisms is, however, limited. The advent and development of 
functional neuroimaging techniques in humans has facilitated the 
investigation of bottom-up processes––brain activations generated 
by signals from the periphery––and top-down processes––the ef-
fect of cognitive and psychological factors––in healthy volunteers. 
Functional neuroimaging is now recognized as an objective and ac-
curate tool in the exploration of the central mechanism of functional 
disorders. Over the past few years, evidence from functional neuro-
imaging studies has endorsed the hypothesis that the dysregulation 
of the brain-gut axis (neuronal and hormonal interactions between 
the brain and the gut) is a key factor in FGIDs. According to previ-
ous reviews,1,2 the functional alterations in sensory, emotional, pain-
related, and homeostatic brain areas (changes of the brain function 
in frontal cortex, somatosensory cortex, insula, anterior cingulate 
cortex, thalamus, hippocampus, and amygdala) are the important 
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pathogenic factors in FGIDs. Most present-day studies involve pa-
tients with irritable bowel syndrome (IBS) and functional dyspepsia 
(FD) and although several other functional neuroimaging methods 
are available, functional magnetic resonance imaging (fMRI) has 
proved to be the most frequently applied technique. Functional 
MRI is completely non-invasive, sensitive to task-related or non-
task-related (resting state) brain activation, with high spatial (a 
few millimeters) and acceptable temporal (a few seconds) resolu-
tion, and facilitates deep brain structure and brain stem-imaging. 
Moreover, due to the availability of standard analysis tool boxes and 
tremendous advances in analysis methods, from univariate to multi-
variate analysis, fMRI has become increasingly popular in cognitive 
and clinical neuroscience studies. 
In this review, we present the technical and practical issues of 
fMRI and show its application in FGIDs-related studies––with 
emphasis on IBS and FD patients––to improve clinicians’ under-
standing of the merits of fMRI studies as well as of their possible 
limitations. Subsequently, we also propose future approaches in this 
field to further knowledge of FGIDs. 
Brief Overview of the Functional Magnetic 
Resonance Imaging Technique  
MRI has already been used to investigate tissue properties. In 
the 1990s, MRI was also deployed to measure the blood oxygen 
level dependent (BOLD) contrast in the investigation of functional 
activations in the brain.3 Activation of neurons in the brain leads to 
the consumption of oxygen as well as to an increased flow of blood 
in the surrounding area (hemodynamic response). These changes 
result in magnetic field distortions in the brain tissue. To record 
these changes, the different relaxation times of the protons are 
measured by a constant magnetic field (nowadays, most fMRI sys-
tems use 1.5-7.0 Tesla, the strength of the constant field is a major 
determinant of the signal strength) and a superimposed gradient 
magnetic field. A BOLD fMRI signal (increased signal intensity 
of T2*-weighted images) is determined by a combination of blood 
flow, volume, and relative oxygenated hemoglobin level. The tem-
poral signal recorded by BOLD fMRI (Fig. 1B) lies in the range 
of seconds and does not correspond directly to neuronal activity, but 
provides a hemodynamic proxy. For the analysis and interpretation 
of BOLD fMRI, the hemodynamic response function (HRF; Fig. 
Figure 1. Example of hemodynamic response (A) and time series blood oxygen level dependent (BOLD) signal from a voxel (B). (A) Neurons 
respond rapidly to internal or external changes and allow the alterations of blood flow and oxygenation in the close area (hemodynamic response) 
that drives the peak of BOLD signal few seconds after the onset of internal or external changes. BOLD signal slowly returns to baseline level fol-
lowing an undershoot. (B) Within the field of view, each slice consists of a certain number of voxels determined by the size of the measurement ma-
trix. The BOLD signal of each voxel is recorded at consecutive time points and this time trace is further analysed to interfere with functional brain 
activation.
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1A) that describes the temporal derivative of the BOLD signal 
related to the neuronal activity must be determined. Most studies 
now use a homogenous HRF for the whole brain; a fixed model 
of temporal changes of BOLD signal due to the neuronal activity 
responding to external stimuli or changes of internal states, which 
peaks roughly 4-5 seconds after the neuronal event. HRF gener-
ates the anticipated BOLD signal which identifies the activation 
map of brain function (see below, Analysis of Functional Resonance 
Imaging Image section), and various methods have been proposed 
with which more spatially or temporally accurate HRF could be 
retrieved so as to improve fMRI analysis.4,5 
To derive changes in neuronal activity, relative changes of signal 
intensity (contrast) are measured rather than absolute fMRI signal 
intensity. Furthermore, fMRI can be used to obtain not only the rel-
ative BOLD signal but also quantitative perfusion measurements. 
Arterial spin labeling is used to measure the cerebral blood flow by 
detecting the signal of magnetically labeled arterial blood.6,7 The use 
of a quantitative measure enables us to more easily draw compari-
sons between studies. In this review, we will focus on BOLD con-
trast. Glossary of terms for fMRI is summarized in Supplementary 
Table.
How Is an Functional Magnetic Resonance 
Imaging Study Performed?  
Design of an Functional Magnetic Resonance 
Imaging Study
Not all fMRI study designs are identical, and the designs are 
adapted depends on the type of research (basic/translational/clinical 
research, uncontrolled or controlled clinical trials, case reports, etc) 
and the purpose of the study. At present, most task-related study de-
signs are either block (Fig. 2A) or event-related designs (Fig. 2B). 
Traditionally, various cognitive tasks, such as perception, attention, 
learning, memory, language skill, emotion, and motor related tasks, 
were applied in fMRI studies to identify the location or network 
of cognitive functions in the brain. However, interest in non-task-
related brain activations, known as resting-state fMRI (rs-fMRI) 
in which participants’ brain are imaged during resting without any 
specific tasks, has increased. 
Task functional magnetic resonance imaging and  
resting-state functional magnetic resonance imaging
In early fMRI studies, fMRI signal responses to the repeated 
task (or stimulation) during a relatively short time interval were 
averaged and compared. For example, several blocks of Task A (or 
Stimulus A) and resting (no task; Fig. 2A, Example 1) or Task A, 
A
B
TASK A TASK ATASK ARest RestRest
Block design
TASK A TASK ATASK BRest RestRest TASK BRest
Event-related design
Example 1
Example 2
Example 1
Example 2
Rest Rest Rest
Rest Rest
TASK A TASK A TASK A
TASK A TASK B TASK B TASK A
Figure 2. Examples of block design 
(A) and event-related design (B). (A) 
Example 1 shows the block design with 
a single task (Task A) and Example 2 
with multiple tasks (Task A, B). (B) 
Event-related design with a single task 
(Example 1, Task A) and multiple tasks 
(Example 2, Task A, B). In both de-
signs, the number of tasks and time du-
rations are laid down in accordance with 
the type of task, hypothesis, and planned 
analysis scheme.
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Task B (control condition), and resting (Fig. 2A, Example 2) are 
presented alternately. In the former case, averaged fMRI signals of 
blocks of Task A were compared to signals of blocks of resting to 
show Task A-related increase (Task A > resting) or decrease (rest-
ing > Task A) of BOLD signal in the brain regions. In the latter 
case, a comparison between the baseline-corrected signals during 
Tasks A and B revealed that different brain activities were associ-
ated with each task. In some cases, two different types of task are 
delivered simultaneously, eg, pain stimulation during the attention 
demanding task,8 or the basic condition of participants, eg, hunger 
or satiety, could be modified.9 Due to its comparatively high statisti-
cal power and large signal changes, block design is an efficient and 
sensitive method for detecting task-specific brain activations.10,11 In 
a block-design fMRI study, a series of identical tasks (stimuli) are 
delivered in single block, whereas an event-related design measures 
the fMRI signal of each single task (stimulation). This approach 
improves the flexibility of the design by order randomization (which 
suppresses participants’ prediction of the following task) or by post-
hoc subgroup analysis (eg, correct vs incorrect tasks). 
Design of functional magnetic resonance imaging  
studies in Functional gastrointestinal disorders
In fMRI studies, visceral distention is the most frequent stimu-
lation performed on patients with FGIDs. The balloon distention 
method now consists of a bag-type balloon which is placed in an 
upper or lower gut compartment and distended (supra- or sublimi-
nally) by a barostat.12 This measures the brain response to visceral 
stimulation in, for example, patients with IBS.13-44 Auditory22,45 and 
somatic pain stimuli19,36 were also delivered to patients with IBS in 
fMRI studies. The results indicate that dysfunction of brain re-
sponses in patients is caused not only by visceral sensation but also 
by non-visceral stimuli, auditory and somatic pain. Cognitive tasks, 
such as affect matching paradigm,46 Wisconsin card sorting test,47 
emotion recognition paradigm,48 and attention network test,49 have 
also been investigated in patients with IBS. Psychological factors 
such as anxiety and depression were also examined and correlated 
with brain activation or network parameters in IBS or FD patients. 
Moreover, fMRI results were reported as the primary outcome 
in case report50 and clinical trials,37,51,52 and brain responses to the 
treatment itself37,53 were examined to ascertain the effect or neuronal 
mechanisms of pharmacological or non-pharmacological treatments 
(acupuncture, moxibustion, hypnosis, etc). In such cases, fMRI 
data were usually obtained before, during, and after the treatment 
(repeated measurements). 
Resting-state fMRI has already been carried out in a number 
of studies with IBS54-61 and FD patients62-68 and its use continues 
to increase. Functional connectivity, (fractional) amplitude of low-
frequency fluctuations ((f)ALFF), regional homogeneity (ReHo), 
independent component analysis (ICA), clustering, and graph the-
ory analysis (see below, Advanced analysis) have been used as well 
as correlation analyses between the effect of adverse history, anxiety 
and depression, symptom severity, and the brain activity. 
Analysis of Functional Magnetic Resonance 
Image  
The initial goal of fMRI analysis was to identify voxels in the 
brain that show significant differences between tasks or against rest. 
In the history of fMRI analysis, great emphasis has always been 
placed on reducing noise and artifacts and on developing methods 
to deal with the multiple comparison problem caused by the large 
number of voxels. The localization of those specific brain regions 
activated during experimental conditions and its interaction with 
behavior and cognitive function data (task outcomes, physiological 
measurements, subjective ratings, questionnaire values, symptom 
severity, etc) were the primary goals of early fMRI studies (task-
fMRI). A newly developed approach to fMRI analysis reveals pat-
terns of fMRI signals such as temporal correlation-based functional 
connectivity, (f)ALFF, ReHo, ICA, clustering, and graph theory 
analysis in both task-based and rs-fMRI. For example, if a fluctua-
tion of a time series signal of voxels corresponds to the timing of a 
certain task in task-based fMRI, then we can detect these voxels 
with general linear model (GLM). On the basis of the availability 
of the HRF and the known onset and duration of tasks, an antici-
pated BOLD signal could be generated (input function × HRF 
= expected BOLD response; Fig. 3A). The expected BOLD sig-
nal is utilized to estimate the task-specific activation of voxels. For 
example, in GLM, the linear relationship between observed (from 
voxels, dependent variable, blue signal in Fig. 3B) and expected 
(from HRF, independent variable, red signal in Fig. 3B) BOLD 
signal is estimated. The voxels whose observed BOLD signal cor-
responds significantly to the expected BOLD signal, as in Figure 
3B, could be defined as the activated voxels following the task. 
The sequence of any fMRI analysis is (1) preprocessing, (2) 
single subject analysis, (3) group analysis, and (4) additional analy-
sis and visualization. A number of software programs and scripts 
have been developed for each step of an fMRI analysis. In general, 
statistical parametric mapping (http://www.fil.ion.ucl.ac.uk/spm/), 
FMRIB software library (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/), 
analysis of functional neuroImages (https://afni.nimh.nih.gov/afni/), 
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BrainVoyager (http://www.brainvoyager.com/), and additional 
toolboxes for certain analysis are used. Since the terminology and 
the steps of analysis differ considerably between the various kinds 
of software, we will confine ourselves to describing the process of 
analysis on the basis of the BOLD signal analysis with statistical 
parametric mapping. 
Statistical Power
As with other types of studies, it is prudent to perform a sta-
tistical power analysis before conducting the main fMRI study. To 
obtain an optimal statistical power (the probability of rejecting the 
null hypothesis when it is false), it is vital that the effect size and the 
sample size be taken into consideration. The size of effect is influ-
enced by the sequence parameters, type of task, study design, inter/
intra-variability of the sample data, and the sample size. The latter 
can easily be controlled by the experimenter. If the anticipated effect 
size is taken from pilot data or open source data from fMRI data-
bases, a power analysis can be conducted before embarking on the 
main study to determine the optimal sample size.69,70 Desmond and 
Glover71 tested simulated fMRI data to estimate the statistical pow-
er. They ascertained that a minimum of 12 subjects is required to 
ensure 80% power at α = 0.05 at the single voxel level and almost 
twice as many are necessary to achieve the same power level after 
multiple comparison correction. However, Yarkoni72 claimed that 
the results in fMRI studies with a small sample size were overesti-
mated and proposed that 50 is a reasonable sample size. At present, 
sample sizes below 20 are generally considered to be rather small.
Task Functional Magnetic Resonance Imaging 
Preprocessing 
Preprocessing is necessary to modify the recorded fMRI sig-
nal into statistical analyzable data by correcting artifacts and noise 
generated either by the MRI scanner (acquisition timing) or by 
participants (head motion, inter-participant variability in anatomical 
features).
(1) Slice timing correction (temporal preprocessing): the brain 
in the field of view is repeatedly scanned every few seconds and one 
scan image is composed of several slices (planar image) of the brain. 
In other words, the slices in one scan image are not collected con-
currently (Fig. 1B). To increase the time-sensitive effects, all times 
series of each slice are adjusted to the acquisition time of one slice 
(reference slice). 
(2) Realignment (spatial preprocessing): participants’ head 
motions, which produce signal noise and voxel mismatch between 
scans, are corrected. Since larger movements (> 2 mm, > 2 degree 
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Figure 3. Illustration of expected and 
measured blood oxygen level dependent 
(BOLD) signal from single voxel in task 
functional magnetic resonance imaging. 
(A) Example of expected BOLD signal 
using hemodynamic response func-
tion (red). (B) Illustration of measured 
BOLD signal in task-specific activated 
voxel (blue) and simulated BOLD sig-
nal (red) from (A). In the general linear 
model, the linear relationship between 
observed (blue) and expected BOLD 
signal (red) is estimated. 
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rotation) can produce significant non-amendable noise, slices with 
large head motion are usually discarded. Smaller movements can be 
corrected or the movement can be taken into consideration during 
the statistical analysis.
(3) Co-registration (spatial preprocessing): registration of an 
anatomical image to match the functional image is required for fur-
ther analysis. 
(4) Segmentation (spatial preprocessing): segmentation of an 
anatomical image to separate brain tissues, cerebral spinal fluid, 
white matter, and gray matter. 
(5) Normalization: individual images are normalized into stan-
dard space to correct between subject variability. This step increases 
sensitivity, and facilitates the generalization of results and compari-
sons between studies. 
(6) Smoothing: a smoothing filter, such as Gaussian kernel, is 
applied to blur the images and reduce the number of independent 
observations based on random field theory. This process suppresses 
noise, increases sensitivity, and makes images more appropriate for 
single-subject and group analysis. 
Single subject and group analysis
In a single subject analysis, also known as subject level or first 
level analysis, design and contrast of all experimental conditions are 
defined. In order to specify the experimental design, information 
about the onset and duration of each task is required. F-contrasts 
(effects of interest) or T-contrasts (the contrasts between tasks or 
task and resting condition) are defined according to the design and 
purpose of the analysis. Movement parameters and other regressors 
are also determined in case they are required. 
In group analysis, also known as second level analysis, t tests, 
ANOVAs and other general linear model analyses with covariates 
or regressors can be performed. In the event of a specific hypothesis 
about the correlation between the clinical symptoms, task perfor-
mance, personality, or duration of the disease and brain activation, 
multiple regression analysis using covariates could identify those 
brain regions that positively or negatively correlate with the covari-
ates. Contrasts for group analysis must also be defined to report 
group level results. In general, the analysis is performed as a whole 
brain analysis. For region-of-interest (ROI) analysis, the equipped 
ROIs in the toolbox library (Automated Anatomical Labeling atlas73) 
or newly generated ROIs using center coordinates and radius or 
number of voxels are used. A ROI-based approach should be used 
only if clear hypotheses are available and the multi-comparison cor-
rection should be taken into account if more than one ROI is used. 
Having set a statistical threshold and multiple comparison correc-
tion thresholds to correct false positives (family-wise error rate or 
false discovery rate is generally used), one can export the results into 
figures, tables, or time series signal data. 
Resting-state Functional Magnetic Resonance Imaging
Once rs-fMRI data is preprocessed in a similar way to task-
fMRI, procedures of single subject and group analysis differ from 
task-fMRI. In resting state analysis, the spontaneous low frequency 
fluctuation (0.01-0.10 Hz) is of major interest. Several approaches, 
including ALFF and (f)ALFF, were developed specifically for 
rs-fMRI analysis in an effort to extract an amplitude or ratio of 
spontaneous low frequency fluctuation from the BOLD signal, 
indicative of a regional intensity of activation.74,75 Functional con-
nectivity, ReHo, and ICA are also applicable in rs-fMRI as well as 
in task-fMRI. Further toolboxes and scripts for rs-fMRI were also 
developed.76,77
Advanced Analysis 
Various advanced analyses have been introduced in fMRI 
analysis. Here, we briefly introduce the analysis technique which 
has been used of late in FGIDs studies.
Functional connectivity, one of the most widespread analysis 
techniques, is defined as ‘temporal correlation between the different 
parts (voxels, clusters, or ROIs) of the brain.38,44,56,57,78 It enables 
us to estimate the connection of brain regions and to compare its 
patterns between groups. Effective connectivity provides us with 
additional information as to which brain areas induce a direct causal 
influence over others.48,51,79 Dynamic causal modeling is an example 
of the effective connectivity analysis method and shows how the 
effective connectivity (causal influence) between brain regions is 
modulated by experimental conditions.47,80 Graph theory analysis, ie, 
the analysis of the properties of connections (edges) between func-
tionally connected brain regions (nodes) to account for the complex 
characteristics of a network, is a further form of connectivity analy-
sis.61,68,81 ReHo is basically a voxel-based connectivity analysis that 
measures the regional similarity of the signals between the specific 
voxel and its neighboring voxels.59,67,82 
Of all the multivariate analyses applied in FGIDs studies, ICA 
pattern classification is the most familiar.29,38,58 ICA works on the 
assumption that an fMRI signal is linearly composed of several 
(spatially or temporally) independent signals, and that the original 
fMRI signal is separated into independent groups.83 Since ICA is 
one of the data-driven analysis methods, it can reveal an intrinsic 
structure of the original signal and can therefore also be utilized to 
generate hypotheses. 
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Interpreting Functional Magnetic Resonance 
Imaging Results in Functional Gastrointesti-
nal Disorders  
In most studies, the list of brain regions (coordinates and sta-
tistical information) displaying increased or decreased activity in 
certain conditions or groups is reported in a voxel-wise or a ROI-
wise manner. In some instances, a group of the brain areas involved 
in the same function (eg, pain processing) is identified as a ‘network.’ 
For example, albeit opinions are deeply divided on this issue, so-
matosensory cortex, insula, anterior cingulate cortex, and thalamus 
are termed a ‘pain network.’84 The most frequently reported brain 
regions in FGIDs studies are the prefrontal cortex, somatosensory 
cortex, insula, cingulate cortex, and thalamus. The contributory net-
works to FGIDs are known as the sensory-motor network, salience 
network, autonomic network, and cognitive/affective network.1,85
Functional MRI data may allow us to elucidate the basic neuro-
physiological and pathophysiological mechanisms in brains which is 
associated with clinical information. For example, the activation map 
following rectal balloon distention can indicate the altered neural 
processing of visceral pain in the somatosensory cortex, frontal cor-
tex, cingulate cortex, insula, thalamus, and (pre)motor cortex with 
higher pain sensation (visceral hypersensitivity) in patients than in 
controls.15,17 Anxiety and depression were associated with the brain 
activation in the cingulate cortex and prefrontal cortex,28 and his-
tory of abuse affected the brain activation in the cingulate cortex.27 
Several studies have attempted to identify the specific mechanisms 
of treatment86 and neuroimaging biomarkers for further disorders.87 
The inhibition effect of pain-related brain activation in IBS patients 
by amitriptyline (tricyclic antidepressants)20 identified the central 
mechanism of antidepressants in the reduction of rectal distention 
pain. The brain activity during acupuncture suggested the modula-
tion of serotonin pathway at insula and the higher cortical regulation 
of affection as potential neural mechanisms of acupuncture treat-
ment.34 Furthermore, correlation analysis between fMRI data and 
psychological indices such as anxiety and depression may demon-
strate the influence of the psychological state on patients.28,35 When 
interpreting the fMRI results on interventions, the blinding issue, 
changes of symptoms, co-morbidities, quality of life, non-specific 
effect, and placebo response should also be taken into consideration 
carefully.
Limitations and Future Approaches of Functional 
Magnetic Resonance Imaging Studies in  
Functional Gastrointestinal Disorders  
Functional MRI measurement is not only expensive and time 
consuming, but also requires extensive skills and resources. Re-
searchers should be aware of the variety of factors which affect the 
brain imaging results before performing experiments, and it is only 
when valid tasks or stimuli, well-structured procedures, controlled 
populations of participants, and proper analyses come together that 
reliable data can be gained. The unusual environment of MRI 
must also be taken into consideration. Patients with a metal implant 
or with claustrophobia should not participate. No movement, par-
ticularly no head movement, is permitted inside the scanner. Recent 
studies have demonstrated in both IBS and in healthy controls that 
visceral pain perception is higher within the MRI environment 
than outside.88 Investigators and participants must therefore adapt 
themselves to the MRI environment. 
Until now, all neuroimaging studies in FGID have used a 
correlation approach. This does not permit us to make any causal 
inference about the direction of influence (central to peripheral, pe-
ripheral to central, or both). At present, inconsistent study designs, 
analysis methods and statistical principles make it difficult to com-
pare or integrate fMRI data in FGIDs across studies using meta-
analysis. However, because FGIDs lack biomarkers such as neu-
rohormones, cytokines, and genes, functional neuroimaging may 
provide further information to elucidate the symptoms in patients. 
Furthermore, fMRI studies may help us to better fathom the role of 
emotional feelings and cognitive functions by combined with other 
neuroimaging techniques or with autonomic response, genetic and 
epigenetic approaches, and neurotransmitter research to identify key 
components of the disease, or to differentiate between subtypes. 
In summary, fMRI is a unique research tool that provides 
information on neuronal mechanisms of symptoms and treatment 
effects in the patient population, and physiological processing in 
healthy volunteers. It should, however, be utilized prudently in re-
search, and its pros and cons should be weighed up carefully. 
Since neuroimaging has been applied in FGIDs for less than 
twenty years and analysis methods are developing and improving 
rapidly, future approaches hold tremendous potential. As yet, only 
experimental pain stimulation and a few cognitive tasks have been 
implemented in FGIDs patients. Besides the pain and anxiety/de-
pression scores, FGIDs patients may have many other pathological, 
behavioral and somatic characteristics; such as impaired affective 
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memory, heightened vigilance, abnormal eating behavior, increased 
stress sensitivity, disordered autonomic regulation, dysbiosis of the 
gut microbiota, additional bowel symptoms such as nausea, bloat-
ing, urgency, and autonomic and somatic co-morbidities. It may be 
advisable to examine the effects of pharmacological or non-phar-
macological therapy, and the influence of such therapies on brain 
activity may help to establish novel treatment strategies. Albeit still 
a far cry from clinical application, neuroimaging data will neverthe-
less one day be used to perform subgroup analyses in patients (eg, 
hypersensitive vs normosensitive or even hyposensitive patients) or 
to distinguish patients from healthy controls.89 The neuroimaging 
data with more numerous tasks, behavioral measurement, and ther-
apies could improve our understanding of the pathophysiology of 
FGIDs and lead to more appropriate treatment options for patients 
in the future. 
Conclusions  
The advent of the fMRI technique has not only provided in-
formation on regional brain activities and the interaction of different 
brain areas, but has also improved our understanding of the neuro-
nal changes and its relationship with symptoms and cognitive/affec-
tive changes in many patient groups. Although its usage in basic or 
clinical neuroscience research in FGIDs patients has been reported 
in only a limited number of studies, and despite its requiring an 
intensive level of knowledge in neurology, physiology, pathology, 
physics, and program coding, it does have considerable potential. 
An accurate understanding and application of fMRI technique in 
FGIDs will hopefully lead to new methods of diagnosing and treat-
ing patients. 
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Note: To access the supplementary table mentioned in this 
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Abstract 
The food-related behavior of functional dyspepsia have been attracting more interest of late. This 
study aims to provide evidence of the physiological, emotional, and attentional aspects of food 
processing in functional dyspepsia patients. The study was performed in 15 functional dyspepsia 
patients and 17 healthy controls after a standard breakfast. We measured autonomic nervous system 
activity using skin conductance response and heart rate variability, emotional response using facial 
electromyography, and visual attention using eyetracking during the visual stimuli of food/non-
food images after standard breakfast ingestion. In comparison to healthy controls, functional 
dyspepsia patients showed a greater craving for food, a decreased intake of food, more dyspeptic 
symptoms, lower pleasantness rating of food images (particularly of high fat), decreased low 
frequency/high frequency ratio of heart rate variability, and suppressed total processing time of 
food images. There were no significant differences of skin conductance response and facial 
electromyography data between groups. The results suggest that high level cognitive functions 
rather than autonomic and emotional mechanisms are more likely to function differently in 
functional dyspepsia patients. Abnormal dietary behavior, reduced subjective rating of 
pleasantness and visual attention to food should be considered as important pathophysiological 
characteristics in functional dyspepsia. 
 
Keywords functional dyspepsia; eye-tracking; food images; fat  
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1. Introduction  
Functional dyspepsia (FD) is defined as a disorder that includes unexplained symptoms 
originating from the gastroduodenal region such as postprandial fullness, early satiation, epigastric 
pain and burning1, 2. So far, our knowledge of pathophysiological abnormalities in FD had been 
limited to functional abnormalities in gastrointestinal tract (visceral hypersensitivity, abnormal 
accommodation, delayed gastric emptying and gastric dysmotility), and only a small number of 
studies had investigated the psychological characteristics of FD patients and revealed the crucial 
role of anxiety, depression, and somatization3.  
More recent studies investigating the role of dietary habit and nutritional intake in FD 
patients suggest that fat ingestion is a potential factor in symptom triggering4-6. Although it is 
already known that FD patients tolerate only small amounts of food, evidence on the extent of 
nutritional intake of daily meals remains inconclusive7. One of the limitations of previous studies 
in FD patients was that a food diary or questionnaire was used to measure their dietary habit, which 
may have caused a recall bias8-10. In studies using real food in FD patients, specific amounts of 
solid or liquid type meals were served to determine the meal-related dyspeptic symptom, gastric 
accommodation, or hormonal changes11-14. Furthermore, the psychophysiological response and 
cognitive processing of food stimuli in FD patients are not well established despite the fact that 
these are important determinants in the pathophysiology of eating disorders such as anorexia 
nervosa, binge eating disorder, and obesity15, 16. Since a close relationship between the exacerbated 
FD symptoms and meal ingestion has been reported11-14, chronic negative experience of eating may 
cause abnormal behavioral and cognitive response, i.e., avoidance or an aversive response rather 
than a positive approach to food stimuli.  
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Visual food stimuli have been used to investigate food-related behavior in patients with 
obesity17, anorexia nervosa18, and binge eating disorder19. Food images are generally used as 
pleasure or incentive stimuli eliciting a positive response or causing an attentional bias20. The eye 
tracking technique, which measures the gaze parameters such as initial fixation and total duration 
of fixation on images21, is well suited to the investigation of initial saliency and the later cognitive 
processing of images. In addition, autonomic nervous system function and facial movements can 
provide further support for altered homeostatic and emotional changes during food image 
processing in FD patients. Skin conductance response (SCR) and heart rate variability (HRV) have 
been used as the parameter of the arousal level of the sympathetic branch of autonomic nervous 
system and of the balance of sympathetic and parasympathetic activity, respectively. 
Electromyography of facial muscles measuring the intensity of the contraction of the corrugator 
supercilii and zygomaticus major muscle has been used to quantify negative and positive facial 
emotional response22.  
 In the current study, we aimed to determine the physiological/emotional response and visual 
attention to food images in FD patients. We evaluated the physiological, emotional, and attentional 
response of FD patients to high fat food, low fat food, and non-food images after taking an ad-
libitum breakfast. We hypothesized that, in comparison to healthy controls, 1) FD patients consume 
a smaller amount of food, but have higher dyspeptic symptoms afterwards; 2) FD patients show 
negative emotional response and increased arousal level to food images, particularly to high fat 
food images; 3) FD patients show decreased visual attention to food images, especially to high fat 
food images.  
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2. Methods  
2.1. Participants 
15 FD patients (3 male, aged 41±4.72 years) and 17 age- and BMI-matched healthy controls 
(HC, 5 male, aged 39.65±4.02 years) were included in the study. The age range was 18-75 years 
and body mass index (BMI, weight/height2) range 19-29 kg/m2. FD patients were diagnosed on the 
basis of ROME III criteria23 and an unsuspicious endoscopy documented in their medical records. 
Participants with visual impairment, severe psychiatric illness, intake of antidepressants or 
antipsychotics, and any food allergy or intolerance were excluded. The study was approved by the 
ethics committee of the Medical Faculty, Tübingen University, Germany (041/2016BO2). All 
participants provided informed consent and all experiments were conducted ethically according to 
the principles of the Declaration of Helsinki.  
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2.2. Procedure 
Study was conducted at the Universitätsklinikum Tübingen, Tübingen, Germany. 
Participants were asked to fast from 10 pm of the evening prior to the study. The study commenced 
at 8 a.m. the following morning. The participants began by rating their physical condition such as 
hunger, appetite, abdominal fullness, satiation, nausea, vomiting, abdominal pain, abdominal 
discomfort, burning, and bloating symptoms (baseline) on a visual analogue scale (VAS; 0=not at 
all, 10=very much). They were then served a standard breakfast consisting of bread (2 slices, 110g), 
butter (36g), jam (46g), milk (1.5% fat, 500ml), orange juice (500ml), and water (total calorie 
402.09kcal, fat 14.52g, carbohydrate 53.61g, protein 12.98g). The participants could eat as much 
as they wished within 10 minutes. VAS ratings were assessed again immediately after breakfast 
(Post1), between Experiment 1 and Experiment 2 (Post2, 20-25 minutes after the meal), and at 
the end of the experiment (Post3, 45-50 minutes after the meal, Figure 1A.). The remaining food 
from each participant was weighed and calorie intake was calculated. 
  
Experiment 1. Emotional and physiological response to food and non-food images  
Skin conductance response was measured with two electrodes attached to the index and 
middle finger of the left hand. Three electrodes were placed on the chest region to measure the 
electrocardiography (ECG) signal. For facial electromyography (EMG) measurement, three 
electrodes were attached on both the corrugator supercilii and zygomaticus major muscles on the 
left side of the face24. The data were recorded with a Biopac MP36 system and Acknowledge 
software ver. 4.1 (Biopac Systems Inc., Goleta, USA). 
Five fixed-order sets of image stimuli (neutral, positive, negative, high fat, and low fat food 
images, n=30, respectively), were each presented in a randomized order for 180 seconds (6 seconds 
for each image) followed by 5-second rest with visual cross fixation between each set. Subjective 
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pleasantness to each image was measured by pressing a button from 1 to 10 on a keyboard (1=very 
unpleasant, 10=very pleasant). Participants were also requested not to move or talk while the 
measurements were being carried out (Figure 1.B.). 
  
Experiment 2. Visual attention to food and non-food images  
After Experiment 1, gaze data were recorded with the eye tracking system iView X Hi-
Speed (SensoMotoric Instruments GmbH, Berlin, Germany). Each participant received a 
standardized 13-point calibration procedure to ensure optimal gaze data quality. Following 
calibration, 24 pairs of images (different from those used in Experiment 1) composed of food 
(high fat n=12, low fat n=12) and non-food images (household items, n=24), were randomly 
presented. Each pair of stimuli images was presented for 3 seconds and a fixation cross at the center 
of the screen was shown for 2 seconds between each pair. Participants were requested to freely 
explore the presented pictures and to fixate the cross when shown (Figure 1.C.).  
After the eye tracking experiment, the anticipated FD symptoms (postprandial fullness, 
early satiation, abdominal pain, and burning sensation) at each food image (high fat n=12, low fat 
n=12) was assessed using VAS (0=not at all, 10=very much). At the conclusion of the study, each 
participant’s dyspepsia symptom intensity and disease-related quality of life were assessed using 
Nepean Dyspepsia Index (NDI)25. Depression and anxiety levels were evaluated using Beck 
Depression Inventory (BDI-II)26 and State-Trait Anxiety Inventory (STAI)27, respectively. 
Furthermore, the Eating Disorders Examination questionnaire (EDE-Q)28, Food Craving 
Questionnaire (FCQ)29, and Fat Preference Questionnaire (FPQ)30 were used to identify eating 
behavior.  
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2.3. Materials and apparatus 
Experiment 1. Positive and negative images were selected from the International affective picture 
system (IAPS)31. Taking the diversity of food and color-matching between food and non-food 
images into consideration, we selected neutral household items and food images from food image 
databases32. Images were presented and subjective pleasantness rating was recorded with 
Presentation® (version 16.5, www.neurobs.com). Physiological signals were recorded with a 
Biopac MP36 system and Acknowledge software 4.1 (Biopac Systems Inc., Goleta, USA). SCR, 
ECG and EMG signals were sampled at 1 kHz. For SCR, a low pass filter of 10Hz, for ECG a 
bandpass filter between 0.5 and 35 Hz, and for EMG a bandpass filter between 30 and 250 Hz were 
applied. 
 
Experiment 2. A validated image set for the eye tracking experiment was used in this study33. The 
food and non-food stimuli were matched in color, brightness, and contrast. The complexity, valence, 
and arousal levels of the images were rated in a previous study34. Eye movements were recorded 
with the IViewX Hi-Speed and IViewX 2.8 software (SensoMotoric Instruments, Berlin, Germany) 
and sampling rate was set at 500 Hz.   
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2.4. Data processing  
Experiment 1. We analyzed the raw SCR signal using Ledalab software (www.ledalab.de). Raw 
SCR was smoothed and event-related activation was extracted when the signal exceeded 0.01muS. 
For the computation of the standardized ratio, the total amplitude of SCR of each block (neutral, 
positive, negative, high, and low fat cues) was divided by the total amplitude to normalize 
individual differences.  
Rectified EMG was derived from raw EMG data, while integrated EMG was defined as the 
area under the curve of the rectified EMG signal. Muscle activation was located every 30ms 
automatically and visually ascertained. To calculate the standardized ratio, we divided the whole 
EMG signal from all muscle activations located in each block by the total amplitude (Acknowledge 
software 4.1, Biopac Systems Inc., Goleta, USA).  
ECG was analyzed with Kubios HRV software (version 2.2, http://kubios.uku.fi/)35. 
Following QRS detection, a medium level of artifacts correction was applied and trend components 
were removed using the smooth priors method (Lambda 500, f=0.035 Hz). Frequency bands were 
set at 0.04-0.15 Hz for LF (low frequency) and at 0.15-0.4 Hz for HF (high frequency), and Fast 
Fourier Transform-based power spectrum estimation was applied.  
 
Experiment 2. The raw gaze data was analyzed using BeGaze 3.0 software (SensoMotoric 
Instruments GmbH, Berlin, Germany). The areas of interest (AOIs) were defined for food and non-
food images and fixation cross. The initial fixation position was defined by the geographical 
position of gaze on AOIs and fixation duration was calculated as the sum of the duration time of 
fixation inside each AOI36. Any trials in which participants did not fixate on the cross at the onset 
of the trial were ruled out. Two variables were defined to test the hypothesis: 1) the coefficient 
percentage (%) of initial fixation on food versus non-food images: (number of initial fixations on 
64 
 
food images–number of initial fixations on non-food images)/(number of initial fixations on food 
images+number of initial fixations on non-food images)*100 (%), 2) the coefficient percentage (%) 
of total fixation duration on food versus non-food images: (fixation duration on food images–
fixation duration on non-food images)/(fixation duration on food images+fixation duration on non-
food images)*100 (%). All authors had access to the study data and reviewed and approved the 
final manuscript. 
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2.5. Statistical analysis  
All statistical analyses were performed with IBM SPSS statistics 24.0 (IBM Corp. New 
York, USA). Independent two sample t-tests were used to assess any differences between study 
groups (FD and HC) that were related to anthropometric data, food consumption data, and 
questionnaire scores. A two-way repeated measures analysis of variance (ANOVA) with the groups 
(FD and HC) and the time factors (baseline, Post1, Post2, Post3) was used to identify the changes 
in meal-induced FD symptom ratings. A two-way ANOVA with the group (FD and HC) and type 
of image (2x5: neutral, positive, negative, high fat food, low fat food; 2x2: high fat, low fat food) 
factors were applied to the pleasantness rating, SCR, EMG, HRV variables, eye tracking data, and 
anticipated FD symptom rating. Two-tailed partial Pearson correlation analysis was also computed 
between BMI, fat and total energy intake, NDI_Symptom- and NDI_QOL (quality of life) scores, 
BDI-II, STAI, FCQ, and FPQ scores, and the eye-tracking variables while controlling for age and 
BMI. The statistical significance level was set at α=0.05 and Bonferroni correction was applied to 
account for multiple testing if necessary. 
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3. Results 
3.1. Sample characteristics 
 Sample characteristics and scores of questionnaires are presented in Table 1. No significant 
differences in age and BMI between groups (p>0.5) was shown. Eleven FD patients showed both 
postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS) (9 females), 3 patients 
(all females) had PDS only, and 1 patient (male) had EPS only. FD patients showed a significantly 
higher NDI_Symptom score (P<.001) and a lower NDI_QOL score (P<.001) than the HC group. 
FD patients also showed significantly higher depression and anxiety levels (P<.05 and P<.01, 
respectively) and higher FCQ-state score (P<.05) than HC. The total and subscale scores in EDE-
Q and FPQ did not differ significantly between groups. 
3.2. Food/energy intake and FD symptoms  
 Following overnight fasting, FD patients ate significantly less bread than HC group (FD: 
61.6±5.07g; HC: 76.71±6.95g, P<.05). Albeit FD patients consumed less fat (FD: 9.25±1.12g; HC: 
10.38±1.63g), carbohydrate (FD: 51.85±6.61g; HC: 62.53±6.60g), and protein (FD: 8.56±1.64g; 
HC 9.27±1.36g) than the HC group, these differences were statistically not significant. Overall, FD 
patients consumed significantly less total energy than the HC group (FD: 332.19±37.77kcal; HC 
389.76±38.03kcal, P<.05).  
FD symptom ratings of baseline, Post1, Post2, Post3 are described in Supplementary Table 
1. Hunger rating decreased immediately after breakfast, and increased subsequently in both groups. 
Appetite also decreased initially and increased gradually afterwards, but FD patients had 
significantly lower appetite at Post3 than HC (P<.05). Abdominal fullness in the FD group was 
only slightly higher than HC before breakfast, but significantly higher immediately after breakfast 
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(P<.05). Significant main effects of group (FD>HC) were found in abdominal pain (P<.05), 
discomfort, burning, and bloating symptoms (P<.01).  
 
Table 1. Baseline characteristics of the study sample 
 Healthy controls FD patients P value 
Gender (m/f) 5/12 3/12 - 
Subgroup - PDS: 2/12, EPS: 3/9 - 
 
Age (year) 37.65±4.02 41±4.72 NS 
BMI (kg/m2) 24.95±0.73 23.27±1.19 NS 
NDI_Symptom 10.56±1.90 70.62±9.51 P<.001 
NDI_QOL 46.8±1.35 23.62±2.33 P<.001 
EDE-Q Total 
       Restraint scale 
       Eating concern     
       Weight concern  
       Shape concern 
1.25±0.26 
1.07±0.28 
0.33±0.14 
1.31±0.32 
1.58±0.35 
1.05±0.29 
0.84±0.23 
0.31±0.15 
1.13±0.34 
1.45±0.33 
NS 
NS 
NS 
NS 
NS 
BDI-II 3.94±1.61 9.77±2.44 P<.05 
STAI_state 
STAI_trait 
31.06±1.64 
31.81±2.06 
43.46±3.21 
44.54±3.34 
P<.01 
P<.01 
FCQ_state 
FCQ_trait 
31.94±3.09 
83.94±7.28 
42.93±3.31 
92.08±9.90 
P<.05 
NS 
FPQ_TASTE 
FPQ_FREQ 
FPQ_DIFF 
55.89±5.26 
52.10±5.05 
3.79±1.73 
65.98±4.81 
57.26±4.83 
8.72±2.23 
NS 
NS 
NS 
Mean±standard error 
BDI: Beck depression inventory; BMI: body mass index; EDE-Q: Eating disorder examination 
questionnaire; EPS: epigastric pain syndrome; f: female; FCQ: Food cravings questionnaire; FD: 
functional dyspepsia; FPQ: Fat preference questionnaire; FPQ_TASTE: how much better high fat 
food taste, FPQ_FREQ: how much high fat food eaten more often, FPQ_DIFF: high fat restriction 
(FPQ_TASTE-FPQ_FREQ); m: male; NDI: Nepean dyspepsia index; NS: statistically not 
significant; PDS: postprandial distress syndrome; QOL: quality of life; STAI: State trait anxiety 
inventory 
P value: two sample t-test FD vs HC  
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3.3. Experiment 1. Measurement of physiological response  
Physiological response and pleasantness ratings of food and non-food images in FD patients 
and HC are summarized in Supplementary Table 2.  
Pleasantness rating: ANOVA analysis for the 5 image sets showed that there was a significant 
main effect of image (P<.001). In accordance with the post-hoc analysis, pleasantness of negative 
images was significantly lower than of any other images (P<.001). Pleasantness of high fat food 
images was significantly lower than of positive images (P<.001). Low fat food images and positive 
images were rated significantly higher than neutral images (P<.001) in both groups. Subsequent 
analysis on high fat and low fat food images showed significant main effects of group and image 
(P<.05). Pleasantness ratings of food images in FD were significantly lower than in HC, and 
pleasantness of high fat food images was rated significantly lower than that of low fat food images 
in FD (P<.05).  
SCR: ANOVA analysis for 5 image sets resulted in a significant main effect of image (P<.001). 
Post-hoc analysis showed that, in both groups, SCR standardized ratio for negative images was 
significantly higher than for other image (vs neutral, positive, high fat images, each P<.001; vs 
low fat images P<.01). There were no significant differences between groups for either ANOVA. 
EMG corrugator supercilii: ANOVA analysis for 5 image sets showed a significant main effect 
of image (P<.001). Post-hoc analysis showed that the EMG response to negative images was 
significantly higher than to any other image (positive, high fat food, low- fat food images, all 
P<.001; neutral image P<.01). There were no significant differences between groups from either 
ANOVA. 
EMG zygomaticus major ANOVA analysis for 5 image sets showed that there was a significant 
main effect image (P<.001) and interaction of group*image (P<.05). Post-hoc analysis showed 
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that the zygomaticus major muscle EMG response to high fat food images was significantly higher 
than to negative (P<.01) and low fat food images (P<.05). EMG signal was significantly higher to 
positive images than to negative, neutral, and low fat food images (all P<.001). No differences 
were found between groups from the 2X5 ANOVA. A 2X2 ANOVA analysis for high fat and low 
fat images showed a significant main effect of image (P<.01). EMG activation was lower in FD 
patients than in HC and significantly higher to high fat food images than to low fat food images in 
HC (P<.01).  
HRV SDNN 2X5 and 2X2 ANOVA analysis showed that there was a marginal main effect of group 
(p=.058, p=.059, respectively) and FD patients showed higher SDNN values than HC group.  
HRV HF No significant main effect was registered for either the group or the images of HF value.  
HRV LF/HF ratio 2X5 and 2X2 ANOVA analysis showed that there was a significant main effect 
of group (P<.01, P<.05, respectively) and FD patients showed significantly lower LF/HF ratio 
than HC group.  
 
3.4. Experiment 2. Eye tracking experiment  
Initial fixation (coefficient %): There were no significant differences according to the ANOVA 
(high fat: FD -24.78±7.53, HC -24.87±6.19; low fat: FD -32.80±5.62, HC -31.33±3.86, Figure 2.A.)  
Fixation duration (coefficient %): There was a significant main effect of group and both high 
and low fat food images were fixated significantly less by FD patients than by HC (high fat: FD 
2.77±5.18, HC 15.07±5.16; low fat: FD 0.60±5.34, HC 12.01±5.53; P<.05, Figure 2.B.).  
Anticipated symptom rating: There was a significant main effect of group on anticipated 
symptom rating, with FD patients showing higher ratings to high fat food images used in 
Experiment 2 than HC (P<.001). Post-hoc analysis showed that FD patients anticipated 
significantly higher pain and burning sensation than the HC group (P<.05, P<.01, respectively) 
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and there were no differences in fullness and satiation between groups. As for the low fat food 
images, none of the symptoms differed between groups (Supplementary Table 3.). 
3.5. Correlation analysis  
Pearson correlation analysis revealed significant negative correlations between the fat 
intake and BDI-II (r=-.88), fat intake and FCQ_DIFF (r=-.93), energy intake and FCQ_DIFF 
(r=-.95), and STAI_state and FCQ_state score (r=-.91, P<.05) in FD patients.  
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4. Discussion  
 We investigated physiological responses and the visual attention to food and non-food 
images in FD patients and healthy controls. Food craving, depression, and anxiety scores were 
significantly higher in FD patients than in HC. After food intake, FD patients experienced more 
symptoms of bloating, nausea, vomiting, abdominal pain, abdominal discomfort and burning 
sensation, despite lower total food/energy (kcal) consumption than the HC group. FD patients rated 
significantly lower pleasantness of both high and low fat food images than HC group. Although 
there was no difference in the initial orientation bias between groups, FD patients also had a 
significantly lower total attentional processing time of food images versus non-food images than 
HC group. The depression score with the consumption of fat, fat restriction score with fat/total 
energy intake, and anxiety level with the food craving state score were negatively correlated in FD 
patients only. 
In this study, FD patients showed higher meal-induced FD symptoms after consuming less 
food and energy than healthy controls. It is noteworthy that pain and burning sensation in FD 
patients subsided immediately after meal ingestion and then gradually increased again. These 
results suggest that food ingestion can not only aggravate but also alleviate FD symptoms. 
According to a previous study12, the intensity of each FD symptom increased significantly 
following meal ingestion. These inconsistent results may be due to the different composition of 
meals and instructions (“eat everything” vs “eat as much as you want”), and sample characteristics. 
We also found that FD patients also suffered from FD symptoms (pain, discomfort, burning, 
bloating) even when they were in a fasted state. FD patients are known to eat more frequently, but 
take smaller portions and are unable to finish a normal meal portion. This may be due to dynamic 
changes of symptoms in a state of hunger or fullness.  
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As often reported in earlier studies, FD patients had significantly higher anxiety and 
depression levels than HC group. In the current study we detected a negative correlation between 
the food craving state score and the state anxiety score, and between the depression score and the 
amount of fat intake in FD patients. Food craving is known to be less related to hunger than to the 
restraint or deprivation of food37. Lower energy consumption in FD patients also suggests that food 
craving may be induced by deprivation. A further explanation is that the food craving is more 
related to a negative mood, such as anxiety38. Although a clear conclusion cannot be drawn from 
correlation analyses, the results may show the mutual influences of a state of anxiety, food craving, 
depression, and eating behavior in FD patients.  
High HRV and decreased sympathetic activation in FD patients were observed regardless 
of the type of pictures, which is akin to the results of previous studies 39, 40. The reduced HRV and 
increased sympathetic activation may therefore be an intrinsic characteristic of FD patients rather 
than a response to external stimuli. Furthermore, the emotional response during the visual 
stimulation of food and non-food cues did not differ significantly between groups. This can be 
interpreted along with the eye tracking results, which showed a similar tendency of initial attention 
with HC group and a lower total attention processing time (fixation duration) to food images in FD 
patients than in the HC group. While visual food images may not immediately induce negative 
emotional and avoidance responses, a late cognitive processing of the images by higher cognitive 
function may cause the avoidance response to food images in FD patients while processing food 
images. These results suggest that high level cognitive functions rather than autonomic and 
emotional mechanisms can operate differently in FD patients. Furthermore, a decreased fixation 
duration on food images in FD patients is at variance with earlier findings in patients with obesity 
and binge eating disorder33, 41 (where increased duration on food images was reported) and is 
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similar to the results in anorexia nervosa patients42 suggesting a positive and negative perception 
of food cues in eating-related diseases.  
The reduced pleasantness of and attentional bias to visual food stimuli in FD patients could 
be a key to future psychotherapeutic intervention and research. Various treatment options have 
been proposed for FD, such as H. pylori eradication, prokinetic agents, acid suppressive 
medications, antidepressants. Nevertheless, a standardized treatment strategy for FD patients has 
yet to be established and cognitive behavioral therapy remains an unexplored area43. A new therapy 
that includes self-restraint response to food, emotional management, and eating behavior 
modification could be considered for patients who do not respond to conventional therapies. 
Furthermore, how FD patients perceive, encode, store, and recall the value of food and how food 
memories influence their food-related decision making are interesting topics for future studies. 
In the interviews conducted before the study, almost all FD patients complained about the 
changes in their eating behavior and their poor quality of life. Most patients avoided symptom-
related foods, such as fatty foods, bread, pasta, or alcohol, which varied from person to person and 
almost all patients requested advice as to what food they should be eating. Fatty foods aggravated 
the symptoms in some patients, whereas others remained unaffected. Nevertheless, the high fat 
restriction score was significantly related to the lower intake of fat and total energy in FD patients 
only and they anticipated more severe symptoms to high fat food images than HC. Previous 
negative memory of the aftereffect of eating could be extended to the restriction of food intake and 
the attentional avoidance20. This fact needs to be better recognized in clinics and clinical studies, 
and food consultation might be instrumental in improving the quality of life and establish healthier 
eating guidelines for patients.  
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A limitation of this study was the difficulty in finding one particular item of food that might 
be either symptom-related or symptom-unrelated to each patient. We therefore used standard 
images for all participants. This may be the basis for the similar autonomic and emotional responses 
to high fat and low fat images in our study. However, since this first-of-its-kind study investigates 
the basic physiological response to food in FD patients, we tried to include various measurements 
with diverse images from established databases. Moreover, our sample size was not large enough 
to conduct further subgroup analysis and we did not examine any differences between PDS and 
EPS, patients with severe and mild FD/depression/anxiety symptoms. Due to the lack of knowledge 
on the food-related behavior, cognitive, emotional, and physiological responses of FD patients, 
further studies with large sample size are necessary.   
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5. Conclusion  
 We observed an increased food craving, decreased amount of food intake, food ingestion- 
induced aggravation of FD symptoms, and abnormal visual processing time and perception of food-
related pleasantness in FD patients. The effectiveness of conventional therapies in FD patients 
might be enhanced by taking dietary consultation and modification of psychological response to 
food as well as somatic symptoms, and future studies on the evaluation of food may identify the 
underlying pathophysiology of FD. 
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Figures and figure legends  
Figure 1. Experimental protocol  
 
A. Experimental procedure of the study. B. Illustration of the Experiment 1 including skin 
conductance response, heart rate, electromyography measurements and pleasantness rating to food 
and non-food images. Randomized order of 5 blocks of images (neutral, positive, negative, high 
fat, and low fat food images, n=30, 6000ms for each image) with fixation cross (5000ms) between 
each block were presented. C. Schematic presentation of the eye tracking experiment using free 
exploration paradigm. Low fat food and non-food pairs and high fat food and non-food pairs (n=12, 
respectively) were presented for 3000 ms with 2000 ms of fixation cross between pairs. Location 
of the images (1st-4th quadrant) was balanced.   
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Figure 2. The coefficient percentage of initial fixation and total fixation time in FD and 
healthy controls 
Mean and standard error of coefficient % of initial fixation (A) and total fixation duration (B) on 
low fat food and high fat food images compared to paired non-food images in FD patients and 
healthy controls. There were no significant differences of initial fixation between groups and 
images. Total fixation time was significantly lower in FD patients than in HC for both high and 
low fat food images (P<.05). 
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Supplementary Table 1. FD symptom ratings before and after breakfast  
  Baseline Post1 Post2 Post3 P value 
(ANOVA) 
Hunger HC 5.09±0.65 1.14±0.40 1.16±0.40 2.62±0.67 main effect of 
time p<0.01 
 
FD 4.5±0.85 0.71±0.28 1.7±0.58 1.75±0.42 
Appetite HC 4.68±0.52 1.82±0.55 2.31±0.60 3.65±0.74 main effect of 
time p<0.05 FD 4.33±0.89 1.5±0.48 2.2±0.69 1.89±0.53* 
Fullness HC 1.16±0.42 2.29±0.60 2.38±0.53 1.97±0.43 main effect of 
time p<0.05 FD 2.67±0.86 4.82±0.92* 3.03±0.69 3.36±0.76 
Satiation HC 1.97±0.58 6.54±0.59 5.50±0.63 4.71±0.74 main effect of 
time p<0.01 
FD 2.07±0.45 5.57±0.77 3.73±0.72 5.14±0.90 
Abdominal 
pain 
HC 0.24±0.08 0.14±0.06 0.13±0.05 0.18±0.07 main effect of 
group p<0.05 
(FD>HC) 
FD 1.93±0.75* 0.82±0.39 0.90±0.31* 1.54±0.60* 
Abdominal 
discomfort 
HC 0.21±0.06 0.14±0.06 0.22±0.10 0.21±0.10 main effect of 
group p<0.01 
(FD>HC) FD 3.83±0.83*** 3.04±0.80** 2.53±0.75** 2.64±0.67*** 
Burning HC 0.50±0.20 0.21±0.08 0.22±0.10 0.18±0.07 main effect of 
group p<0.01 
(FD>HC) FD 2.47±0.97*** 1.39±0.62** 1.17±0.64** 2.93±0.82*** 
Bloating HC 0.29±0.13 0.39±0.16 0.38±0.17 0.41±0.19 main effect of 
time p<0.05 
main effect of 
group p<0.01 
(FD>HC) 
FD 2.50±0.83* 4.43±0.87*** 3.07±0.77** 4.32±0.83*** 
Nausea HC 0.53±0.20 0.78±0.06 0.31±0.15 0.29±0.14 main effect of 
time p<0.05 FD 1.47±0.66 1.07±0.64 1.23±0.41* 1.64±0.62* 
Vomiting HC 0.18±0.06 0.14±0.06 0.38±0.21 0.24±0.10 Not 
significant FD 0.77±0.33 1.07±0.64 0.77±0.26 0.71±0.22* 
Mean±standard error 
ANOVA: analysis of variance; Baseline: baseline VAS rating before breakfast; HC: healthy 
controls; Post1: VAS rating after breakfast; Post2: VAS rating 20-25 minutes after breakfast; Post3: 
VAS rating 45-50 minutes after breakfast; FD: functional dyspepsia patients 
*, **, ***: two sample t-test FD vs HC. p>0.05, >0.01, >0.001, respectively  
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Supplementary Table 2. Physiological response to and pleasantness rating of emotional and 
food images in FD patients and healthy controls 
  non-food emotional images food images P value (ANOVA) 
  Neutral Positive Negative High 
-fat 
Low 
-fat 
General effect 
(2X5) 
Fat effect 
(2X2) 
Pleasantness HC 5.08± 
0.39 
7.46± 
0.38 
2.17± 
0.18 
6.61±
0.40 
7.38± 
0.27 
Main effect of 
image p<0.001 
Main effect of 
group p<0.05 
Main effect of 
image p<0.05  
FD 5.27± 
0.52 
7.94± 
0.30 
1.97± 
0.20 
5.62±
0.47 
6.79± 
0.39 
SCR (ratio) HC 0.92± 
0.17 
0.61± 
0.11 
1.69± 
0.27 
0.88±
0.12 
0.83± 
0.16 
Main effect of 
image p<0.001 
NS 
FD 0.85± 
0.17 
0.83± 
0.24 
1.55± 
0.24 
0.72±
0.08 
1.05± 
0.17 
EMG_corruga
tor supercilii 
(ratio) 
HC 1.03± 
0.19 
0.26± 
0.10 
1.96± 
0.39 
0.90±
0.17 
0.69± 
0.20 
Main effect of 
image p<0.001 
 
NS 
FD 0.94± 
0.21 
0.77± 
0.20 
1.69± 
0.31 
0.66±
0.18 
0.91± 
0.15 
EMG_zygomat
icus major 
(ratio) 
HC 0.90± 
0.17* 
1.35± 
0.25 
0.41± 
0.10 
1.67± 
0.35 
0.59± 
0.14 
Main effect of 
image p<0.001 
Interaction effect 
of group*image 
p<0.05 
Main effect of 
image p<0.01 
FD 0.37± 
0.08 
2.00± 
0.38 
0.40± 
0.11 
0.89± 
0.26 
0.52± 
0.12 
HRV_SDNN 
(ms) 
HC 28.79±3.
81 
25.78± 
2.51 
25.79± 
2.50 
25.90
±3.01 
25.04± 
2.86 
Main effect of 
group p=0.058 
 
Main effect of 
group 
p=0.059 FD 31.52±4.
53 
32.32± 
4.66 
27.14± 
4.75 
32.06
±5.02 
35.43± 
5.37 
HRV_HF HC 383.86±
96.79 
236.05 
±42.07 
309.05 
±56.23 
331.3
7 
±60.3
6 
235.21 
±42.00 
NS NS 
FD 401.50 
±82.67 
338.32 
±109.64 
261.48 
±108.06 
298.9
3 
±83.3
7 
459.14 
±143.1
8 
HRV_LF/HF 
ratio 
HC 1.75± 
0.42 
1.44± 
0.21 
1.38± 
0.31 
1.06± 
0.13 
1.67± 
0.31 
Main effect of 
group p<0.01 
 
Main effect of 
group p<0.05 
FD 1.02± 
0.17 
1.21± 
0.25 
0.48± 
0.07* 
0.92± 
0.21 
0.86± 
0.17 
Mean±standard error 
EMG: electromyography; FD: functional dyspepsia patients; HC: healthy controls; HF: high 
frequency; HRV: heart rate variability; LF: low frequency; NS: not significant; SCR: skin 
conductance response; SDNN: standard deviation of all normal RR intervals  
*, **, ***: post-hoc analysis, FD vs HC. p>0.05, >0.01, >0.001, respectively 
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Supplementary Table 3. Anticipated FD symptom rating to food images 
 Healthy controls FD patients P value (ANOVA) 
High fat 
food 
Abdominal 
fullness 
5.03±0.44 5.71±0.34 Main effect of 
group p<0.01 
(FD>HC) Satiation 4.91±0.51 5.33±0.50 
Abdominal 
Pain 
2.49±0.32 3.89±0.57* 
Burning 2.13±0.35 4.13±0.54** 
Low fat 
food 
Abdominal 
fullness 
5.02±0.54 5.39±0.46 Not significant 
Satiation 4.82±0.47 5.07±0.58 
Abdominal 
Pain 
2.96±0.61 3.34±0.55 
Burning 2.47±0.52 3.36±0.51 
Mean±standard error 
ANOVA: analysis of variance; FD: functional dyspepsia; HC: healthy controls 
 *, **, ***: post-hoc analysis, FD vs HC. p>0.05, >0.01, >0.001, respectively 
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8. Paper IV. The effect of fat label on gastrointestinal symptoms and brain activity 
in functional dyspepsia patients: an fMRI study 
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Abstract 
High fat meals in particular are associated with dyspeptic symptoms in functional dyspepsia 
(FD) patients. However, it is still unclear what neural processes are involved and how they can be 
modulated by psychological factors such as expectation. We aimed to investigate brain activity by 
functional magnetic resonance imaging (fMRI) after the ingestion of high and low fat food with 
correct and incorrect fat information. Methods: We compared 12 FD patients and 14 age- and BMI-
matched healthy controls (5 males in each group). We recorded resting state fMRI on four different 
days after an overnight fast before and after ingestion of one of four yogurts (200ml, either 10% or 
0.1% fat, with ‘low fat’ or ‘high fat’ label (2x2 factorial design), sequence-randomized across 
subjects). The statistical significance level was set at α=0.05 and multiple comparison correction 
was applied. Results: FD patients showed more pronounced dyspeptic symptoms after consuming 
high fat-labeled yoghurt than low fat-labeled yoghurt, irrespective of the actual fat content. This is 
indicative of either a placebo effect of low fat information, or a nocebo effect of high fat 
information on symptom expression. FD patients showed greater activity than healthy controls in 
occipital areas before and after ingestion regardless of fat content and label as well as greater 
activity in the middle frontal gyrus before ingestion. In addition, functional connectivity (FC) from 
the insula to occipital cortex (I-O) increased after high fat and decreased after low fat ingestion in 
FD patients. FC from the insula to the precuneus (I-P) was higher in FD patients than in healthy 
controls after ingestion of yoghurt with a low fat label. In FD patients, I-O functional connectivity 
negatively correlated with nausea and I-P functional connectivity with FD symptom intensity, food 
craving, and depression. In summary, our results endorse the importance of psychological 
perception of food on the incidence of dyspeptic symptoms and on the altered brain activities. 
Taken together, these findings provide further evidence for the importance of cognitive 
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components in perception of fat, food craving, depression, and brain functions in 
pathophysiological mechanisms of FD.   
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1. Introduction  
 Functional dyspepsia (FD) is characterized by postprandial fullness, early satiation, 
epigastric pain, bloating, nausea symptoms after meals, particularly high fat food [1, 2], in the 
absence of any structural abnormalities in the gastrointestinal tract [3, 4]. The effect of fat in the 
altered gastrointestinal sensitivity and symptoms is a well-known pathophysiological feature in FD 
patients. Intra-duodenal infusion of lipids, not glucose nor saline, were shown to induce nausea, 
bloating, and vomiting symptoms in FD patients [5, 6]. After ingestion of a high fat meal, nausea 
and pain symptoms were greater than after a high carbohydrate meal [1] and food diaries revealed 
that FD patients consumed lower amounts of fat and that bloating symptoms were related to the 
amount of fat ingested [2].  
Feinle-Bisset et al. showed that a low fat meal, served to FD patients under the pretense 
that it was high fat meal, caused more severe fullness and bloating symptoms than a low fat meal 
served to with the correct fat information. [7]. In addition it has been shown in healthy volunteers 
that ghrelin levels, as a physiological marker of satiation, varied after ingestion of identical 
milkshakes when subjects were informed before that this was either a high fat, high calorie or a 
low fat, low calorie milkshake. These findings suggest that the cognitive perception of fat at the 
central nervous system level plays a prominent role in the secretion of hormones, altered perceptual 
response to fat, and symptom reporting. The non-specific improvement (or worsening) of 
symptoms by an inactive treatment or treatment-unrelated cue – the placebo (or nocebo) effect – is 
due to the belief or expectation of symptom relief (or exacerbation). It is conceivable that if FD 
patients were aware of a close association between their symptoms and high-fat diet, the 
information on the amount of fat (more or less) could have an impact on their dyspeptic symptoms.  
One hypothesis from the early 1990s proposed that abnormalities of the brain-gut axis are 
one of the key mechanisms governing FD [8]. The presence of the food or nutrient in the 
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gastrointestinal tract is signaled to the central nervous system which, in turn, modulates 
gastrointestinal function and eating behavior, and controls the gastrointestinal symptoms [9]. 
Furthermore, some of the brain’s many pathways for controlling the perception of internal and 
external stimuli might be impaired in FD patients and cause somatic symptoms. The recent 
development of functional magnetic resonance imaging (fMRI) technique has enabled scientists to 
characterize the intrinsic brain activities and networks, and its intervention-related changes. A large 
number functional neuroimaging studies have investigated the brain activities and networks during 
the resting state (no-tasks) [10-17] and in reaction to the visceral distention [18-20]. They suggest 
that there is an alteration in the activation of the cognitive and pain processing brain regions 
(prefrontal cortex, somatosensory cortex, insula, cingulate cortex, thalamus, etc.) in FD patients 
[21]. However, little is known about how fat or fat information is processed in the brain or how it 
is mediated by pathological changes such as FD symptoms, decreased quality of life, increased 
depression and anxiety, food craving, etc., in FD patients. 
In the current study, we investigated the effect of fat ingestion and fat label, and 
pathological factors on the resting state brain activities in FD patients and healthy controls (HC). 
We hypothesized that i) the resting state brain activity in cognitive and pain processing networks 
are mainly affected in FD patients, and ii) the functional connectivity (FC) emerging from the 
middle-posterior insula is associated with the pathological variables in FD patients. Bilateral 
middle-posterior insula was selected as a seed region since it is involved in signaling interoceptive 
visceral sensation and homeostatic information. It responds to a wide variety of experimental 
stimuli including pain/non-painful/salient/emotional stimuli as a region of the homeostatic afferent 
network [22-27]. Moreover, the insula is activated during baseline condition (compared to healthy 
controls) and in response to visceral distention (compared to baseline) [19, 20, 28], and correlates 
with FD symptom intensity [10, 13], disease-related quality of life [29], and disease duration [16] 
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in FD patients. We tested our hypotheses by measuring resting state fMRI in the fasted and fed 
state and performing seed-based FC analysis, correlation analysis, and mediation analysis.   
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2. Methods 
2.1. Participants 
12 FD patients (5 males, age 46.46±5.64 years, mean±standard error) and 14 for age- and 
BMI controlled healthy subjects (HCs, 5 males, age 45.79±4.71 years) participated in the study. 
Right-handed volunteers within the range of 18-75 years of age and with a body mass index (BMI, 
weight/height2) of 19-29 kg/m2 were included. FD patients were diagnosed on the basis of the 
ROME III criteria [30] as well as an unsuspicious endoscopy documented in their medical records. 
Volunteers with non-removable metal implants, claustrophobia, severe psychiatric illness, 
substance dependence and abuse, and any food allergy or intolerance were excluded from the study. 
The ethics committee of the Medical Faculty, University of Tübingen, Germany (633/2015802) 
approved the study and all participants gave their informed consent. 
 
2.2. Test food  
Two plain yogurts, low fat (0.1% fat, 200ml, 106kcal, 13.8g carbohydrate, 11g protein) and 
high fat (10% fat, 200ml, 266kcal, 14g carbohydrate, 6g protein, Weihenstephan, Freising, 
Germany) were used. Congruent or incongruent labels were attached to each yogurt (high fat yogurt 
with ‘high fat’ label: HH, high fat yogurt with ‘low fat’ label: HL, low fat yogurt with ‘high fat’ 
label: LH, low fat yogurt with ‘low fat’ label: LL).  
 
2.3. Study design  
Each participant was examined in the morning (7-11 a.m.) on four separate occasions 
following an overnight fast. Smoking and consumption of alcohol, coffee, or tea were prohibited 
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during the fasting period. Participants completed a visual analogue scale (VAS; 0=no symptoms at 
all, 10=very severe symptoms) to assess hunger, appetite, abdominal fullness, satiation, nausea, 
vomiting, abdominal pain and uncomfortable, burning, and bloating (baseline FD symptoms). 
Identical VAS ratings were assessed again immediately (Post1), 10 minutes (Post2), and 20 minutes 
(Post3) after the yogurt consumption. Between the pre-yogurt and post-yogurt fMRI sessions, 
participants were permitted to exit the scanner and were served one of the 4 yogurts (HH, HL, LH, 
LL) in randomized order. Participants were asked to sit on the MRI table and eat a whole portion 
of yogurt within 5 minutes. At the end of the study, patients indicated their dyspepsia symptom 
intensity, and disease-related quality of life was measured using Nepean Dyspepsia Index (NDI) 
[31]. Depression and anxiety levels were evaluated using Beck Depression Inventory (BDI-II) [32] 
and State-Trait Anxiety Inventory (STAI) [33]. Furthermore, the Eating Disorders Examination 
Questionnaire (EDE-Q) [34], Food Craving Questionnaire (FCQ) [35], and Fat Preference 
Questionnaire (FPQ) [36] were used to evaluate their eating behavior. 
 
2.4. Imaging protocol  
All images were obtained with a 3 Tesla scanner (Siemens MAGNETOM Prisma, Erlangen, 
Germany). On the first day, a high resolution T1-weighted anatomical image (magnetization-
prepared rapid gradient-echo) was recorded (repetition time (TR)=2300ms, echo time 
(TE)=4.18ms, 176 slices, matrix=256×256, voxel size=1×1×1cm3). Whole brain blood 
oxygenation level-dependent (BOLD) data were obtained using standard T2*-weighted echo planar 
sequence (160 volumes, TR=2000ms, TE=30ms, 30 slices, matrix=64×64, flip angle=80°, voxel 
size=3×3×3.4cm3) before and after ingestion.  
 
2.5. Imaging processing  
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Preprocessing of the BOLD signal was performed using Data Processing Assistant for 
Resting-State fMRI (DPARSF, http://restfmri.net, v2.2) [37] and SPM8 (Statistical Parametric 
Mapping, Wellcome Trust Centre for Neuroimaging, London, UK). Images for each subject were 
assessed to identify any excessive movement (>2mm or 2º degree) and the first 4 volumes were 
discarded for signal equilibrium and adaptation. Slice time-correction and head motion- correction 
were applied to raw images, and functional images were realigned and co-registered with the 
structural image. Images were normalized into the Montreal Neurological Institute (MNI) space 
and smoothed with a Gaussian kernel full width at half maximum 6mm. Following preprocessing, 
amplitude of low frequency fluctuations (ALFF) analysis within the low frequency band (0.01-
0.1Hz) was performed using the DPARSF. The time series data of each voxel was transformed into 
the frequency domain, and the power spectrum amplitude was calculated. The square root was 
calculated at each frequency of the power spectrum, and the average square root was then obtained 
across 0.01-0.1 Hz at each voxel. This average square root was taken as the ALFF and mean ALFF 
(mALFF) was calculated as the original ALFF value/averaged ALFF across all voxels. 
For seed-based FC analysis, 8mm sphere ROIs of the left and right middle-posterior insula 
were defined by peak coordinates (x=-42, y=-33, z=17; x=36, y=-15, z=13, respectively) of clusters 
from a resting state ALFF map (family-wise error (FWE) corrected p<0.05, cluster dimension k>10 
voxels). The averaged time course was then obtained from the ROIs and the correlation analysis 
was performed in a voxel-wise fashion. Finally, the correlation coefficient map was converted into 
z maps by Fisher’s r-to-z transform to improve the normality (zFC). For correlation and mediation 
analysis, the first eigenvariate of each cluster that survived the threshold from mALFF and zFC 
maps was extracted. 
 
2.5 Statistical analysis 
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All statistical analyses were performed using IBM SPSS statistics 24.0 (IBM Corp. New 
York, USA). An independent two sample t-test was used to compare sample characteristics 
between the groups. For VAS ratings of FD symptoms, a two-way repeated ANOVA was conducted 
with time (pre, post1, post2, post3) and the group (HC, FD) factors. For ALFF and FC maps, SPM 
second level t-tests between the groups (HC, FD), fat content (high, low), and labels (high, low) 
were performed. Two-tailed Pearson’s partial correlation analysis was also computed between 
questionnaire variables and the intensity of ALFF and FC while controlling for age and BMI. 
Mediation analysis was performed as described by Hayes using the PROCESS macro [38]. Age 
and BMI were included as covariates in the simple mediation model with 1000 bootstrap samples. 
The statistical significance level was set at α=0.05 while FWE correction for fMRI analysis and 
Bonferroni correction for the analysis of behavior data were applied to account for multiple 
comparison. 
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3. Results 
3.1. Sample characteristics 
 Sample characteristics and questionnaire scores are presented in Table 1. We ascertained 
no significant differences in age and BMI between the groups (p>0.5). FD patients showed a 
significantly higher NDI_Symptom score and lower NDI_QOL score (p<0.001) than HC. FD 
patients also had significantly higher depression, anxiety state and trait levels (p<0.01, p<0.001, 
p<0.05, respectively) and higher FCQ-state scores (p<0.05) than HC. Among FPQ subscales 
(FPQ_TASTE: % of high fat food which tastes better than low fat food, FPQ_FREQ: % of high fat 
food which is eaten more frequently than low fat food, FPQ_DIFF: TASTE-FREQ), only 
FPQ_TASTE score was significantly higher in FD patients than HC. No significant differences 
were observed between the groups in EDE-Q total and subscale scores. 
Table 1 Baseline characteristics of the study sample 
 Healthy controls FD patients P value 
Gender (m/f) 5/9 5/7 - 
Subgroup - PDS: 4/6, EPS: 5/4 - 
 FD duration 
(month) 
- 156±57.24 
 
- 
Age (year) 45.79±4.71 
 
46.46±5.64 
 
- 
BMI (kg/m2) 23.79±0.91 
 
22.93±0.63 
 
- 
NDI_Symptom 4.5±1.35 
 
64.5±9.10 
 
<0.001 
NDI_QOL 49.44±0.25 
 
31.56±3.74 
 
<0.001 
EDE-Q Total 
       Restraint  
       Eating concern     
       Weight concern  
       Shape concern 
1.30±0.26 
1.13±0.18 
0.44±0.22 
1.71±0.39 
1.87±0.49 
0.80±0.34 
0.38±0.17 
0.20±0.13 
0.86±0.36 
1.33±0.44 
 
NS 
NS 
NS 
NS 
NS 
BDI-II 3.07±1.70 
 
13.17±2.57 
 
<0.01 
STAI_state 
STAI_trait 
29.64±1.97 
30.63±2.17 
 
43.17±2.78 
41.92±3.76 
 
<0.001 
<0.05 
FCQ_state 
FCQ_trait 
31.82±1.72 
77.71±8.47 
38.07±1.94 
87.17±9.82 
 
<0.05 
NS 
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FPQ_TASTE 
FPQ_FREQ 
FPQ_DIFF 
46.48±4.03 
40.63±4.54 
5.85±3.57 
 
67.56±12.24 
55.67±5.60 
11.88±6.52 
 
<0.01 
NS 
NS 
Mean±standard error 
BDI: Beck depression inventory; BMI: body mass index; EDE-Q: Eating disorder examination 
questionnaire; EPS: epigastric pain syndrome; f: female; FCQ: Food cravings questionnaire; FD: 
functional dyspepsia; FPQ: Fat preference questionnaire; FPQ_TASTE: % of high fat food which 
tastes better than low fat food; FPQ_FREQ: % of high fat food which is eaten more frequently than 
low fat food; FPQ_DIFF: high fat restriction (TASTE-FREQ); m: male; NDI: Nepean dyspepsia 
index; NS: statistically not significant; PDS: postprandial distress syndrome; QOL: quality of life; 
STAI: State trait anxiety inventory 
P value: independent two sample t-test, FD vs HC 
 
3.2. Food induced FD symptoms  
FD symptom ratings are described in Supplementary Table 1. The significant main effect 
of time was found in appetite, hunger (decreased after ingestion and later increased), and satiation 
ratings (increased after ingestion and later decreased, p<0.001). The significant main effects of 
group were found in nausea, vomiting, and bloating symptoms (FD>HC, p<0.001). Both significant 
main effects of group (FD>HC, p<0.01) and time (increased after ingestion and decreased later in 
both groups, p<0.001) were found in fullness rating. Both significant main effects of group and 
label were found in abdominal pain, discomfort, and burning symptoms. FD patients reported more 
severe symptoms than HC (p<0.001, p<0.001, p<0.01, respectively) and the high fat labeled yogurt 
resulted in more pronounced symptoms than the low fat labeled yogurt (p<0.05, p<0.01, p<0.05, 
respectively). Interaction of the group and the label was found in the symptom of discomfort 
(p<0.05) and the main effect of time was also found in the symptom of burning (which decreased 
after yogurt eating and later increased, p<0.05). No adverse events were recorded.  
 
3.3. Resting state brain activity  
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3.3.1. Baseline ALFF (pre-yogurt session)  
 FD patients showed a significantly greater ALFF than HC in the bilateral middle frontal 
gyrus, left middle and right inferior occipital gyrus and lower ALFF in the left superior frontal 
gyrus and left middle cingulate gyrus (all p<0.001, FWE corrected, Table 2). 
 
3.3.2. Changes of ALFF (post-yogurt vs pre-yogurt session)  
After yogurt ingestion, significant group differences of changes of ALFF were observed in 
the left middle occipital gyrus and right cerebellum. ALFF increased in FD patients regardless of 
the type of yogurt consumed but decreased in HC compared to baseline. ALFF of the left middle 
occipital gyrus is significantly higher in FD patients than in HC, particularly in HH state (all p<0.05, 
FWE corrected, Table 2). 
Table 2 Brain regions showing amplitude of low frequency fluctuation (ALFF) differences at 
baseline (pre-yogurt) and changes of ALFF (post-pre yogurt) between groups 
Regions  Z scores of 
peak voxel 
Coordinates of peak 
voxel in MNI space 
P value 
pre-yogurt FD>HC    
  Left mid. frontal gyrus  
  Right mid. frontal gyrus 
Right inf. occipital gyrus 
Left mid. occipital gyrus 
6.12 
5.68 
5.48 
5.23 
-48, 30, 38  
36, 15, 60 
39, -93, -13  
-36, -75, 8 
P<0.001 
pre-yogurt HC>FD    
Left sup. frontal gyrus 
Left mid. cingulate cortex  
6.14 
5.45 
-12, 15, 72 
-9, 18, 34 
P<0.001 
post-yogurt vs pre-yogurt FD>HC    
Left mid. occipital gyrus 
Right cerebellum 
4.36 
4.06 
-33, -81, 34  
48, -60, -30 
P<0.05 
 
post-yogurt vs pre-yogurt FD>HC, HH    
Left mid. occipital gyrus 4.43 -30, -81, 38  P<0.05 
Family-wise error-corrected p value, cluster dimension k>10 voxels  
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FD: functional dyspepsia; HC: healthy controls; inf.: inferior; mid.: middle; MNI: Montreal 
Neurological Institute; sup.: superior 
 
3.4. Functional connectivity  
 In FD patients, functional connectivity of the left insula to the right insula and the left 
inferior occipital gyrus increased significantly after eating high fat yogurt (HH, HL) and decreased 
after eating low fat yogurt (LH, LL) regardless of the label (p<0.05). There were no significant 
differences of changes in FC in HC.  
 In comparison to HC, FD patients showed increased FC between the right insula and the 
bilateral precuneus while FC decreased in HC compared to baseline after they had eaten low fat 
labeled yogurt (p<0.05, Table 3).  
Table 3 Changes of functional connectivity (post-pre yogurt) within and between groups  
 
Condition 
Seed 
region 
Regions of significant 
FC changes 
Z scores of 
peak voxel 
Coordinates of peak 
voxel in MNI space 
P value 
High fat>low fat 
in FD 
Left 
insula 
Right insula 
Left inf. Occipital gyrus 
5.09 
4.30 
39, 18, -4 
-33, -87, -4  
<0.05 
FD>HC 
low fat label 
yogurt 
Right 
insula 
Left precuneus 
Right precuneus 
3.71 
3.71 
-6, -57, 13  
21, -51, 21 
<0.05 
Family-wise error corrected p value, cluster dimension k>10 voxels  
FC: functional connectivity; FD: functional dyspepsia; HC: healthy controls; inf.: inferior; MNI: 
Montreal Neurological Institute 
 
3.5. Pearson’s correlation analysis 
Significant negative correlations were established between the intensity of FD symptom 
and disease-related quality of life (r=-0.85, p<0.01), and positive correlations between the intensity 
of FD symptom and state depression level (r=0.52, p<0.05) in FD patients. Baseline resting state 
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brain activity (ALFF) in the left middle frontal gyrus negatively correlated with the intensity of FD 
symptom (r=-0.77), food craving score (r=-0.78, p<0.01), and depression (r=-0.73, p<0.001) and 
positively correlated with QOL (r=0.73, p<0.05) in FD patients. FC intensity before ingestion (pre-
yogurt session) between the right insula and right precuneus negatively correlated with the FD 
symptom intensity, food craving (p<0.01), quality of life, and depression level (p<0.05) and 
positively correlated with QOL (p<0.05) in FD patients. The FC intensity of the post-yogurt session 
between the left insula and left inferior occipital gyrus negatively correlated with nausea symptom 
rating in FD patients (p<0.05, Table 4).  
 
Table 4 Pearson’s partial correlation analysis 
 NDI_QOL STAI_state pre-yogurt 
ALFF left mid. 
frontal gyrus 
pre-yogurt FC 
right insula-
right precuneus 
post-yogurt FC 
left insula-left inf. 
occipital gyrus 
NDI_symptom -0.85** NS -0.77** -0.70** NS 
FCQ_state NS 0.72* -0.78** -0.69** NS 
BDI-II NS NS -0.73*** -0.64* NS 
Nausea (Post3) NS NS NS NS -0.64* 
Correlation coefficients with p values (*, **, ***: p<0.05, <0.01, <0.001, respectively) 
Age, sex, BMI controlled and multiple comparison-corrected 
ALFF: amplitude of low frequency fluctuations; BDI: Beck depression inventory; FC: functional 
connectivity; FCQ: Food cravings questionnaire; inf.: inferior; mid.: middle; NDI: Nepean 
dyspepsia index; NS: statistically not significant; QOL: quality of life; STAI: State trait anxiety 
inventory 
 
3.6. Mediation analysis 
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 To assess the relationship of FD-related psychological symptoms, mediation analysis was 
performed. The models and the investigated variables are described in Figure 3. The total effect of 
the quality of life on depression was significant (path c p<0.05), and was fully mediated by FD 
symptom (path a p<0.001; path b p<0.05; path c’ not significant; standardized indirect effect=-0.51, 
95% confidence interval [-1.07, -0.25]) in FD patients (Figure 3.B., Model 1). The total effect of 
depression on the quality of life was also significant (path c p<0.01) and fully mediated by FD 
symptom (path a p<0.01; path b p<0.001; path c’ not significant; standardized indirect effect=-0.43, 
95% confidence interval [-0.59, -0.26]) in FD patients (Figure 3.B., Model 2). We also found that 
the total effect of food craving on the baseline resting state brain activity in the left middle frontal 
gyrus (path c p<0.001) is fully mediated by depression (path a p<0.01; path b p<0.01; path c’ not 
significant; standardized indirect effect=-0.17, 95% confidence interval [-0.29, -0.07]) in FD 
patients (Figure 3.B., Model 3).  
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Discussion 
 Our data demonstrate I) an expectancy effect of the information about the fat content on 
symptom severity, either in high fat or low fat yogurt condition, II) the altered resting state brain 
activities in the prefrontal, occipital, cingulate, and cerebellum cortices, III) high fat-induced 
changes in the FC of the insula-inferior occipital gyrus (vs low fat) and the group difference of the 
changes in FC between the insula-precuneus in response to low fat label, IV) the negative 
correlations between FD symptom, food craving, depression and the middle frontal gyrus activity, 
nausea and the FC amplitude of the insula- inferior occipital gyrus, and V) the mediation effect of 
depression on the influence of food craving to the middle frontal gyrus activity in FD patients.  
Psychological factors in FD patients 
 Among the many psychological factors in functional dyspepsia, anxiety and depression 
have been most frequently studied. In general, anxiety and depression are more severe in FD 
patients than in healthy controls and correlate with various dyspeptic symptoms [39-42]. In this 
study, anxiety, depressive, and also food craving state were more intense in FD patients than in 
healthy controls. In a bid to understand the psychological processes in FD patients, mediation 
analysis was performed. This enabled us to determine which independent variable affects another 
(dependent variable) and which variable mediates it. We found that the bidirectional effect between 
depression and disease-related QOL scores is mediated by FD symptom severity. This indicates 
that increased depression, symptoms and decreased QOL in FD patients are influenced by each 
other and that the role of dyspeptic symptoms is crucial in these psychological interactions. 
Moreover, the inhibitory effect of craving for food on the amplitude of prefrontal brain activity is 
also mediated by depression, leading to the plausible hypothesis that food craving enhances 
depression and suppresses the brain activity involved in executive control in FD patients.  
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Expectancy effect of fat label on FD symptom  
The effect of high fat food on symptom aggravation was not established in this study, albeit 
high fat-labeled food induced more severe symptoms (abdominal pain, discomfort, and burning) 
than low fat-labeled food. This result provides new knowledge on the pathophysiology of dyspeptic 
symptoms since it demonstrates an expectancy effect of the information about fat content; these 
may be called placebo or nocebo effects [43]. While other dyspeptic symptoms, including fullness, 
nausea, vomiting, and bloating symptoms were higher in FD patients than in HC, these remained 
unchanged for the different yogurts. This may indicate that some, but not all of the visceral 
symptoms are subjective and can be modulated by cognitive factors. In particular, pain and burning 
symptoms are mainly observed in patients with epigastric pain syndrome, a subtype of functional 
dyspepsia known to be not exclusively meal-related. This may suggest that patients in different 
subgroups of functional dyspepsia may have other underlying mechanisms of peripheral and 
cognitive responses to food.  
The behavior results are inconsistent with the previous study in which both a high fat 
content and an information of high fat (HH, LH) caused higher fullness and bloating ratings than 
low fat-labeled low fat yogurt (LL) in FD patients [7]. Furthermore, the effect of label was for both 
high and low fat yogurt in our study while previous findings did not demonstrate the effect of low 
fat label for high fat yogurt (no differences between HH and HL). This might be due to the total fat 
amount in the high fat yogurt used in our study (18g vs 23.6g) and different sample characteristics. 
The high fat yogurt used in this study may not suffice to provoke high fat effect on the symptom 
reporting. The threshold of fat amount and varieties of symptoms which are affected by 
psychological factors together with the role of expectation and previous experience of food in the 
placebo/nocebo effect on visceral symptoms in FD patients will require further investigation.  
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Functional connectivity between the insula and the precuneus 
Functional connectivity of the insula-precuneus negatively correlated to the FD symptom, 
food craving, and depression in hunger state. This is enhanced in response to low fat-labeled yogurt 
in FD patients compared to HC. The precuneus and insula are known to be functionally connected 
during resting [44] and activated in response to smoking cues in smokers [45]. Insula is the core 
region of the visceral sensory [25, 26] and interoceptive networks [22-24], and is believed to be 
involved in ingestive behavior [46]. The precuneus is related to the episodic memory retrieval and 
processing of self [47, 48], appetite control [49, 50], reward of food receipt [51], reappraisal of 
benefits of eating the food [52], and comprises the default mode network [53]. Taken together, this 
connection may be affected by visceral symptoms and psychological factors and strengthened by 
the food signal processing in reward context (low fat label) by retrieving previous memories of 
food.  
Food craving 
We isolated two hyper-sensitized brain regions; the middle frontal gyrus in the prefrontal 
cortex (PFC) and the inferior occipital gyrus; which probably subserve different functions. We 
found a higher craving for food in FD patients than in HC in a hunger state. Furthermore, food 
craving influenced the middle frontal gyrus activity indirectly via depression. Food craving and 
depression affect each other reciprocally and FD symptom mediates the influence. Food craving, 
an intense urge to eat a particular food, is more related to the restraint or deprivation of food and 
calories [54, 55] or negative emotional state [56] than to hunger. Although the role of the food 
craving in obesity and eating disorders has been well established [57], it has not yet received 
sufficient attention in FD patients. The PFC is well known for the executive functions (decision-
making, reward evaluation, associative learning, and control of eating behavior) and the inhibitory 
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regulation of craving for drug [58], smoking [59], and food [46]. In terms of craving, PFC has been 
used for transcranial direct current stimulation to reduce food craving and calorie intake [60, 61]. 
Its activity increased more dramatically in the bulimia nervosa patients than in either healthy 
controls or binge eating disorder patients [62]. With mediation analysis results, it is plausible that 
the long-term experience of FD symptoms and consequent dietary restriction lead to higher food 
craving, and that craving disrupts the functional demands of the PFC indirectly, with depression as 
a mediator.  
Nausea and the occipital cortex  
The amplitude of functional connectivity between the insula and the inferior occipital gyrus 
negatively correlated with the nausea ratings after food ingestion. FD patients suffered from higher 
nausea symptom than HC and they reported more pronounced nausea after ingestion of high fat 
yogurt than of low fat yogurt (statistically not significant). The occipital cortex is one of the most 
frequently reported brain areas in other functional neuroimaging studies in FD patients [21]. 
However, the underlying cause of the functional change in the occipital cortex in patients remains 
unclear. Previous studies showed that a visually induced nausea correlated with the occipital gyrus 
activity [63] and that a gastric electrical stimulation with an anti-emesis effect increased the brain 
activity in the occipital cortex [64]. The occipital gyrus is presumably affected by the food-induced 
nausea as well as by visually induced nausea. A study on the food-induced nausea and the occipital 
cortex activity would provide insight into the central mechanisms of nausea in patients.  
In summary, our results showed the placebo/nocebo effect of fat information, the reward 
cue- related change of functional connectivity of the insula-precuneus, the food craving-induced 
activity in the PFC, and nausea-related functional connectivity of the insula-occipital cortex. These 
results provide further important information about the underlying mechanism of brain activities 
concerned with somatic symptoms and psychological factors in FD patients. Limitations are a 
 
 
105 
relatively small sample size and the food used in the study. Various food items were avoided or 
preferred by FD patients and the unusual environment of MRI restricted the choice of the test meal. 
Yogurt was selected since it had already proved successful in inducing FD symptoms in patients 
in an earlier study, and because its fat composition is familiar to the participants and easily 
modulated. However, patients suffering from lactose intolerance were unable to participate. Larger 
sized studies are required to comprehend the central mechanisms of responses to food in FD 
patients.   
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Conclusion 
Individuals with FD have latent impairments in their cognitive perception of high fat food, 
altered activity of the PFC, occipital cortex, and impaired connectivity between the insula and 
occipital cortex, precuneus. Intensity of intrinsic FD symptom, food craving and depression, food-
induced nausea symptom correlated with abnormal brain activities in patients. Cognitive perception 
of fat, food craving, depression, and altered brain functions as well as the somatic symptoms should 
be deemed important pathological characteristics of FD.  
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Figures and figure legends  
Figure 1 Study procedure 
 
Schematic illustration of the study procedure with timeline. Following an overnight fast the study 
commenced in the morning (7-11AM). Baseline (Pre-VAS) and three subsequent dyspeptic 
symptoms after ingestion (Post1, 2, 3-VAS) were assessed every 10 minutes using visual analogue 
scale.  
BOLD: Blood oxygen level-dependent contrast imaging; T1: T1-weighted image for structure 
imaging; min: minutes; Post-: after yogurt ingestion; Pre-: before yogurt ingestion; VAS: visual 
analogue scale  
 
Figure 2 Seed-based FC analysis 
 
Effects of fat and fat information on functional connectivity between the left insula and the right 
insula, left inferior occipital gyrus, and between the right insula and the bilateral precuneus. (A) 
High fat yogurts (HH, HL) increased the functional connectivity of the left insula to the left inferior 
occipital gyrus and the right insula, while low fat yogurts (LH, LL) reduced the strength of identical 
connections after ingestion (p<0.05) in FD patients. (B) Low fat-labeled yogurts (HL, LL) 
increased the functional connectivity of the right insula to the bilateral precuneus in FD patients, 
while the identical connections decreased in healthy controls (p<0.05). Family-wise error-corrected, 
cluster dimension k>10 voxels.  
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inf.: inferior; FD: functional dyspepsia; HC: healthy controls; HH: high fat yogurt with high fat 
label; HL: high fat yogurt with low fat label; LH: low fat yogurt with high fat label; LL: low fat 
yogurt with low fat label; post-: after yogurt ingestion; pre-: before yogurt ingestion;  
 
Figure 3 Conceptual diagram of mediation analysis 
 
A. Conceptual diagram of mediation analysis model with one mediator as used in this study. Total 
effect of X on Y (c) = indirect effect of X on Y through M (ab) + direct effect of X on Y (c’). B. 
Model 1: FD_QOL (X), FD_Symptom (M), depression (Y); Model 2: depression (X), 
FD_Symptom (M), FD_QOL (Y); Model 3: food craving (X), resting state brain activity in left 
middle frontal gyrus before eating yogurt (Y), depression (M). Path coefficients with p values (*, 
**, ***: p<0.05, <0.01, <0.001, respectively). 
 ALFF: amplitude of low frequency fluctuations; FD: functional dyspepsia; QOL: quality of life 
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Supplementary Table 1 FD symptom ratings before (baseline) and after (Post) yogurts 
ingestion 
  Baseline Post1 Post2 Post3 P value 
(ANOVA) 
Hunger HC HH 3.86±0.78 2.11±0.58 1.79±0.39 2.39±0.55 Main effect of 
time (p<0.001) HL 3.07±0.71 1.83±0.59 2.23±0.54 2.37±0.54 
LH 3.29±0.79 1.89±0.44 1.96±0.46 2.18±0.48 
LL 3.03±0.81 1.83±0.66 2.23±0.71 2.70±0.73 
FD HH 5.85±0.98 2.50±0.63 2.69±0.76 3.71±0.75 
HL 4.50±0.92 2.45±0.74 3.23±1.01 3.09±0.95 
LH 4.79±0.85 2.96±0.61 3.33±0.82 4.29±0.82 
LL 4.38±0.98 2.77±0.83 2.88±0.79 3.46±0.80 
Appetite HC HH 3.86±0.68 3.29±0.64 2.18±0.39 2.18±0.45 Main effect of 
time (p<0.01) HL 2.83±0.66 2.17±0.55 2.03±0.48 2.13±0.45 
LH 2.96±0.81 1.46±0.41 1.65±0.42 2.00±0.42 
LL 3.70±0.81 2.40±0.71 2.64±0.72 2.67±0.66 
FD HH 5.15±0.88 3.27±0.66 2.77±0.75 3.42±0.80 
HL 3.41±0.70 2.77±0.72 3.14±1.00 3.59±0.96 
LH 3.54±0.91 3.54±0.81 3.63±0.93 4.42±0.99 
LL 4.62±0.93 3.88±0.92 3.15±0.81 4.17±0.76 
Fullness HC HH 0.61±0.27 1.64±0.63 1.89±0.69 1.68±0.71 Main effect of 
group (FD>HC, 
p<0.01), time 
(p<0.001)  
HL 0.43±0.33 1.80±0.58 1.80±0.56 1.50±0.45 
LH 0.75±0.39 1.89±0.68 1.75±0.57 1.39±0.50 
LL 0.83±0.36 1.47±0.58 1.20±0.49 1.30±0.40 
FD HH 2.27±0.68 3.00±0.59 2.69±0.67 2.38±0.47 
HL 1.64±0.60 4.09±0.85 2.82±0.72 2.95±0.74 
LH 1.79±0.72 3.63±0.89 4.54±0.81 4.25±0.87 
LL 1.42±0.45 3.73±0.77 2.77±0.70 2.54±0.46 
Satiation HC HH 1.50±0.41 3.14±0.85 2.93±0.80 3.39±0.93 Main effect of 
time (p<0.001) HL 2.20±0.91 3.87±0.80 3.27±0.93 3.20±0.88 
LH 1.86±0.76 3.14±0.94 2.79±0.80 2.54±0.72 
LL 1.77±0.69 3.10±0.77 2.60±0.77 2.47±0.71 
FD HH 2.31±0.83 3.62±0.57 3.58±0.70 3.21±0.84 
HL 1.36±0.51 3.73±0.89 2.86±0.71 2.91±0.75 
LH 1.46±0.43 4.71±0.82 4.38±0.72 4.88±0.85 
LL 1.88±0.66 4.04±0.90 3.77±0.97 2.63±0.61 
Abdominal 
pain 
HC HH 0.25±0.10 0.21±0.09 0.18±0.07 0.21±0.10 Main effect of 
group (FD>HC, 
p<0.001), label 
(high>low, 
p<0.05) 
HL 0.13±0.06 0.07±0.05 0.10±0.05 0.07±0.05 
LH 0.18±0.08 0.21±0.11 0.18±0.08 0.11±0.06 
LL 0.13±0.08 0.13±0.06 0.17±0.06 0.13±0.08 
FD HH 2.35±0.95 1.15±0.36 1.65±0.45 1.17±0.34 
HL 1.36±057 0.91±0.41 1.27±0.61 1.45±0.62 
LH 0.88±044 1.08±0.44 1.17±0.32 1.58±0.31 
LL 1.42±0.76 1.35±0.74 1.31±0.75 0.54±0.24 
HC HH 0.25±0.09 0.32±0.15 0.36±0.17 0.39±0.20 
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Abdominal 
discomfort 
HL 0.20±0.11 0.23±0.14 0.20±0.14 0.20±0.14 Main effect of 
group (FD>HC, 
p<0.001), label 
(high fat>low fat, 
p<0.01), 
interaction of 
group*label 
(p<0.05) 
LH 0.25±0.11 0.32±0.17 0.21±0.10 0.25±0.15 
LL 0.30±0.14 0.30±0.14 0.20±0.08 0.17±0.11 
FD HH 3.38±0.92 2.77±0.60 2.73±0.84 1.75±0.53 
HL 3.09±0.93 1.73±0.60 2.09±0.79 1.95±0.82 
LH 2.42±0.76 2.50±0.78 2.21±0.51 2.96±0.62 
LL 2.38±0.86 1.62±0.79 1.85±0.79 1.17±0.45 
Burning HC HH 0.32±0.11 0.25±0.09 0.14±0.06 0.18±0.08 Main effect of 
group (FD>HC, 
p<0.001), label 
(high fat>low 
fat), time 
(p<0.05) 
HL 0.13±0.06 0.07±0.05 0.10±0.05 0.10±0.05 
LH 0.32±012 0.29±0.13 0.18±0.08 0.18±0.08 
LL 0.30±0.14 0.23±0.10 0.20±0.08 0.13±0.08 
FD HH 1.46±0.60 1.08±0.55 1.15±0.50 1.63±0.70 
HL 2.18±0.95 1.27±0.60 1.18±0.62 1.36±0.73 
LH 2.46±0.90 1.46±0.60 1.67±0.52 1.92±0.63 
LL 2.15±1.02 1.12±0.74 1.31±0.73 0.50±0.16 
Bloating HC HH 0.29±0.09 0.29±0.11 0.25±0.10 0.29±0.13 Main effect of 
group (FD>HC, 
p<0.001) 
HL 0.13±0.06 0.07±0.05 0.10±0.05 0.13±0.08 
LH 0.36±0.13 0.29±0.13 0.25±0.10 0.29±0.10 
LL 0.37±0.14 0.27±0.11 0.23±0.08 0.20±0.10 
FD HH 1.88±0.68 1.85±0.54 2.23±0.74 2.17±0.79 
HL 1.91±0.56 1.91±0.51 1.73±0.57 1.82±0.53 
LH 1.58±0.68 1.46±0.47 1.29±0.36 2.04±0.68 
LL 1.96±0.88 1.96±0.82 1.69±0.86 0.96±0.43 
Nausea HC HH 0.21±0.09 0.25±0.11 0.18±0.08 0.18±0.08 Main effect of 
group (FD>HC, 
p<0.001) 
HL 0.10±0.05 0.07±0.05 0.13±0.10 0.07±0.05 
LH 0.21±0.43 0.25±0.11 0.18±0.08 0.07±0.05  
LL 0.13±0.08 0.60±0.53 0.53±0.43 0.10±0.05 
FD HH 2.81±0.99 1.31±0.54 1.69±0.80 0.79±0.24 
HL 1.64±0.76 1.14±0.64 1.00±0.50 1.09±0.63 
LH 0.83±0.37 0.42±0.12 1.00±0.32 0.75±0.29 
LL 1.08±0.75 1.50±0.74 1.46±0.79 1.58±0.48 
Vomiting HC HH 0.18±0.08 0.21±0.09 0.18±0.08 0.18±0.08 Main effect of 
group (FD>HC, 
p<0.001) 
HL 0.13±0.06 0.07±0.05 0.07±0.05 0.07±0.05 
LH 0.21±0.09 0.18±0.08 0.18±0.08 0.11±0.06 
LL 0.13±0.08 0.13±0.06 0.10±0.05 0.11±0.06 
FD HH 1.23±0.78 1.38±0.64 1.54±0.81 0.71±0.30 
HL 1.23±0.76 1.00±0.64 1.00±0.48 0.86±0.52 
LH 0.50±0.19 0.50±0.21 0.79±0.23 0.54±0.16 
LL 1.62±0.83 1.38±0.80 1.46±0.78 0.92±0.41 
Mean±standard error 
ANOVA: analysis of variance; Baseline: baseline VAS rating before ingestion; FD: functional 
dyspepsia patients; HC: healthy controls; HH: high fat yogurt with high fat label; HL: high fat 
yogurt with low fat label; LH: low fat yogurt with high fat label; LL: low fat yogurt with low fat 
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label; Post1: VAS rating immediately after ingestion; Post2: VAS rating 10 minutes after ingestion; 
Post3: VAS rating 20 minutes after ingestion 
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9. Conclusion and future direction  
 In functional dyspepsia, we observed 1) the absence of previous studies on neural 
mechanisms of food-related tasks or food-related psychological factors, 2) higher food craving 
scores but a reduced amount of food intake from standard breakfast compared to healthy controls, 
3) lower pleasantness and total visual attention time to food images compared to healthy controls, 
4) placebo/nocebo effects of fat label on dyspeptic symptoms, in both high fat or low fat food 
ingestion sessions, and 5) altered resting state brain activities and functional connectivity in the 
prefrontal cortex, occipital cortex, insula, and precuneus and their associations with dyspeptic 
symptoms and psychological factors. The effectiveness of conventional treatments and basic 
researches for functional dyspepsia might be improved by dietary consultation and modification of 
their distorted perception of food. This will require the expansion of our conventional perspective 
of functional dyspepsia, from the peripheral gastrointestinal tracts to the mental process of and 
behavioral response to food. 
 
Future studies  
We propose future studies according to the following categories: studies on 1) the new 
knowledge of basic mechanisms, 2) the understanding of psychology and placebo/nocebo effects, 
and 3) clinical diagnosis and therapy in functional dyspepsia patients. 
Although we did not find that the effect of high fat food triggered the dyspeptic symptom 
in patients, the effect of nutritional factors on the dyspeptic symptom development needs to be 
tested with further food types. Since symptoms related to different types of food or nutrients may 
be different in each patient, individualized items should be tested in future studies to gain results 
that are closer to the reality. To achieve this goal, we will require well-structured interviews and 
validated questionnaires for clinicians and researchers. Future studies on the neuronal mechanisms 
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on the evaluation, perception, processing of food and behavioral responses to food are necessary 
to unravel the pathophysiology of functional dyspepsia. How patients perceive, encode, store, and 
recall the value of food and how negative experience of previous food-induced suffering influences 
their food decision and eating behavior could be investigated using functional neuroimaging 
techniques and physiological measurements during food-related tasks.  
It would also be worthwhile to study the effect of the food consumption on the composition 
of microbiota and their contribution to the gastric symptoms. The role of microbiota in the 
abnormal function of the brain-gut axis is still unclear despite the wide use of probiotics or 
antibiotics in irritable bowel syndrome patients. Gastric microbiota and fecal microbiota 
transplantation have been investigated in functional dyspepsia only in the last few years [152, 153]. 
Various approaches including studies on microbiomics [154], efficacy and mechanisms of 
probiotics, antibiotics, and fecal microbiota transplantation, changes of emotional, cognitive, and 
behavioral response to food or other external stimuli (social stress, pain), individualized screening 
and medication using microbiota may be a revolution in the functional dyspepsia research. 
Another valuable approach is to investigate the efficacy and brain mechanisms of the 
placebo treatment using low fat label on food to relieve the dyspeptic symptoms in patients. Apart 
from the fact that there is no standard treatment guideline for functional dyspepsia patients, the 
only intervention whose neuronal mechanism has been studied so far is acupuncture [155, 156]. If 
the placebo treatment really works in functional dyspepsia patients, its peripheral and neuronal 
mechanisms may promote the development of new treatment for functional dyspepsia.  
We also discovered a new psychological factor which might be important in the 
pathophysiology of functional dyspepsia: craving for food. Despite increased food craving when 
fasting, functional dyspepsia patients ate smaller amounts of food compared to healthy controls 4. 
Furthermore, food craving significantly affected the resting state activity in the middle frontal gyrus 
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in functional dyspepsia patients, but not in healthy controls. Besides the abnormal responses to 
external painful stimuli, (e.g., barostat distension) and the effects of anxiety and depression, the 
physiological cause and effect of increased food craving score in functional dyspepsia patients need 
to be replicated and further investigated in large-scale studies.  
Objective outcomes from functional neuroimaging studies, screening of the composition of 
microbiota, well-structured interview about eating behavior and cognitive processes of food may 
improve the current diagnosis. To improve existing treatments for functional dyspepsia, the 
efficacy, safety, and protocol of psychotherapies with the manipulation of eating behavior, 
consultation of food choice, and modification of negative response to food should be defined. 
Moreover, placebo treatments using symptom relief cues, e.g., low fat label, symptom-independent 
nutrients, elimination or supplement of microbiota, or placebo tools (which are similar or identical 
to the treatment appliances without any actual effects) need to be tested.  
  
 
119 
 
10. Acknowledgements  
I would like to express my gratitude to Prof. Dr. Paul Enck and Prof. Dr. Hubert Preissl for 
their support and patient supervision. They guided me throughout my PhD and encouraged me 
whenever I faced difficulties. I owe to them everything that I know about psychology and 
neuroscience. I also learned how to write a manuscript, give a good scientific presentation, and 
how to be patient and steady in research. 
I am very thankful to the members of the Psychosomatic Medicine and Psychotherapy 
department and fMEG center. They shared their ideas and experimental techniques, and also spent 
time and labor for my PhD studies. Their considerable and motivating criticism improved the 
studies enormously.  
I am grateful to the Graduate Training Centre of Neuroscience in Tübingen for their 
financial and administrative support. I am also extremely grateful to all the participants of my 
studies. Particularly the functional magnetic resonance imaging study was challenging for me as 
an experimenter, would not have been possible without their cooperation. 
Lastly, I would like to thank my family for their encouragement and emotional support. 
Their trust gave me confidence and allowed me to grow professionally. Most importantly, their 
love made me love my life more than ever before.  
  
 
120 
 
11. References 
1. Tack, J., et al., Functional gastroduodenal disorders. Gastroenterology, 2006. 130(5): p. 1466-79. 
2. Drossman, D.A. and D.L. Dumitrascu, Rome III: New standard for functional gastrointestinal 
disorders. J Gastrointestin Liver Dis, 2006. 15(3): p. 237-41. 
3. Mahadeva, S. and K.L. Goh, Epidemiology of functional dyspepsia: a global perspective. World J 
Gastroenterol, 2006. 12(17): p. 2661-6. 
4. El-Serag, H.B. and N.J. Talley, Systemic review: the prevalence and clinical course of functional 
dyspepsia. Aliment Pharmacol Ther, 2004. 19(6): p. 643-54. 
5. Lacy, B.E., et al., Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther, 
2013. 38(2): p. 170-7. 
6. Moayyedi, P. and J. Mason, Clinical and economic consequences of dyspepsia in the community. 
Gut, 2002. 50 Suppl 4: p. iv10-2. 
7. Van Oudenhove, L., et al., Risk factors for impaired health-related quality of life in functional 
dyspepsia. Aliment Pharmacol Ther, 2011. 33(2): p. 261-74. 
8. Drossman, D.A., et al., Rome IV Functional Gastrointestinal Disorders: Disorders of Gut-Brain 
Interaction. 4th ed. 2017, Raleigh, NC: Rome Foundation. 
9. Douglas A. Drossman, et al., ROME III: The Functional Gastrointestinal Disorders. 3rd ed. 2006: 
Yale University Section of Digestive Disease: Degnon Associates. 
10. Piessevaux, H., et al., Dyspeptic symptoms in the general population: a factor and cluster analysis 
of symptom groupings. Neurogastroenterol Motil, 2009. 21(4): p. 378-88. 
11. Keohane, J. and E.M. Quigley, Functional dyspepsia and nonerosive reflux disease: clinical 
interactions and their implications. MedGenMed, 2007. 9(3): p. 31. 
12. Pleyer, C., et al., Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of 
functional dyspepsia in a USA community. Neurogastroenterol Motil, 2014. 26(8): p. 1163-71. 
13. Corsetti, M., et al., Impact of coexisting irritable bowel syndrome on symptoms and 
pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol, 2004. 99(6): p. 
1152-9. 
14. Ford, A.C., et al., Systematic review and meta-analysis of the prevalence of irritable bowel 
syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol, 2010. 8(5): p. 401-9. 
15. Drossman, D.A., et al., Identification of subgroups of functional bowel disorders. Gastroenterol 
Int. 1990;3:159–172. Gastroenterol Int, 1990. 3: p. 159-172. 
16. Drossman, D.A., et al., The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, 
and Treatment. A Multinational Consensus. 1994, Boston: Little Brown & Co. 
17. Drossman, D.A., et al., Rome II: A multinational consensus document on functional 
gastrointestinal disorders. Gut, 1999. 45(suppl II): p. 1–81. 
18. Bisschops, R., et al., Relationship between symptoms and ingestion of a meal in functional 
dyspepsia. Gut, 2008. 57(11): p. 1495-503. 
19. Spiegel, B.M., et al., Measuring symptoms in the irritable bowel syndrome: development of a 
framework for clinical trials. Aliment Pharmacol Ther, 2010. 32(10): p. 1275-91. 
20. Brun, R. and B. Kuo, Functional dyspepsia. Therap Adv Gastroenterol, 2010. 3(3): p. 145-64. 
21. Talley, N.J., M. Verlinden, and M. Jones, Validity of a new quality of life scale for functional 
dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol, 
1999. 94(9): p. 2390-7. 
22. Talley, N.J., et al., Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. 
Aliment Pharmacol Ther, 1999. 13(2): p. 225-35. 
 
121 
 
23. Talley, N.J., M. Verlinden, and M. Jones, Quality of life in functional dyspepsia: responsiveness of 
the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol 
Ther, 2001. 15(2): p. 207-16. 
24. Moayyedi, P., et al., The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence 
and severity of dyspepsia. Aliment Pharmacol Ther, 1998. 12(12): p. 1257-62. 
25. Hu, W.H., et al., The Hong Kong index of dyspepsia: a validated symptom severity questionnaire 
for patients with dyspepsia. J Gastroenterol Hepatol, 2002. 17(5): p. 545-51. 
26. Lee, E.H., et al., Development and validation of a functional dyspepsia-related quality of life (FD-
QOL) scale in South Korea. J Gastroenterol Hepatol, 2006. 21(1 Pt 2): p. 268-74. 
27. Carbone, F., et al., Validation of the Leuven Postprandial Distress Scale, a questionnaire for 
symptom assessment in the functional dyspepsia/postprandial distress syndrome. Aliment 
Pharmacol Ther, 2016. 44(9): p. 989-1001. 
28. el-Omar, E.M., et al., The Glasgow Dyspepsia Severity Score--a tool for the global measurement 
of dyspepsia. Eur J Gastroenterol Hepatol, 1996. 8(10): p. 967-71. 
29. Fujikawa, Y., et al., Postprandial Symptoms Felt at the Lower Part of the Epigastrium and a 
Possible Association of Pancreatic Exocrine Dysfunction with the Pathogenesis of Functional 
Dyspepsia. Intern Med, 2017. 56(13): p. 1629-1635. 
30. Vanheel, H., et al., Pathophysiological Abnormalities in Functional Dyspepsia Subgroups 
According to the Rome III Criteria. Am J Gastroenterol, 2017. 112(1): p. 132-140. 
31. Khodarahmi, M. and L. Azadbakht, Dietary fat intake and functional dyspepsia. Adv Biomed Res, 
2016. 5: p. 76. 
32. Goktas, Z., et al., Nutritional habits in functional dyspepsia and its subgroups: a comparative 
study. Scand J Gastroenterol, 2016. 51(8): p. 903-7. 
33. Fried, M. and C. Feinle, The role of fat and cholecystokinin in functional dyspepsia. Gut, 2002. 51 
Suppl 1: p. i54-7. 
34. Van Oudenhove, L. and Q. Aziz, The role of psychosocial factors and psychiatric disorders in 
functional dyspepsia. Nat Rev Gastroenterol Hepatol, 2013. 10(3): p. 158-67. 
35. Mearin, F., et al., The origin of symptoms on the brain-gut axis in functional dyspepsia. 
Gastroenterology, 1991. 101(4): p. 999-1006. 
36. Lee, I.S., et al., Functional neuroimaging studies in functional dyspepsia patients: a systematic 
review. Neurogastroenterol Motil, 2016. 28(6): p. 793-805. 
37. Gathaiya, N., et al., Novel associations with dyspepsia: a community-based study of familial 
aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil, 2009. 21(9): p. 922-
e69. 
38. Holtmann, G., et al., G-protein beta 3 subunit 825 CC genotype is associated with unexplained 
(functional) dyspepsia. Gastroenterology, 2004. 126(4): p. 971-9. 
39. Shimpuku, M., et al., G-protein beta3 subunit 825CC genotype is associated with postprandial 
distress syndrome with impaired gastric emptying and with the feeling of hunger in Japanese. 
Neurogastroenterol Motil, 2011. 23(12): p. 1073-80. 
40. Singh, R., B. Mittal, and U.C. Ghoshal, Functional dyspepsia is associated with GNbeta3 C825T 
and CCK-AR T/C polymorphism. Eur J Gastroenterol Hepatol, 2016. 28(2): p. 226-32. 
41. Dal, K., et al., Decreased parasympathetic activity in patients with functional dyspepsia. Eur J 
Gastroenterol Hepatol, 2014. 26(7): p. 748-52. 
42. Lorena, S.L., et al., Autonomic function in patients with functional dyspepsia assessed by 24-hour 
heart rate variability. Dig Dis Sci, 2002. 47(1): p. 27-31. 
43. Park, D.I., et al., Role of autonomic dysfunction in patients with functional dyspepsia. Dig Liver 
Dis, 2001. 33(6): p. 464-71. 
44. Stanghellini, V., et al., Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer 
dyspepsia. Gut, 1992. 33(2): p. 184-90. 
 
122 
 
45. Salet, G.A., et al., Responses to gastric distension in functional dyspepsia. Gut, 1998. 42(6): p. 
823-9. 
46. Stanghellini, V., et al., Risk indicators of delayed gastric emptying of solids in patients with 
functional dyspepsia. Gastroenterology, 1996. 110(4): p. 1036-42. 
47. Gilja, O.H., et al., Impaired accommodation of proximal stomach to a meal in functional 
dyspepsia. Dig Dis Sci, 1996. 41(4): p. 689-96. 
48. Tack, J., et al., Role of impaired gastric accommodation to a meal in functional dyspepsia. 
Gastroenterology, 1998. 115(6): p. 1346-52. 
49. Piessevaux, H., et al., Intragastric distribution of a standardized meal in health and functional 
dyspepsia: correlation with specific symptoms. Neurogastroenterol Motil, 2003. 15(5): p. 447-55. 
50. Castillo, E.J., et al., A community-based, controlled study of the epidemiology and 
pathophysiology of dyspepsia. Clin Gastroenterol Hepatol, 2004. 2(11): p. 985-96. 
51. Bredenoord, A.J., et al., Gastric accommodation and emptying in evaluation of patients with 
upper gastrointestinal symptoms. Clin Gastroenterol Hepatol, 2003. 1(4): p. 264-72. 
52. Kindt, S. and J. Tack, Impaired gastric accommodation and its role in dyspepsia. Gut, 2006. 
55(12): p. 1685-91. 
53. Geeraerts, B., et al., Influence of experimentally induced anxiety on gastric sensorimotor function 
in humans. Gastroenterology, 2005. 129(5): p. 1437-44. 
54. Quartero, A.O., et al., Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-
analysis. Dig Dis Sci, 1998. 43(9): p. 2028-33. 
55. Konturek, S.J., et al., Cholecystokinin in the inhibition of gastric secretion and gastric emptying in 
humans. Digestion, 1990. 45(1): p. 1-8. 
56. Perri, F., et al., Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection 
and delayed gastric emptying. Am J Gastroenterol, 1998. 93(11): p. 2082-8. 
57. Sarnelli, G., et al., Symptoms associated with impaired gastric emptying of solids and liquids in 
functional dyspepsia. Am J Gastroenterol, 2003. 98(4): p. 783-8. 
58. Tack, J., et al., Symptoms associated with hypersensitivity to gastric distention in functional 
dyspepsia. Gastroenterology, 2001. 121(3): p. 526-35. 
59. Farre, R., et al., In functional dyspepsia, hypersensitivity to postprandial distention correlates with 
meal-related symptom severity. Gastroenterology, 2013. 145(3): p. 566-73. 
60. Lemann, M., et al., Abnormal perception of visceral pain in response to gastric distension in 
chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci, 1991. 36(9): p. 1249-
54. 
61. Vandenberghe, J., et al., Regional cerebral blood flow during gastric balloon distention in 
functional dyspepsia. Gastroenterology, 2007. 132(5): p. 1684-93. 
62. Van Oudenhove, L., et al., Abnormal regional brain activity during rest and (anticipated) gastric 
distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J 
Gastroenterol, 2010. 105(4): p. 913-24. 
63. Van Oudenhove, L., et al., Regional brain activity in functional dyspepsia: a H(2)(15)O-PET study 
on the role of gastric sensitivity and abuse history. Gastroenterology, 2010. 139(1): p. 36-47. 
64. Samsom, M., et al., Abnormal clearance of exogenous acid and increased acid sensitivity of the 
proximal duodenum in dyspeptic patients. Gastroenterology, 1999. 116(3): p. 515-20. 
65. Schwartz, M.P., M. Samsom, and A.J. Smout, Chemospecific alterations in duodenal perception 
and motor response in functional dyspepsia. Am J Gastroenterol, 2001. 96(9): p. 2596-602. 
66. Barbera, R., C. Feinle, and N.W. Read, Abnormal sensitivity to duodenal lipid infusion in patients 
with functional dyspepsia. Eur J Gastroenterol Hepatol, 1995. 7(11): p. 1051-7. 
67. Bjornsson, E., et al., Effects of duodenal lipids on gastric sensitivity and relaxation in patients with 
ulcer-like and dysmotility-like dyspepsia. Digestion, 2003. 67(4): p. 209-17. 
 
123 
 
68. Verne, G.N., M.E. Robinson, and D.D. Price, Hypersensitivity to visceral and cutaneous pain in the 
irritable bowel syndrome. Pain, 2001. 93(1): p. 7-14. 
69. Bharucha, A.E., et al., Increased nutrient sensitivity and plasma concentrations of enteral 
hormones during duodenal nutrient infusion in functional dyspepsia. Am J Gastroenterol, 2014. 
109(12): p. 1910-20; quiz 1909, 1921. 
70. Barbera, R., C. Feinle, and N.W. Read, Nutrient-specific modulation of gastric mechanosensitivity 
in patients with functional dyspepsia. Dig Dis Sci, 1995. 40(8): p. 1636-41. 
71. Feinle, C., et al., Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of 
functional dyspepsia. Gut, 2001. 48(3): p. 347-55. 
72. Pilichiewicz, A.N., et al., Functional dyspepsia is associated with a greater symptomatic response 
to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J 
Gastroenterol, 2008. 103(10): p. 2613-23. 
73. Lee, K.J., et al., A pilot study on duodenal acid exposure and its relationship to symptoms in 
functional dyspepsia with prominent nausea. Am J Gastroenterol, 2004. 99(9): p. 1765-73. 
74. Quigley, E.M., Review article: gastric emptying in functional gastrointestinal disorders. Aliment 
Pharmacol Ther, 2004. 20 Suppl 7: p. 56-60. 
75. Shinomiya, T., et al., Plasma acylated ghrelin levels correlate with subjective symptoms of 
functional dyspepsia in female patients. Scand J Gastroenterol, 2005. 40(6): p. 648-53. 
76. Shindo, T., et al., Comparison of gastric emptying and plasma ghrelin levels in patients with 
functional dyspepsia and non-erosive reflux disease. Digestion, 2009. 79(2): p. 65-72. 
77. Akamizu, T., et al., Repeated administration of ghrelin to patients with functional dyspepsia: its 
effects on food intake and appetite. Eur J Endocrinol, 2008. 158(4): p. 491-8. 
78. Chua, A.S., et al., Cholecystokinin hyperresponsiveness in dysmotility-type nonulcer dyspepsia. 
Ann N Y Acad Sci, 1994. 713: p. 298-9. 
79. Tucci, A., et al., Helicobacter pylori infection and gastric function in patients with chronic 
idiopathic dyspepsia. Gastroenterology, 1992. 103(3): p. 768-74. 
80. Suzuki, H. and P. Moayyedi, Helicobacter pylori infection in functional dyspepsia. Nat Rev 
Gastroenterol Hepatol, 2013. 10(3): p. 168-74. 
81. Sarnelli, G., et al., Symptom patterns and pathophysiological mechanisms in dyspeptic patients 
with and without Helicobacter pylori. Dig Dis Sci, 2003. 48(12): p. 2229-36. 
82. Moayyedi, P., et al., An update of the Cochrane systematic review of Helicobacter pylori 
eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. 
Am J Gastroenterol, 2003. 98(12): p. 2621-6. 
83. Du, L.J., et al., Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review 
and meta-analysis. World J Gastroenterol, 2016. 22(12): p. 3486-95. 
84. Mearin, F., et al., Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis 
outbreak: one-year follow-up cohort study. Gastroenterology, 2005. 129(1): p. 98-104. 
85. Futagami, S., T. Itoh, and C. Sakamoto, Systematic review with meta-analysis: post-infectious 
functional dyspepsia. Aliment Pharmacol Ther, 2015. 41(2): p. 177-88. 
86. Kindt, S., et al., Intestinal immune activation in presumed post-infectious functional dyspepsia. 
Neurogastroenterol Motil, 2009. 21(8): p. 832-e56. 
87. Futagami, S., et al., Migration of eosinophils and CCR2-/CD68-double positive cells into the 
duodenal mucosa of patients with postinfectious functional dyspepsia. Am J Gastroenterol, 2010. 
105(8): p. 1835-42. 
88. Talley, N.J., et al., Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic 
population-based case-control study. Clin Gastroenterol Hepatol, 2007. 5(10): p. 1175-83. 
89. Vanheel, H., et al., Impaired duodenal mucosal integrity and low-grade inflammation in 
functional dyspepsia. Gut, 2014. 63(2): p. 262-71. 
 
124 
 
90. Walker, M.M., et al., Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as 
possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment 
Pharmacol Ther, 2009. 29(7): p. 765-73. 
91. Wang, X., et al., Quantitative evaluation of duodenal eosinophils and mast cells in adult patients 
with functional dyspepsia. Ann Diagn Pathol, 2015. 19(2): p. 50-6. 
92. Li, X., et al., The study on the role of inflammatory cells and mediators in post-infectious 
functional dyspepsia. Scand J Gastroenterol, 2010. 45(5): p. 573-81. 
93. Lee, S., et al., Stress, coping, and depression in non-ulcer dyspepsia patients. J Psychosom Res, 
2000. 49(1): p. 93-9. 
94. Cheng, C., W.M. Hui, and S.K. Lam, Coping style of individuals with functional dyspepsia. 
Psychosom Med, 1999. 61(6): p. 789-95. 
95. Jones, M.P., L.K. Sharp, and M.D. Crowell, Psychosocial correlates of symptoms in functional 
dyspepsia. Clin Gastroenterol Hepatol, 2005. 3(6): p. 521-8. 
96. Locke, G.R., 3rd, et al., Psychosocial factors are linked to functional gastrointestinal disorders: a 
population based nested case-control study. Am J Gastroenterol, 2004. 99(2): p. 350-7. 
97. Koloski, N.A., N.J. Talley, and P.M. Boyce, A history of abuse in community subjects with irritable 
bowel syndrome and functional dyspepsia: the role of other psychosocial variables. Digestion, 
2005. 72(2-3): p. 86-96. 
98. Ochi, M., et al., Perfectionism underlying psychological background correlated with the 
symptoms of functional dyspepsia. J Gastroenterol, 2008. 43(9): p. 699-704. 
99. Talley, N.J., et al., Relation among personality and symptoms in nonulcer dyspepsia and the 
irritable bowel syndrome. Gastroenterology, 1990. 99(2): p. 327-33. 
100. Jain, A.K., et al., Neuroticism and stressful life events in patients with non-ulcer dyspepsia. J Assoc 
Physicians India, 1995. 43(2): p. 90-1. 
101. Van Oudenhove, L., et al., Abuse history, depression, and somatization are associated with 
gastric sensitivity and gastric emptying in functional dyspepsia. Psychosom Med, 2011. 73(8): p. 
648-55. 
102. Ly, H.G., et al., Acute Anxiety and Anxiety Disorders Are Associated With Impaired Gastric 
Accommodation in Patients With Functional Dyspepsia. Clin Gastroenterol Hepatol, 2015. 13(9): 
p. 1584-91 e3. 
103. Fischler, B., et al., Heterogeneity of symptom pattern, psychosocial factors, and 
pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology, 2003. 124(4): 
p. 903-10. 
104. Taggart, D. and B.P. Billington, Fatty foods and dyspersia. Lancet, 1966. 2(7461): p. 465-6. 
105. Crum, A.J., et al., Mind over milkshakes: mindsets, not just nutrients, determine ghrelin response. 
Health Psychol, 2011. 30(4): p. 424-9; discussion 430-1. 
106. Feinle-Bisset, C., et al., Role of cognitive factors in symptom induction following high and low fat 
meals in patients with functional dyspepsia. Gut, 2003. 52(10): p. 1414-8. 
107. Furness, J.B., et al., "The enteric nervous system and gastrointestinal innervation: integrated local 
and central control." Microbial endocrinology: The microbiota-gut-brain axis in health and 
disease. 2014, New York: Springer  
108. Hansen, M.B., The enteric nervous system I: organisation and classification. Pharmacol Toxicol, 
2003. 92(3): p. 105-13. 
109. Hansen, M.B., Neurohumoral control of gastrointestinal motility. Physiol Res, 2003. 52(1): p. 1-
30. 
110. Shanahan, F., Enteric neuropathophysiology and inflammatory bowel disease. 
Neurogastroenterol Motil, 1998. 10(3): p. 185-7. 
111. Matsueda, K., et al., A placebo-controlled trial of acotiamide for meal-related symptoms of 
functional dyspepsia. Gut, 2012. 61(6): p. 821-8. 
 
125 
 
112. Xiao, G., et al., Efficacy and safety of acotiamide for the treatment of functional dyspepsia: 
systematic review and meta-analysis. ScientificWorldJournal, 2014. 2014: p. 541950. 
113. Ochoa-Reparaz, J. and L.H. Kasper, The Second Brain: Is the Gut Microbiota a Link Between 
Obesity and Central Nervous System Disorders? Curr Obes Rep, 2016. 5(1): p. 51-64. 
114. Tack, J., et al., Assessment of meal induced gastric accommodation by a satiety drinking test in 
health and in severe functional dyspepsia. Gut, 2003. 52(9): p. 1271-7. 
115. Cirillo, C., et al., Evidence for neuronal and structural changes in submucous ganglia of patients 
with functional dyspepsia. Am J Gastroenterol, 2015. 110(8): p. 1205-15. 
116. Mayer, E.A., B.D. Naliboff, and A.D. Craig, Neuroimaging of the brain-gut axis: from basic 
understanding to treatment of functional GI disorders. Gastroenterology, 2006. 131(6): p. 1925-
42. 
117. Coss-Adame, E. and S.S. Rao, Brain and gut interactions in irritable bowel syndrome: new 
paradigms and new understandings. Curr Gastroenterol Rep, 2014. 16(4): p. 379. 
118. Lee, I.S., H. Preissl, and P. Enck, How to Perform and Interpret Functional Magnetic Resonance 
Imaging Studies in Functional Gastrointestinal Disorders. J Neurogastroenterol Motil, 2017. 
23(2): p. 197-207. 
119. Konturek, S.J., et al., Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol, 
2004. 55(1 Pt 2): p. 137-54. 
120. Gaman, A. and B. Kuo, Neuromodulatory processes of the brain-gut axis. Neuromodulation, 
2008. 11(4): p. 249-259. 
121. Aro, P., et al., Anxiety Is Linked to New-Onset Dyspepsia in the Swedish Population: A 10-Year 
Follow-up Study. Gastroenterology, 2015. 148(5): p. 928-37. 
122. Koloski, N.A., et al., The brain--gut pathway in functional gastrointestinal disorders is 
bidirectional: a 12-year prospective population-based study. Gut, 2012. 61(9): p. 1284-90. 
123. Wiley, N.C., et al., The microbiota-gut-brain axis as a key regulator of neural function and the 
stress response: Implications for human and animal health. J Anim Sci, 2017. 95(7): p. 3225-3246. 
124. De Palma, G., S.M. Collins, and P. Bercik, The microbiota-gut-brain axis in functional 
gastrointestinal disorders. Gut Microbes, 2014. 5(3): p. 419-29. 
125. Simren, M., et al., Intestinal microbiota in functional bowel disorders: a Rome foundation report. 
Gut, 2013. 62(1): p. 159-76. 
126. Pilichiewicz, A.N., et al., Relationship between symptoms and dietary patterns in patients with 
functional dyspepsia. Clin Gastroenterol Hepatol, 2009. 7(3): p. 317-22. 
127. Feinle-Bisset, C. and F. Azpiroz, Dietary and lifestyle factors in functional dyspepsia. Nat Rev 
Gastroenterol Hepatol, 2013. 10(3): p. 150-7. 
128. Kearney, J., et al., Dietary intakes and adipose tissue levels of linoleic acid in peptic ulcer disease. 
Br J Nutr, 1989. 62(3): p. 699-706. 
129. Mullan, A., et al., Food and nutrient intakes and eating patterns in functional and organic 
dyspepsia. Eur J Clin Nutr, 1994. 48(2): p. 97-105. 
130. Kaess, H., M. Kellermann, and A. Castro, Food intolerance in duodenal ulcer patients, non ulcer 
dyspeptic patients and healthy subjects. A prospective study. Klin Wochenschr, 1988. 66(5): p. 
208-11. 
131. Kazemi, M., et al., Changes in serum ghrelin level in relation to meal-time in patients with 
functional dyspepsia. United European Gastroenterol J, 2015. 3(1): p. 11-6. 
132. Yamawaki, H., et al., Improvement of meal-related symptoms and epigastric pain in patients with 
functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in 
Japan. Neurogastroenterol Motil, 2016. 28(7): p. 1037-47. 
133. Amiriani, T., et al., Assessment of Gastric Accommodation in Patients with Functional Dyspepsia 
by 99mTc-Pertechtenate Single Photon Emission Computed Tomography Imaging: Practical but 
not Widely Accepted. Mol Imaging Radionucl Ther, 2015. 24(3): p. 105-9. 
 
126 
 
134. Nijs, I.M. and I.H. Franken, Attentional Processing of Food Cues in Overweight and Obese 
Individuals. Curr Obes Rep, 2012. 1(2): p. 106-113. 
135. Scaife, J.C., et al., Differential activation of the frontal pole to high vs low calorie foods: The 
neural basis of food preference in Anorexia Nervosa? Psychiatry Res, 2016. 258: p. 44-53. 
136. Wolz, I., et al., Subjective craving and event-related brain response to olfactory and visual 
chocolate cues in binge-eating and healthy individuals. Sci Rep, 2017. 7: p. 41736. 
137. Higgs, S., Cognitive processing of food rewards. Appetite, 2016. 104: p. 10-7. 
138. Lacy, B.E., et al., Review article: current treatment options and management of functional 
dyspepsia. Aliment Pharmacol Ther, 2012. 36(1): p. 3-15. 
139. Gilja, O.H., et al., Effect of glyceryl trinitrate on gastric accommodation and symptoms in 
functional dyspepsia. Dig Dis Sci, 1997. 42(10): p. 2124-31. 
140. Sarnelli, G., et al., Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol 
Gastrointest Liver Physiol, 2004. 287(5): p. G988-92. 
141. Tack, J., et al., Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric 
sensorimotor function in humans. Aliment Pharmacol Ther, 2003. 17(4): p. 603-8. 
142. Tack, J., et al., Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. 
Clin Gastroenterol Hepatol, 2012. 10(11): p. 1239-45. 
143. Mearin, F., et al., Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and 
gastric sensorial responses. Am J Gastroenterol, 1999. 94(1): p. 116-25. 
144. Enck, P., et al., The placebo response in functional dyspepsia--reanalysis of trial data. 
Neurogastroenterol Motil, 2009. 21(4): p. 370-7. 
145. Folkvord, F., et al., The role of attentional bias in the effect of food advertising on actual food 
intake among children. Appetite, 2015. 84: p. 251-8. 
146. Schwartz, G.E., S.L. Brown, and G.L. Ahern, Facial muscle patterning and subjective experience 
during affective imagery: sex differences. Psychophysiology, 1980. 17(1): p. 75-82. 
147. Lang, P.J., et al., Looking at pictures: affective, facial, visceral, and behavioral reactions. 
Psychophysiology, 1993. 30(3): p. 261-73. 
148. Liu, Y., et al., The temporal response of the brain after eating revealed by functional MRI. Nature, 
2000. 405(6790): p. 1058-62. 
149. Liu, M.L., et al., Cortical-limbic regions modulate depression and anxiety factors in functional 
dyspepsia: a PET-CT study. Ann Nucl Med, 2012. 26(1): p. 35-40. 
150. Liu, P., et al., Alterations of the default mode network in functional dyspepsia patients: a resting-
state fmri study. Neurogastroenterol Motil, 2013. 25(6): p. e382-8. 
151. Nan, J., et al., Brain-based Correlations Between Psychological Factors and Functional Dyspepsia. 
J Neurogastroenterol Motil, 2015. 21(1): p. 103-10. 
152. Nakae, H., et al., Gastric microbiota in the functional dyspepsia patients treated with probiotic 
yogurt. BMJ Open Gastroenterol, 2016. 3(1): p. e000109. 
153. Wang, J., et al., 16S rDNA Gene Sequencing Analysis in Functional Dyspepsia Treated With Fecal 
Microbiota Transplantation. J Pediatr Gastroenterol Nutr, 2017. 64(3): p. e80-e82. 
154. Wong, A.C., et al., Behavioral Microbiomics: A Multi-Dimensional Approach to Microbial Influence 
on Behavior. Front Microbiol, 2015. 6: p. 1359. 
155. Zeng, F., et al., Brain areas involved in acupuncture treatment on functional dyspepsia patients: a 
PET-CT study. Neurosci Lett, 2009. 456(1): p. 6-10. 
156. Zeng, F., et al., Influence of acupuncture treatment on cerebral activity in functional dyspepsia 
patients and its relationship with efficacy. Am J Gastroenterol, 2012. 107(8): p. 1236-47. 
 
 
